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Abstract 
Endomembranes are integral to cellular function and particularly to plant defence. 
Environmental signals are perceived and immediate signalling responses are triggered from 
the PM, but how information is effectively transduced to generate the appropriate responses 
is less well understood. Furthermore the role of endosomes in implementing these 
responses is also not well understood. Outstanding questions are the importance of 
signalling by proteins from locations other than the PM and the relevance this has to overall 
signal transduction and how do endosomes contribute to defence. The work in this Ph. D. 
focussed on the understanding the role of endosome localised signalling proteins in 
response to detection of the bacterial PAMP flagellin and the corresponding proteome 
changes occurring in endosomes following detection of bacteria as part of defence 
responses. 
 
To understand and test the role of endosomes in defence I characterised the proteomes of 
several endomembrane compartments including endosomes with an IP based method. Data 
obtained through this IP method is biologically relevant and simpler than other methods for 
preparation of endomembranes for proteomic analysis. The proteomic data was used to 
accurately predict the localisation of three members of the PRA1 RAB GTPase regulatory 
family of proteins. Furthermore this data was able to elucidate the differences in RFP-
RABF2b/ARA7 and RABF1/ARA6-RFP labelled LE/MVBs and their interaction with the TGN. 
 
Assessment of endosomal proteomes after flagellin treatment reveals a potential role for 
LE/MVB mediated secretion of flavonols in pathogen defence. Moreover, MPK cascade 
components were found in endosomal proteomes both before and after flagellin perception. 
Upon treatment, the flagellin responsive MPKs (MPK3, 4 and 6) were activated at 
endosomes and putative targets for phosphorylation by these MPKs identified. These data 
suggest endosomal signalling by MPKs occurs following flg22 treatment. Furthermore 
endosomal signalling is implicated in LE/MVB formation, cytoskeletal rearrangement and 
secretion of antimicrobial compounds. 
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1 Introduction 
Plant cells live in a constantly changing environment. Information about the developmental, 
biotic and abiotic conditions must be constantly perceived and effectively signalled to 
produce the appropriate response. If we want to effectively engineer plants to suit the needs 
of our society, we need to understand how information is perceived by plant cells and how 
signals are transduced to give an appropriate response.  
1.1 The plant immune system is an excellent model with which to 
study signalling 
Plants are constantly interacting with microbes including viruses, bacteria, fungi and 
oomycetes, as well as nematodes and insects (Agrios 1989). These interactions can be 
beneficial to the plant, for example by fungi promoting nutrient uptake, or detrimental to plant 
growth as the microbe parasitizes the plant. The interactions between plant and microbial 
pathogens can cause a variety of diseases. When a susceptible plant is successfully 
invaded by a virulent pathogen, this is known as a compatible interaction, and conversely 
when a plant is resistant through activation of defence mechanisms this is known as an 
incompatible interaction (avirulent pathogen), reviewed (Jones and Dangl 2006). 
Furthermore, when all known accessions of a species are resistant to all known accessions 
of a pathogen species, this is known as non-host resistance from the plant (Mysore and Ryu 
2004). Conversely when there are both compatible and incompatible interactions between a 
plant and a pathogen species, this is known as host resistance (Mysore and Ryu 2004). 
 
One of the major determinants of the outcome of a plant pathogen interaction is the plant 
immune system. Plants do not have mobile immune cells, as in mammals, but rather most 
cells are independently able to detect pathogens and elicit an appropriate response. 
Furthermore all immune receptors are encoded into the plant genome, like mammalian 
innate immunity (Jones and Dangl 2006). The major steps in plant immune signalling have 
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been fairly well characterised. Plants have a two layered immune system, of which the first 
layer is the pattern recognition receptors (PRRs) that detect conserved pathogen associated 
molecular patterns (PAMPs) (Dodds and Rathjen 2010). PAMPs are conserved molecules 
produced by potential microbial pathogens and detection of PAMPs by PRRs activates 
PAMP triggered immunity (PTI) (Jones and Dangl 2006). Pathogens may try and subvert 
resistance or manipulate other host processes to maximise their growth through the 
production of intra or extracellular effector proteins. The second layer of immunity utilises 
intracellular resistance proteins (R proteins) that detect the action of effectors on host 
processes, reviewed (Dodds and Rathjen 2010). Upon recognition of PAMPs or effectors 
defence signalling is activated and the plant cell must respond accordingly.  
 
PRRs fall into two general categories; those with a kinase domain or without. All 
characterised receptors have an extracellular domain, such as a leucine rich repeat (LRR) 
domain for Brassinosteroid (BR) insensitive 1 (BRI1) or lysine motif (lysM) domains for Chitin 
elicitor receptor kinase 1 (CERK1) that are involved in ligand perception (Hothorn et al. 
2011, She et al. 2011, Liu et al. 2012), two juxtamembrane regions that can have a 
regulatory role and a single transmembrane domain (TM) (Gómez-Gómez et al. 2001, Shiu 
and Bleecker 2001). Extracellular receptors with an intracellular kinase domain are called 
Receptor Like Kinases (RLKs) or if they lack the kinase domain are known as Receptor Like 
Proteins (RLPs) (Shiu and Bleecker 2001).A. thaliana potentially has over 610 RLKs which 
aretransmembrane proteins, representing almost 2.5% of protein coding sequences (Shiu 
and Bleecker 2001). Yet very few (<20) have characterised ligands, or indeed roles within 
the cell (Monaghan and Zipfel 2012, Butenko et al. 2014).  
 
RLKs and RLPs are involved in development, such as Clavata 1 (CLV1), CLV2, Coryne 
(CRN) (Clark et al. 1995, Kayes and Clark 1998, Bleckmann et al. 2010), BRI1 (Clouse et al. 
1996) and Feronia (FER) (Escobar-Restrepo et al. 2007, Duan et al. 2010), as well as 
defence (reviewed (Monaghan and Zipfel 2012). Linear pathways are of course, an 
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oversimplification as there are many examples of cross talk between defence and 
development; signalling from BRI1 interferes with defence (Albrecht et al. 2011, Belkhadir et 
al. 2011, Lozano-Duran et al. 2013) and CLV2 signalling is induced by nematodes during 
parasitism of plants to suppress defence responses by promoting stem cell identity (Chen et 
al. 2014).  
 
RLKs in defence are excellent models with which to study defence signalling. The cognate 
ligands of several receptors involved in development have been identified such as the CLV3 
peptide for CLV1 and CLV2/CRN (Clark et al. 1995, Kayes and Clark 1998, Bleckmann et al. 
2010) and brassinosteroid for BRI1 (Clouse et al. 1996). However, the receptors involved in 
developmental signalling are activated by endogenous signals such as peptides or 
hormones. This can make control of their signalling for experimental purposes difficult and 
inhibitor treatments are often necessary to ensure the required synchronicity of signalling 
required for analysis (Asami et al. 2000). As defence signalling is elicited by molecules not 
produced by the plant, this provides an excellent system with which to study signalling. 
Responses can be triggered specifically by application of highly purified PAMP. Furthermore 
the cognate PRRs for several individual PAMPs have been well characterised. The 
generalised structure of FLS2, BRI1 and EFR with their ligand and co-receptor BAK1 is 
outlined in Figure 1.1 in comparison with the homodimer of EGFR. 
 
Figure 1.1 Comparison of FLS2/BRI1/EFR and EGFR, adapted from Macho and Zipfel et 
al. 2014 
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1.1.1 FLS2 is a good model for defence signalling 
PRRs are excellent models with which to study signalling. However, A. thaliana has a 
multitude of PRRs that detect PAMPs from bacteria such as Flagellin sensing 2 (FLS2) and 
Elongation factor Tu receptor (EFR), from fungi - CERK1 whilst other PRRs detect 
endogenous peptides released by plants upon damage (DAMPs) – Elicitor peptide 1 
receptor 1 (PEPR1), PEPR2 or wounding and herbivory associated molecular patterns 
(WAMPs and HAMPs) reviewed in Monaghan and Zipfel (2012). FLS2 and EFR are LRR-
RLKs and as such, show homology to insect Toll receptors or mammalian Toll like receptors 
(TLRs) (Mogensen 2009) that are also involved in immunity. 
 
PRRs do not function alone in signalling. Many PRRs require a co-receptor or co-regulator to 
function properly and recruit additional cytoplasmic proteins. For FLS2, EFR, PEPR1 and 
PEPR2 (amongst others) the five members of the LRR-RLK family of SERKs fulfil this role 
(Chinchilla et al. 2007, Heese et al. 2007, Roux et al. 2011). The different SERKs exhibit 
slightly different preferences for the different PRRs but BRI1 associated kinase 1/Somatic 
embryogenesis receptor kinase 3 (BAK1/SERK3) is the preferred co-receptor for FLS2 
(Roux et al. 2011). Interestingly BAK1 is also a co-receptor for the developmental RLK BRI1 
(Li et al. 2002, Nam and Li 2002, Li 2003).  
 
The signalling pathway of FLS2 has been relatively well characterised, making it an excellent 
model with which to study signal transduction. FLS2 is a membrane localised LRR-RLK that 
detects the bacterial PAMP flagellin to trigger defence signalling (Gómez-Gómez and Boller 
2000, Gómez-Gómez et al. 2001). A specific epitope of 22 amino acids (flg22) derived from 
the flagellin produced by Pseudomonas aeruginosa is commonly used experimentally to 
activate FLS2 (Felix et al. 1999, Gómez-Gómez and Boller 2000, Gómez-Gómez et al. 
2001), trigger defence signalling and ultimately PTI (Zipfel et al. 2004). The signalling 
cascade triggered after FLS2 and BAK1 activation by flg22 initially activates receptor like 
cytoplasmic kinases (RLCK), which lack a TM, such as Botrytis induced kinase (BIK1) (Lu et 
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al. 2010). BIK1 then phosphorylates and activates the enzyme respiratory burst oxidase-D 
(RBOHD) to generate an extracellular Reactive oxygen species (ROS) burst (Lu et al. 2010, 
Zhang et al. 2010, Kadota et al. 2014). There is an influx of Ca2+ which activates Calcium 
dependent protein kinases (CDPKs), and two Mitogen activated protein kinase (MPK) 
cascades are activated.Mitogen-activated protein kinase/extracellular signal-regulated 
protein kinase (MEK) kinase 1 (MEKK1) activates a cascade of Mitogen-activated protein 
kinase kinase1/2 (MKK1/2) and MPK4 whilst an unknown MEKK activates a cascade of 
MKK4/5 and MPK3/6 (Asai et al. 2002, Ichimura et al. 2006, Nakagami et al. 2006, Su et al. 
2007, Suarez-Rodriguez et al. 2007, Gao et al. 2008). MPK3, 4 and 6 are activated by 
phosphorylation upon their activation loop on a conserved TEY motif (Müller et al. 2010). 
MPKs then phosphorylate protein targets to activate mechanisms of defence. Ultimately 
defence signalling triggers broad spectrum resistance, also known as PTI, through stomatal 
closure, deposition of callose and secretion of antimicrobial defence compounds to name a 
few typical responses.  
 
Interestingly, the contribution of FLS2 to immunity was initially believed to be negligible, as 
plants producing non-functional FLS2 are not more susceptible to infection by the virulent 
pathogen Pseudomonas syrinagae pv tomato (Pto) DC3000 upon vacuum infiltration (Zipfel 
et al. 2004). However one of the main contributions of FLS2 signalling to immunity is 
stomatal closure, which prevents bacteria from accessing the apoplast, reviewed (Segonzac 
and Zipfel 2011). Vacuum infiltration of pathogen bypasses this defence mechanism so the 
effect of FLS2 signalling is bypassed. When spray inoculation is used, fls2 mutants are more 
susceptible to Pto DC3000 demonstrating the need for appropriate assays to determine the 
importance of a proteins, process or signalling pathway (Zipfel et al. 2004). 
1.2 The endomembrane system regulates signalling and defence 
The endomembrane system refers to the collection of interacting membrane compartments 
within plant cells and provides the primary mechanism by which a cell interacts with the 
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environment.Endomembranes regulate signalling and mediate defence responses in a 
variety of ways, the role of endocytosis, secretion and several endomembrane 
compartments in immunity as well as general cellular function will now be discussed.  
1.2.1 RAB GTPases, tethers and SNAREs regulate endomembrane trafficking 
To understand the role of endomembranes in immunity we must also understand how 
endomembranes are controlled. The identity and trafficking of endomembrane 
compartments is mediated by a variety of proteins. The primary means of compartment 
recognition is a protein complex consisting of a RAB GTPase, a Soluble N-ethylmaleimide 
sensitive factor (NSF) attachment protein (SNAP) receptor (SNARE) complex and a 
tethering factor, reviewed by Uemura and Ueda (2014). These proteins dictate the 
interactions a compartment can make. RAB GTPases regulate compartment identity by 
recruiting intra-membrane tethers to link separate endomembrane compartments over a long 
range, reviewed (Uemura and Ueda 2014). RAB GTPases also recruit SNARE proteins, 
which promote the direct fusion of membranes once tethering factors have brought them into 
close contact, reviewed (Uemura and Ueda 2014).  
 
One significant limiting factor in our understanding of endomembranes in immunity is that we 
do not fully understand the roles of many the endomembrane regulators. The biochemical 
function of SNAREs, tethers and RAB GTPases is fairly well characterised, however, the 
specific time and location in which they act is unclear for many A. thaliana regulators. 
Therefore, a particular regulatory protein may be detected in a defence mutant screen, but it 
is difficult to relate this phenotype to the process that the protein regulates.  
 
Inferences about function can be made based on homology with better characterised animal 
or yeast systems but there are significant differences between the regulators in A. 
thaliana,and mammals or yeast due to their evolutionary history. 33 of the 41 mammalian 
RAB GTPases have no clear ortholog in A. thaliana (Rutherford and Moore 2002). All A. 
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thaliana RAB GTPases are orthologs of just eight of the mammalian RAB GTPases, and 
have been assigned into eight families A-H and each family member assigned a letter and 
number based on homology e.g. RABG3f (Rutherford and Moore 2002).The major trafficking 
steps regulated by each RAB GTPase family (A-H) in A. thaliana have been characterised 
but exactly which family member regulates which specific trafficking step under which 
conditions is unclear (there are eight members of the RABG family in A. thaliana) 
(Rutherford and Moore 2002). Therefore, the main hindrance to work is a lack of knowledge 
about A. thaliana endomembrane regulators and the compartments on which they reside. 
 
The same is true for tethering complexes. All the major endomembrane tethering complex 
families characterised in yeast and animals are present in A. thaliana(Koumandou et al. 
2007) but their functions have not been extensively studied. Endomembrane tethering 
factors are divided into two classes. The first class is the single protein tethers such as the 
Golgins (Latijnhouwers et al. 2005, Latijnhouwers et al. 2007). The second class is the 
protein complex tethering factors. There are eight different tethering complexes in A. thaliana 
and they are the Transport Protein Particle 1 (TRAPPI), TRAPPII, Golgi-associated 
retrograde protein (GARP), Homotypic fusion and vacuole protein sorting (HOPS), Class C 
core vacuole/endosome tethering (CORVET), Conserved oligomeric Golgi (COG), EXOCYST 
and Dependence on SLY1-20 (DSL) (Koumandou et al. 2007, Peplowska et al. 2007, 
Lachmann et al. 2011). There are 24 different orthologs of the mammalian EXO70 subunit 
(Zhang et al. 2010). These differences reduce confidence in the inferences made about the 
function of endomembrane regulators based on homology and imply that exocytic trafficking, 
mediated by the EXOCYST requires more complex regulation than in animals or yeast.  
 
In addition to problems caused by lack of homology at the protein level there are also 
differences in the functioning of the endomembrane system that make inferences difficult. 
The TGN in mammals functions as an independent organelle from the EE, the TGN 
regulates secretory traffic to the PM and EE, whereas in plants an independent EE has not 
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been observed (summarised in Figure 1.2). For example, the TRAPPII complex is needed 
for secretion to the PM and the forming cell plate (Thellmann et al. 2010, Qi et al. 2011). 
However, the lack of an Early endosome (EE) (Viotti et al. 2010, Scheuring et al. 2011) in 
plants makes the role of the TRAPPII complex, which tethers the TGN to EE in mammals 
(Cai et al. 2005), impossible to infer from homology alone. The TRAPPII complex 
component, TRAPP subunit 120 (TRS120), was identified in a TGN proteome with Syntaxin 
of plants 61 (SYP61) proteome suggesting TRAPPII still mediates trafficking to or from the 
TGN in A. thaliana (Drakakaki et al. 2012). Interestingly, in trs120 and trs130 mutants (two 
TRAPPII specific components) the transport of the FM4-64 lipophilic dye is inhibited, as is 
the recycling of Pin-formed 2 (PIN2) from the Plasma membrane (PM) (Thellmann et al. 
2010, Qi et al. 2011, Qi and Zheng 2011). It therefore appears that TRAPPII regulates 
secretion from the TGN and endocytosis. The role of a tethering complex in two pathways, in 
this case secretion and endocytosis has not been described and so is unlikely (Whyte and 
Munro 2002, Koumandou et al. 2007, Bonifacino and Hierro 2011, Lachmann et al. 2011, 
Miller and Ungar 2012). Instead the TRAPPII complex is probably involved in one of these 
pathways but interference with the TRAPPII complex alters the organelle so that the TGN 
cannot properly function in either endocytosis or secretion. Supporting the role of the TGN in 
Figure 1.2. Comparison of the mammalian and plant TGN and EE.Adapted from 
Scheuring et al. 2012. 
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secretion is the implication of the TRAPPII complex in activation of the secretion associated 
RABA family in A. thaliana (Qi and Zheng 2011). 
 
1.2.2 Endomembranes are altered during plant-pathogen interactions 
Highlighting the importance of endomembranes in defence, pathogens target regulators of 
the endomembrane system with intracellular effectors. Most of the major classes of 
endomembrane regulators, including tethers and SNAREs, are suggested targets of 
pathogen effectors (Mukhtar et al. 2011). Endomembranes must be important in defence for 
pathogens to evolve inhibitory effector proteins. For example the endomembrane regulatory 
ADP ribosylation factor (ARF)-Guanine exchange factor (GEF) MIN7 is targeted and 
degraded by the bacterial effector Hrp outer protein M1 (HopM1) to alter secretory traffic 
(Nomura et al. 2006, Nomura et al. 2011). Furthermore various drugs now used as inhibitors 
for endomembrane trafficking were isolated from pathogens. Brefeldin A (BFA) inhibits 
GNOM function and was isolated from Eupenicillium brefeldianum(Misumi et al. 
1986)whilstwortmannin, which inhibits Phosphoinositide 3-kinase (PI3K) activity was isolated 
fromPenicillium funiculosum(Arcaro and Wymann 1993).Yet our knowledge of how these 
drugs or effectors alter endomembranes is not clear. For example, the exact role of HopM 
interactor 7 (MIN7) is not clear (Nomura et al. 2011) and the function of GNOM was recently 
re-assessed (Naramoto et al. 2014). The importance of secretion in defence responses is 
also highlighted by the up-regulation of secretory pathway genes following application of the 
defence hormone Salicylic Acid (SA) (Cheng et al. 2008). 
 
The cytoskeleton is another example of regulation of endomembrane trafficking that is 
altered following pathogen challenge. The actin cytoskeleton is formed of filaments 
comprised of the multiple monomers of the 10 different actins in the A. thaliana genome, 
reviewed (Ketelaar 2013). Actin is the major filament on which the organelles are anchored 
and move (Cai et al. 2014), thus regulating their movement. Myosin XI, a motor protein that 
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moves along actin filaments drives the movement of the Endoplasmic reticulum (ER), Golgi, 
endomembrane vesicles, peroxisomes and mitochondria(Cai et al. 2014). These filaments 
are formed into actin arrays, which are highly dynamic and are altered following biotic and 
abiotic stress, as extensively reviewed (Staiger et al. 2009, Higaki et al. 2011, Smertenko 
and Franklin-Tong 2011). When cells are mechanically stressed by pressure from glass or 
tungsten needles very highly bundled filament arrays are formed at the site of the stimulus 
(Hardham et al. 2008). Upon removal of the needle, the filament array is disassembled, 
highlighting the dynamic nature of these formations (Hardham et al. 2008). Interestingly, 
these filament dynamics are reminiscent of the changes that occur during filamentous 
pathogen infection where the actin cytoskeleton depolymerises and re-bundles underneath 
the sites of attempted or actual cell penetration (Staiger et al. 2009, Higaki et al. 2011, 
Smertenko and Franklin-Tong 2011). Furthermore movement of compartments on the actin 
cytoskeleton is required for resistance to the fungal pathogen Blumeria graminis f. sp. hordei 
(Bgh)(Yang et al. 2014). There is dynamic actin filament remodelling following challenge with 
non-filamentous pathogens as well. Pto DC3000 infection or application of flg22 to A. 
thaliana induces rapid actin depolymerisation and subsequent remodelling, presumably 
towards the sites of pathogen detection (Henty-Ridilla et al. 2013). The re-orientation of the 
cytoskeleton probably allows the focal accumulation of organelles around sites of pathogen 
detection (Yang et al. 2014).  
 
Therefore, these regulatory proteins are clearly essential regulators of defence, however to 
determine how defence is implemented and manipulated by pathogens, we need to know 
more about endomembranes in general. 
1.2.3 Secretion via the TGN mediates pathogen perception and defence responses 
Secretion has several specific roles in defence. LRR-RLKs such as FLS2 and BRI1 have 
signal peptides on their N terminus that cause the mRNA to be directed to the ER for 
synthesis (Li and Chory 1997, Gómez-Gómez and Boller 2000). FLS2 is synthesised in the 
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ER and trafficked through the Golgi to the PM (Saijo et al. 2009, Haweker et al. 2010). En 
route it is glycosylated and its folding monitored by quality control machinery (Saijo et al. 
2009, Haweker et al. 2010). Strikingly different PRRs have different quality control 
requirements; protein accumulation of EFR is more affected in ER-Quality control (QC) 
mutants than FLS2 (Nekrasov et al. 2009, Saijo et al. 2009, Haweker et al. 2010). This is 
also true for the RLK BRI1, where ER-QC carefully monitors folding of BRI1 (Hong et al. 
2008, Belkhadir et al. 2010). Improperly folded or otherwise defective RLKs are re-directed 
away from the PM for degradation by ER associated degradation (ERAD) (Su et al. 2011). 
Furthermore the early secretory route, especially the ER, may be the location in which 
receptor-co-receptor pairs are formed. There are specific pools of BAK1 that are associated 
with either FLS2 or BRI1, although how these pools of BAK1 are defined is unclear (Albrecht 
et al. 2012). It is likely that the definition of the ultimate role for BAK1, in either FLS2 or BRI1 
signalling, occurs during synthesis. Recent evidence has also demonstrated that BRI1-BAK1 
partially exists in pre-formed complexes at the PM (Bücherl et al. 2013) and for Epidermal 
growth factor (EGF) receptor (EGFR) in animal systems (Bader et al. 2009) and these 
associations of receptor and co-receptor may form as early as the ER. Interestingly FLS2-
BAK1 does not appear to form as closely associated complexes as BRI1-BAK1 before ligand 
application (Schulze et al. 2010, Bücherl et al. 2013).  
 
Post-Golgi vesicle traffic plays a major role in plant defence, in addition to the role in 
secretion of PRRs. The TGN has a myriad of functions including secretion to the PM and cell 
plate during cell division as well as sorting endocytosed proteins for recycling to the PM or 
direction to a late endosomal route to the vacuole (Richter et al. 2009, Viotti et al. 2010). The 
sorting function of the TGN is similar to the animal EE, leading to the term TGN/EE being 
commonly used in plant literature (Viotti et al. 2010). For simplicity I will only use the term 
TGN to describe this organelle. After synthesis and glycosylation in the ER and Golgi RLKs 
are secreted to the PM via the TGN (Russinova et al. 2004, Nekrasov et al. 2009, Saijo et al. 
2009, Haeweker et al. 2010, Saijo 2010, Beck et al. 2012). 
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Secretion to the apoplast or cell wall also plays a role in defence. Resistance in A. thaliana 
against Bgh is mediated by the SNARE complex of Penetration 1 (PEN1), Soluble SNAP33, 
Vesicle associated membrane protein 721/722 (VAMP721/722) (Collins et al. 2003, Kwon et 
al. 2008). This SNARE complex accumulates at sites of attempted fungal penetration to 
mediate the exocytosis of cell wall reinforcing compounds. Furthermore,the fungal toxin BFA 
interferes with the endomembrane regulator GNOM (Geldner et al. 2003) and causes altered 
Golgi and post-Golgi traffic ultimately preventing proper callose deposition (Nielsen et al. 
2012).  
 
Several tethering complex components are involved in defence related secretion. Recently 
EXOCYST components EXO70B2 and EXO70H1 were shown to be transcriptionally up 
regulated following elf18 treatment (Pečenková et al. 2011). Furthermore plants deficient in 
either EXO70B2 or EXO70H1 protein were more susceptible to bacterial and fungal infection 
(Pečenková et al. 2011), probably because of the role of their role in exocytic secretion. To 
further support this hypothesis, EXO70B2 is targeted for ubiquitination and degradation by 
the E3 ubiquitin ligase, and negative regulator of PTI, Plant U-box protein (PUB22) 
(Stegmann et al. 2012). Moreover, another EXO70 homolog is involved in Barley penetration 
resistance to Bgh (Ostertag et al. 2013). This screen also identified a intra-Golgi tethering 
complex subunit COG3 in penetration resistance, as well as a homolog of mammalian RAB 
GTPase 1 (Ostertag et al. 2013). These proteins are involved in secretion, but it is unclear 
from exactly which compartment, reinforcing the importance of secretion in defence and 
emphasising that more information is needed to fully understand the roles of these proteins. 
 
PEN2 is a peroxisome localised gycosyl hydrolase and its hydrolytic products are required 
for callose deposition (Bednarek et al. 2009, Clay et al. 2009). The PEN3 ATP binding 
cassette (ABC) transporter (Stein et al. 2006), localises around papillae and presumably 
translocates PEN2 produced glucosinolates into the apoplast, as genetics show PEN3 is in a 
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PEN2 dependent defence pathway (Lipka et al. 2005). Peroxisomes traffic to sites of 
attempted pathogen penetration but PEN3 is also endocytosed into a TGN compartment 
following PAMP perception (Underwood and Somerville 2013). This endocytosis may be to 
promote re-localisation of PEN3 to where it is needed and demonstrates that production or 
activation of a defence protein is not sufficient to mediate resistance, correct localisation is 
essential. 
1.2.4 Unconventional secretion allows defence protein secretion to the apoplast 
Other defence related proteins are secreted into the apoplast, such as the Pathogenesis 
related (PR) proteins, in a Golgi independent manner (Matsushima et al. 2002, Watanabe et 
al. 2013). These proteins, which have signal peptides but no transmembrane domains, are 
produced in the ER and accumulate in ER bodies, ER bodies are spindle like structures 
formed from the ER that accumulate upon pathogen challenge, wounding or Jasmonic acid 
(JA) treatment (Matsushima et al. 2002). Upon infection of A. thaliana, with the fungal 
pathogen Colletotrichum gloeosporioides, ER bodies accumulate and PR proteins are 
secreted into the apoplast (Watanabe et al. 2013). ER bodies have not been observed to 
directly fuse with the PM, thus it has been postulated that secretion from ER bodies could be 
through vesicle trafficking directly to the PM. Evidence is, however, lacking for either 
secretory route(Watanabe et al. 2013). Another route of defence related secretion is through 
direct fusion of the vacuole to the PM, allowing the bulk deposition of vacuolar enzymes into 
the apoplast to lyse bacteria (Hatsugai et al. 2009, Hatsugai and Hara-Nishimura 2010). This 
form of secretion was observed in a plant-pathogen interaction between A. thaliana and P. 
syringae and initiates programmed cell death (Hatsugai et al. 2009, Hatsugai and Hara-
Nishimura 2010).   
1.2.5 The endocytic route in defence 
Compartments on the endocytic route also play a role in defence. The endomembrane 
system mediates traffic from the PM to the vacuole and this is known as the endocytic route. 
Proteins are endocytosed to the TGN then trafficked to Late endosome/Multivesicular bodies 
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(LE/MVBs) en route to the vacuole (Viotti et al. 2010, Scheuring et al. 2011). Endocytic 
compartments are involved in defence, as demonstrated with the TGN (Section 1.2.2). 
 
LE/MVBs are altered in their function during infection. These compartments were observed 
to cluster around sites of pathogen penetration (Lu et al. 2012, Bozkurt et al. 2014). 
LE/MVBs are also involved in the secretion of defence compounds, although the exact 
mechanism is unclear. Phenolics and H2O2 are produced in LE/MVBs and secreted, 
presumably though exosomes, to sites of attempted pathogen penetration (An et al. 2006, 
An et al. 2006). An open question is exactly how LE/MVBs can be modified from their role as 
an endocytic compartment to provide this new role in pathogen defence. Answering this 
question will help us understand how a plant mediates resistance to pathogens. 
 
LE/MVBs may also have a role in maintaining the cell’s outer membrane. During infection, 
filamentous pathogens can produce membrane bound feeding structures or haustoria inside 
the host cell. The plant must then expand the size of its outer membrane to prevent cell lysis. 
The extra haustorial membrane, the plant derived membrane surrounding a haustoria, is 
different from the PM in terms of protein content (Lu et al. 2012), suggesting it is not formed 
only as an extension of the PM. It may be that the redirection of LE/MVBs towards haustoria 
is part of the mechanism by which the cell membrane is expanded to accommodate the 
pathogen and prevent cell lysis (Bozkurt et al. 2014). 
 
The endocytic route also regulates defence signalling. RLK abundance at the PM is 
regulated by endocytosis. FLS2 is constitutively recycled between the TGN and the 
PM(Beck et al. 2012) and BRI1 displays a constitutive PM and endosomal localisation 
(Russinova et al. 2004). Interestingly, upon flg22 treatment FLS2 is redirected into a late 
endosomal pathway and co-localises with the LE/MVB markers RAB GTPase 
F1/Arabidopsis Rab GTPase 6 (RABF1/ARA6) -RFP and RFP-RABF2b/ARA7 (Beck et al. 
2012). These observations have led to the suggestions that endocytosis of FLS2 may be 
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relevant for the propagation of signalling (Raikhel and Hicks 2007, Geldner and Robatzek 
2008, Irani and Russinova 2009), however direct evidence is lacking. In contrast, the 
sensitivity of cells to flg22 is mediated by endocytosis of the receptor (Smith et al. 2014). 
FLS2 activation and endocytosis through a late endocytic route that leads to a de-sensitised 
period after FLS2 activation (Smith et al. 2014). Subsequent secretion of receptor allows re-
sensitisation of the cell to flg22 by receptor replenishment (Smith et al. 2014). Redirection of 
endocytosed FLS2 into a late endosomal pathway leads to receptor degradation (Beck et al. 
2012, Smith et al. 2014).  
 
One mechanism by which FLS2 is directed for endocytosis to a late endosomal pathway is 
through receptor ubiquitination. FLS2 is ubiquitinated by the PUB E3 ligases PUB12 and 
PUB13 and subsequently degraded, presumably in the vacuole, although the proteasome 
has also been implicated (Lu et al. 2011).  Supporting the role of receptor endocytosis into a 
late endosomal pathway in negative regulation of signalling, in A. thaliana plants lacking 
PUB12/13 display elevated immune responses (Lu et al. 2011). These mutants do, however 
hyper-accumulate SA, which could also explain this phenotype (Lu et al. 2011).  
1.2.6 Do endocytic compartments contribute to defence signalling? 
The question has been posed several times in the literature about whether endosomes can 
function as sites of signal transduction during RLK signalling (Raikhel and Hicks 2007, 
Geldner and Robatzek 2008, Bar and Avni 2014) in a phenomenon referred to as endosomal 
signalling. As FLS2 signalling has been extensively investigated, it is an excellent model with 
which to study endosomal signalling in plants. Endosomal signalling was first suggested for 
the mammalian EGFR where it was observed that downstream signalling components, 
including MPKs, were localised to EEs (Vieira et al. 1996). It has since been demonstrated 
that the endosomal localisation of EGFR activated MPKs is required for their full activation 
(Teis et al. 2002, Nada et al. 2009). Furthermore, after EGF treatment of HeLa cells, the 
endocytosed EGFR receptor is trafficked to the perinuclear region with the transcription 
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factor Adapter protein containing PH domain 1 (APPL1) then alters transcription 
(Miaczynska et al. 2004). There are numerous other examples of endosome localised 
proteins contributing to overall receptor signal transduction including for the Neuronal growth 
factor (NGF) receptor tropomyosin-related kinase A (TrkA). The transcription factor APPL1 is 
again trafficked via endosomes to the nucleus following application of NGF and endocytosis 
of the activated receptor, TrkA in human PC12 cells (Varsano et al. 2006). APPL1 then 
recruits a G-protein regulator and both are trafficked to the perinuclear region of the cell to 
dissociate and promote TrkA signalling  (Lin et al. 2006, Varsano et al. 2006) by nucleosome 
remodelling (Miaczynska et al. 2004). 
 
There have also been numerous studies investigating the importance of receptor 
endocytosis in signal transduction. Inhibition of receptor endocytosis can either lead to 
enhanced or reduced MPK activation (Vieira et al. 1996, Miaczynska et al. 2004, Purvanov 
et al. 2010, Brankatschk et al. 2012, Sousa et al. 2012). The most convincing study to date 
utilises multiple mutants that limit EGFR trafficking to different endocytic compartments and 
microarrays to transcriptionally profile the response (Brankatschk et al. 2012). From this 
study it is clear that the majority of EGFR regulated genes are controlled from the PM whilst 
a subset of genes do not respond when endocytic trafficking is altered. It must be noted 
here, however, that the sum of EGFR signalling is not MPK activation and transcriptional 
reprogramming, other changes occur within cells including cytoskeletal remodelling (Balbis 
and Posner 2010). Therefore studying solely MPK activation or gene activation cannot 
determine the total importance of endosomes in signalling. 
 
An important distinction must be made here between two hypotheses relating endosomal 
signalling and are directly relevant to studying endosomal signalling with FLS2. The first is 
“Do any proteins in the FLS2 signalling pathway signal from endosomes?”. The second is “ 
Is signalling from endosomes relevant to the overall cell response to flg22?”. These two 
hypotheses are linked but the second requires the first to be true. Therefore, to answer the 
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question of endosomal function in signalling during bacteria attack, the first hypothesis must 
be tested before the second can be tested properly. Exactly how endosomes contribute to 
signalling must be determined (if at all) before the contribution of endosomal signalling 
proteins can be determined, otherwise the wrong responses may be monitored. Therefore, 
until the direct functions of endosomal signalling are determined, the relevance of 
endosomal signalling proteins in FLS2 signalling cannot be determined. Interesting parallels 
between the relevance of endosomes as sites of signal transduction and the importance of 
FLS2 in defence against pathogens can be drawn. FLS2 was initially thought to have a 
negligible contribution to plant defence (Section 1.1.1) because an inappropriate assay was 
used to test relevance. As the role of endosomes in FLS2 signal transduction is unknown, 
the importance of endosomes to signalling overall cannot be tested yet.  
 
Therefore to determine whether endosomes can contribute to signalling, and test the first 
hypothesis, the proteins localised to endosomes must be determined. It is unlikely that the 
endocytosed FLS2 is signalling directly from LE/MVBs as it was demonstrated that FLS2 is 
localised to intraluminal vesicles of LE/MVBs (Spallek et al. 2013). Numerous other 
signalling proteins have, however, been localised to endosomes or the endomembrane 
system. The MPKKK Enhanced disease resistance 1 (EDR1) that functions in negative 
regulation of immunity localises to endosomes (Gu and Innes 2011). Furthermore MPK4 has 
been localised to microtubules and is essential for the formation of the cell plate, whilst 
MPK6 localises to the TGN (Beck et al. 2011). Both of these kinases are flg22 responsive, 
but their endosome localisation has not been tested for its relevance in FLS2 induced 
signalling. Furthermore MPK6 co-fractionates with FLS2 following flg22 treatment (Müller et 
al. 2010). Demonstrating MPKs localise to endosomes is not conclusive evidence for 
endosomal signalling; the MPKs must be localised to the cytosolic face of the LE/MVB. 
Before testing the relevance of endosomes to signalling, the proteomes of different 
endosomes must be elucidated. Thus, only when the role of endosomes in signalling has 
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been established and can be correctly monitored, can the overall importance of endosomes 
in signalling be defined. 
 
Therefore, to understand signalling and plant defence, we also need to understand 
endomembranes and their proteomes. Furthermore significant advances could be made with 
good quality endomembrane proteomic data. 
1.3 Methods for protein identification 
There are numerous methods with which to identify proteins in a sample and they can 
generally be divided into biased and unbiased approaches. Biased approaches require 
defined proteins of interest or candidates, and their presence can be tested with specific 
antibodies raised against the protein or against a tag fused to the protein candidate. When 
assessing the presence of a protein in a subcellular compartment confocal laser scanning 
microscopy (CLSM) can also be used. Here the localisation of proteins can be inferred from 
living cells by the emission of light from a recombinant protein fused to a fluorescent protein 
tag. Proteins such as GFP or RFP absorb light at one wavelength (395 and 584 nm 
respectively) and emit it at another (509 and 687 nm respectively), allowing the spatial 
localisation of proteins to be inferred (Tsien 1998, Campbell et al. 2002).  
1.3.1 Shotgun proteomics for high throughput protein identification 
The principal method for unbiased high throughput identification of proteins is with a mass 
spectrometer (MS) in what is known as shotgun proteomics (Aebersold and Mann 2003). 
Here, proteins in a sample are detected in an identity independent manner with a MS. There 
are multiple different types of MS and several will be used in this study.  
 
MS analysis of complex protein mixtures requires several experimental steps. In most cases 
samples must be separated by fractionation, even purified endomembranes or Co-
Immunoprecipitations (CoIPs) (Steen and Mann 2004). This can be achieved in a variety of 
ways at either the protein or peptide level. The overall aim of separation of complex samples 
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is to concentrate the eventual individual peptides and to allow the instrument time to analyse 
them (Steen and Mann 2004). Whilst there is no ‘correct’ way to fractionate a sample as 
methods depend on experimental aims and amount of protein available, there are a few 
common techniques. The protein sample can be fractionated with SDS-PAGE after 
denaturation, most commonly for protein separation (Aebersold and Mann 2003). Protein 
migration is predominantly influenced by size during Sodium dodecyl sulphate (SDS)-
Polyacrylamide gel electrophoresis (PAGE), but folding or modification also influence 
migration time. For example FLS2 migrates much more slowly during SDS-PAGE than 
would be predicted from its size alone, as glycosylation of the LRR further reduces motility 
(Haweker et al. 2010). Other methods to separate proteins are native electrophoresis, in 
which proteins are not denatured, or isoelectric focussing, in which molecules migrate based 
on their charge in a pH gradient (Aebersold and Mann 2003). The gels are subsequently 
sliced into sections and the proteins cleaved into peptides with a protease, for example 
trypsin.  
 
Alternatively liquid chromatography can be used to fractionate samples. These techniques 
can separate at either the protein (followed by cleavage to peptides) or at the peptide level. 
Reverse phase chromatography and strong cation exchange (SCX) chromatography are 
commonly used (and in this thesis). In both of these techniques species are allowed to bind 
to a chromatography column then a gradient is applied to the column: acetonitrile for reverse 
phase or strong cation solution is passed over the column for SCX,and peptides eluted. 
Peptides are therefore sorted based on their hydrophobicity (reverse phase) or charge 
(SCX). The elution from an Liquid chromatography (LC) column can then be pooled into 
fractions for further fractionation with another technique. Alternatively the elution from an LC 
column can be directly injected into the MS if volatile salts are used in the ion exchange.  
 
For the principal MS used in this thesis, we used SDS PAGE to fractionate protein mixtures 
before tryptic digestion to peptides. The peptides were fractionated by reverse phase LC and 
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are sprayed directly into the MS, an Linear trap quadrupole (LTQ)-Orbitrap XL (Orbitrap), 
using a voltage differential to generate gas phase ions to be measured. Measurement 
occurs in the Orbitrap by the radial oscillation of ions (ideally peptides but contaminants such 
as ionic detergents will also be detected) and calculating mass/charge (m/z) ratios from the 
frequency of the oscillations of the all ions (Hu et al. 2005). Intact peptide (precursors) can 
then be isolated with Fourier transformation to derive the individual ion overlapping patterns. 
The instrument  measures m/z ratios of ions in milli-seconds to generate a m/z by intensity 
spectrum. Species intensity is measured in the Orbitrap to generate MS1 spectrum (Hu et al. 
2005). The top 5 most abundant species are selected for collision induced dissociation 
(CID). In CID, species are accelerated and allowed to collide with neutral molecules (He) 
and fragment to form ions (Steen and Mann 2004). These ions are then trapped in the ion 
trap and scanned over an m/z range to generate MS/MS or MS2 data. The combination of 
m/z measurements from one CID event in an MS2 is referred to as a spectrum and the 
spectrum can be matched to the predicted fragmentation of peptides from a known protein 
set, for example the TAIR10 annotated A. thaliana genome. Thus the presence of a peptide 
in a sample can be inferred as the best match for a spectrum obtained (Steen and Mann 
2004). The presence of a protein is subsequently inferred from the presence of its 
constituent peptides in a sample (Steen and Mann 2004). Therefore a peptide or a protein is 
never truly identified but matched to a spectrum, however, I will use the term identified for 
confidence in a spectrum match of over 95% and identification of two peptides for a protein 
to be identified. The software MASCOT (www.matrixscience.com) is the most commonly 
used software to match spectra to peptides. The strength of a match relies on the difference 
between observed and predicted m/z rations for the database proteins and is adversely 
affected by the presence of non-matched spectra (Perkins et al. 1999). 
 
The data obtained via Orbitrap benefits from high resolution and mass accuracy (Hu et al. 
2005). High resolution refers to the discriminatory power of a MS to distinguish between 
species with similar m/z ratios (Steen and Mann 2004). Mass accuracy refers to the ability of 
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a MS to measure the correct mass of a species and is calculated as difference in the 
theoretical m/z and the measured m/z.  
 
As an alternative to the Orbitrap a Q-time of flight (TOF) can be used (Aebersold and Mann 
2003). These MS measure the m/z ratios of species by measuring their TOF after 
acceleration through an electric field. With the same kinetic energy, the velocities of species 
depend only on their m/z ratio therefore the m/z ratio of species can be measured. Low m/z 
species taking longer to reach the target than high m/z species. Q-TOFs, including the 
Synapt G2 used in this thesis, has less sensitivity than the Orbitrap but greater linearity, 
dynamic range and acquisition times (Hu et al. 2005).  
1.4 Thesis Aims 
Endosomes have frequently been implicated as sites of signal transduction however direct 
evidence is lacking. Several recent studies have demonstrated that endosomal signalling 
does not contribute significantly to the signalling of BRI1. In order to determine the 
contribution of endosomal signalling to the overall cell response to flg22 good quality 
proteomic data on endosomes is needed. Using this data the potential role of endosomes in 
signalling can be investigated. Changes in the endosomal proteome need to be quantified 
after flg22 treatment and signalling proteins in endosomes identified. Only then can the 
activity of proteins signalling from endosomes be monitored. Furthermore proteomic data 
from endosomes and how they change following flg22 treatment will allow for a greater 
understanding of plant cell defence responses in general.  
 
Thus to determine the contribution of endosomes to signalling during bacterial attack I set 
several aims: 
1. Establish the proteomes of LE/MVBs. 
2. Determine LE/MVB proteome changes relevant to FLS2-induced signalling. 
3. Investigate endosome localised proteins involved in immune signalling. 
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4. Examine the relevance of endosome-localised pools of signalling proteins to the 
overall cellular response to flg22. 
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2 Experimental procedures 
2.1 Plant material 
Name AGI Details Reference 
UBQ10::YFP  Col-0 (Ueda et al. 2004) 
UBQ10::mCherry  Col-0 (Ueda et al. 2004) 
UBQ10::RFP-RABF2b/ARA7 AT4G19640 Col-0 (Ueda et al. 2004) 
UBQ10::RABF1/ARA6 AT3G54840 Col-0 (Ueda et al. 2004) 
UBQ10::YFP-RAG3f AT3G18820 Col-0 (Geldner et al. 2009) 
UBQ10::YFP-GOT1 AT3G03180 Col-0 (Geldner et al. 2009) 
UBQ10::YFP-VAMP711 AT4G32150 Col-0 (Geldner et al. 2009) 
UBQ10::YFP-RABD2a/ARA5 AT1G02130 Col-0 (Geldner et al. 2009) 
35s::CLC2-GFP AT2G40060 Ws-2 (Geldner et al. 2009) 
pVLN3::VLN3-GFP AT3G57410 vln3/Col-0 (Bao et al. 2012) 
UDP AT3G29360 SALK_098492C Alonso et al. 2003 
KING1 AT3G48530 SALK_074554 Alonso et al. 2003 
KING1 AT3G48530 SAIL_679_E05 Alonso et al. 2003 
EIF3C AT3G56150 SALK_015933C Alonso et al. 2003 
VLN3 AT3G57410 SALK_078340C Alonso et al. 2003 
VLN3 AT3G57410 SALK_117097C Alonso et al. 2003 
WD40 AT3G63460 SALK_035921C Alonso et al. 2003 
ALDH3F1 AT4G36250 SALK_045231C Alonso et al. 2003 
ACT-TK AT4G38470 SALK_112195C Alonso et al. 2003 
ACT-TK AT4G38470 SALK_113076C Alonso et al. 2003 
SNX2B AT5G07120 SALK_087925C Alonso et al. 2003 
SNX2B AT5G07120 SALK_054621C Alonso et al. 2003 
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HMZ AT5G18230 SALK_037715C Alonso et al. 2003 
EIF3B-1 AT5G27640 SALK_107766C Alonso et al. 2003 
GTP binding AT5G46070 SALK_016366C Alonso et al. 2003 
rhm1-2 AT1G78570  (Diet et al. 2006) 
rhm1-1 AT1G78570  (Diet et al. 2006) 
vln2,3 AT2G41740, 
AT3G57410 
 (van der Honing et al. 2012) 
vln2 AT2G41740  (van der Honing et al. 2012) 
vln3 AT3G57410  (van der Honing et al. 2012) 
 
2.1.1 Plant growth on soil 
A.thaliana seeds were sown on F2 compost. Seedlings were grown in a growth chamber 
under controlled conditions: 21-23ºC; 10 h light / 14 h dark; 75% humidity for A. thaliana. 
Two weeks old mature seedlings were individually transferred to fresh pots filled with 
compost mix for A.thaliana (F2 compost supplemented with grit and systemic insecticide 
INTERCEPT). Plants were grown in the same conditions as for seedlings as mentioned 
above. 
2.1.2 In vitro seedling growth for IP 
A. thalianaseeds were surface-sterilized for 12 hours in a sealed chamber by chlorine gas 
(produced by mixing 8 ml of 8 M HCl with 200 ml of bleach). 5 x 0.1 g of A.thaliana seed for 
all constructs were grown in 5 x sterile 250 ml conical flasks with 200 ml of Murashige and 
Skoog medium at 22 °C, 16 hours light, shaken at 120 rpm for 8 days. 
2.1.2.1 Elicitation of in vitro grown seedlings with flg22 
A solution of 20 μM flg22 was prepared and 10 ml added to each flask of A. thaliana 
seedlings with mixing via shaking and mild vacuum was applied for 90 s, followed by slow 
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release of vacuum over 3 min. At the annotated time following flg22 application seedlings 
were filtered using miracloth (Millipore) and frozen on liquid nitrogen. 
2.1.3 In vitro seedling growth for PAMP induced resistance (PIR) 
A. thalianaseeds were surface-sterilized for 12 hours in a sealed chamber by chlorine gas 
(produced by mixing 8 ml of 8 M HCl with 200 ml of bleach). Seeds for each construct were 
grown on solid Murashige and Skoog mediumat 22 °C, 16 hours light for 6 days then 
transplanted into 96 well plates with 100 µl of ½ Murashige and Skoog medium and grown 
for a further 4 days at 22 °C, 16 hours light, shaken at 120 rpm.  
2.2 Plant pathology assays 
2.2.1 Microorganisms used in this study 
Species Pathovar Designation Details 
Escherichia coli  TOP10 For Gateway cloning 
Agrobacterium 
tumafasciens 
 GV3101 For transient expression of 
proteins in N.benthamiana 
Pseudomonas 
syringae 
Tomato DC3000  
Pseudomonas 
syringae 
 
Tomato Lux DC3000  
 
2.2.2 Bacterial cultures 
Each bacterial strain was grown on solid or in liquid L medium (For 1 L: 10 g tryptone, 5 g 
NaCl, 1 g glucose, 5 g yeast extract, pH 7.0; for solid medium, 10 g agar was included) with 
the appropriate antibiotics. E. coli strains were grown in an incubator at 37°C, P. 
syringaeand A. tumafasciensstrains at 28°C. 
2.2.3 Soil grown A. thaliana infection with Pto DC3000. 
P. syringae strains were streaked on fresh selective media and grown for (28 0C) 24 to 48 h. 
Bacteria were scraped from the plates and resuspended in H2O. OD600 was measured and 
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adjusted to 0.02. 0.04% (v/v) Silvet was added and bacteria solution sprayed onto the A. 
thalianaleaves, axial and abaxial surfaces.   
2.2.3.1 Estimation of Pto DC3000 growth 
3 A. thalianaleaf disks (each sample equalling 1 cm2) were collected 3 days after inoculation 
with bacteria (OD600 = 0.001, 5x105cfu/mL) and then ground in water. Serial dilutions (10-2, 
10-3, 10-4and 10-5) were then spotted on selective media. After 2 days incubation, bacterial 
colonies were counted according to the dilution spot and normalized in cfu/cm2of plant leaf. 
2.2.4 PIR in In vitro grown A. thalianainfection with Pto DC3000 Lux 
A. thaliana seedlings were treated with 1 μm flg22, 24 hours after transplantation from solid 
to liquid medium in 96 well plates. PtoDC3000 Lux was streaked on fresh selective media 
and grown for (28 0C) 24 to 48 h. Bacteria were scraped from the plates and re-suspended in 
10 mM MgCl2. OD600 was measured and adjusted to 0.2. After 48 hours of growth in liquid 
medium A. thaliana seedlings were inoculated with bacteria to a final OD600 of 0.02 
2.2.4.1 Estimation of Pto DC3000Lux growth 
After two days of growth, photons emitted from plates were measured over 2.5 min with an 
ICCD photon counting camera (Photek).  
2.2.5 ROS burst assay 
16 leaf discs (No. 1 cork borer – 3.8 mm diameter) were harvested from soil grown plants 
and incubated in dH2O overnight in the dark. The water was removed and replaced with 100 
μl of 20 μM luminol (Sigma-Aldrich), 1 μg of horseradish peroxidase (Sigma-Aldrich) and 100 
nM of flg22. Light emission was immediately recorded with an ICCD photon counting camera 
(Photek). 
2.3 Molecular biology 
2.3.1 DNA based techniques 
2.3.1.1 List of selective chemicals used in this study 
Selective Chemical Stock Concentration Working dilution 
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Kanamycin 50 mg/ml in water 50 µg/ml 
Spectinomycin 50 mg/ml in water 50 µg/ml 
Streptomycin 50 mg/ml in water 50 µg/ml 
 
2.3.1.2 List of plasmids used in this study 
Construct Insert Backbone Type of vector Reference 
UBQ10::YFP-
PRA1.B1 
PRA1.B1 coding 
sequence 
pUBQ10::YFP-N 
(Grefen et al. 2010) 
Binary vector This study 
UBQ10::YFP-
PRA1.B2 
PRA1.B2 coding 
sequence 
pUBQ10::YFP-N 
(Grefen et al. 2010) 
Binary vector This study 
UBQ10::YFP-
PRA1.F1 
PRA1.F1 coding 
sequence 
pUBQ10::YFP-N 
(Grefen et al. 2010) 
Binary vector This study 
UBQ10::RFP-
PRA1.B1 
PRA1.B1 coding 
sequence 
pUBQ10::RFP-N 
(Grefen et al. 2010) 
Binary vector This study 
UBQ10::RFP-
PRA1.B2 
PRA1.B2 coding 
sequence 
pUBQ10::RFP-N 
(Grefen et al. 2010) 
Binary vector This study 
UBQ10::RFP-
PRA1.F1 
PRA1.F1 coding 
sequence 
pUBQ10::RFP-N 
(Grefen et al. 2010) 
Binary vector This study 
 
2.3.1.3 Plant genomic DNA extraction 
The Chelex 100 (Biorad) chelating resin diluted 1:10 in distilled H2O was used for quick DNA 
extraction and genotyping reactions. A. thaliana leaf disks sampled using a N01 cork borer. 
The leaf disc was placed in 100 μl in Chelex suspension and disrupted with a pipette tip. The 
mixture was vortexed briefly, incubated at 95 0C for 5 min and centrifuged at 13 000 rpm for 
1 min. 5 μl of supernatant was used per PCR reaction. 
2.3.1.4 Polymerase chain reaction 
PCRs were performed with 10 – 100 ng DNA as template in 25 μl final volume. Each 
reaction contained 1x PCR TAQ buffer or Phusion buffer, 0.2 mM dNTPs, 5 U/μl Taq DNA 
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polymerase (NEB) or 2.5 U/μl Phusion high-fidelity DNA polymerase (NEB), 10 μM of each 
primer. PCR was performed with successive cycles in a thermocycler (DNA engine PTC225, 
MJ Research). The temperatures and length of each temperature step were optimised to 
primers and length of product desired. 
2.3.1.5 Plant RNA extraction and cDNA production 
Plant tissue was collected in Eppendorf tubes, frozen in liquid nitrogen and ground to a fine 
powder using a rotating drill (pre-chilled in liquid nitrogen). 900 μl of TriReagent (Sigma) was 
added and the mixture incubated for 5 min at room temperature. 100 μl of Bromo-
chloropropane was added, tubes agitated by flicking then centrifuged at 10 000 g for 20 min 
at 4 0C. The supernatant was then transferred into a new Eppendorf tube and 400 μL of 
isopropanol was added to the solution followed by centrifugation at 10 000 g for 20 min. The 
supernatant was discarded and the pellet washed with 70% ethanol.  Ethanol was removed 
and the pellet air dried for 5 min. The RNA was re-suspended in RNase-free water and 
DNAse treated according to the DNase I RNase-free protocol (Roche). 10% SDS and 
proteinase K were added to the RNA and the solution incubated for 15 min at 42 0C. RNA 
was then purified using the RNeasy MinElute cleanup kit (Qiagen) and eluted in RNase-free 
water. Total RNA was quantified with a Nanodrop (Thermo Scientific). 
2.3.1.6 DNA electrophoresis 
Presence and length of DNA fragments after PCR were confirmed using electrophoresis. 
PCR products were mixed with 6x loading dye and in gels containing 1-2% agarose diluted 
in TAE and ethidium bromide. DNA migration was tested in an electrophoresis tank filled 
with TAE buffer applied with 100 V for 10-30 minutes. Fragment length was estimated using 
the 1 kb DNA ladder (40 ng/µl from NEB) loaded on the same gel. DNA was visualised by 
exposing the gel to UV light in a UV transilluminator from BIO-RAD. 
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2.3.1.7 Purification of DNA from agarose gel 
DNA bands of interest were visualised and excised on a UV table using a scalpel blade. The 
fragments were purified using QIAquick Spin columns (Qiagen). The DNA was either stored 
at -20 0C or used directly. 
2.3.1.8 Gateway® cloning from cDNA 
Coding sequences were amplified from cDNA by PCR into pENTR/D/TOPO entry vectors 
according to the protocol supplied by Invitrogen. Vectors were then transformed into 
chemically competent TOP10 cells by heat shock. Positive clones were confirmed by colony 
PCR and plasmid sequencing. Genes of interest were then transferred into expression 
vectors using the LR clonase II enzyme. The LR reaction was carried out using the protocol 
outlined by the manufacturer. In short, 150 ng of entry vector and 150 ng of destination 
vector were mixed with 1 µl of LR clonase II enzyme mix. Samples were vortexed quickly 
and incubated for 1 h at 25 0C. The reaction was then halted by addition of 0.5 µl of 
proteinase K to the mixtures and the reactions incubated at 37 0C for 10 mins. 1 µl of the LR 
reaction was then transformed into chemically competent TOP10 cells.  
2.3.1.9 Transformation of chemically competent E.coli 
TOP10E.coliwere transformed with 250 ng of purified plasmid DNA or 1 μl of LR/gateway 
reaction. 50 μl of chemically competent cells were incubated in a 1.5 ml Eppendorf tube on 
ice for 30 min followed by a 30 s incubation at 40 0C. 250 μl of L media was added and the 
bacteria incubated at 37 0C for 60 min and bacteria plated on selective media. 
2.3.1.10 Transformation of electro-competent A. tumafasciens 
A. tumafasciens (GV3101) were transformed with 250 ng of purified plasmid DNA. 50 μl of 
chemically competent cells were thawed directly from -80 0C stock on ice. Cells were mixed 
with DNA and inserted into a pre-chilled electroporation cuvette with 1 mm gap. A Gene 
Pulser Xcell (BIO-RAD) cell porator was used for electroporation with these following 
conditions: voltage = 1800 V, capacitance = 25 μF, resistance = 200 Ω. 250 μl of L media 
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was added and the bacteria incubated at 28 0C for 60 min and bacteria plated on selective 
media. 
2.3.1.11 Colony PCR 
To recover transformants following cloning with colony PCR, individual colonies were picked 
with a tip and a smear inserted into each PCR reaction tube. PCR reaction followed the PCR 
protocol to confirm specific gene/product. Colonies with the correct DNA fragments were 
allowed to grow overnight in 10 ml selective L media. 
2.3.1.12 Plasmid purification 
Transformed bacteria were pelleted after overnight culture with a single 10 min x 1000 g 
centrifugation step. Plasmid was purified using the QIAprep Spin Miniprep Kit, Qiagen. 
Plasmid was eluted in 50 μl dH2O, quantified with nanodrop and stored at -20 
0C. Correct 
sequence of the DNA insert was confirmed with sequencing performed by the GATC Biotech 
company (http://www.gatc-biotech.com/en/index.html). 
2.3.2 Protein biochemistry 
2.3.2.1 BCA protein quantification assay 
Protein solutions were diluted with dH2O to between 0.5 and 2 mg/ml of protein. 160 µl of 4% 
CuSO4 (w/v) was added to 8 ml of bicinchoronic acid (BCA) solution (Sigma). 100 µl of 
solution was added to wells of a clear plastic 96 well plate with 20 µl of protein solution. 
Solutions of Bovine serum albumin (BSA) at 0.5, 1, 1.5 and 2 mg/ml were prepared as 
standards. All solutions were measured in triplicate and the mean average taken. The plate 
was then incubated at 37 0C for 30 min and absorbance at 562 nm measured with a plate 
reader (Varioskan Flash - Thermofisher).  
2.3.2.2 List of protein extraction buffers used 
 Base Buffer Sucrose 
gradient buffer 
IP buffer Phosphorylation 
IP Buffer 
Na-HEPES 150 mM, pH 7.5 150 mM, pH 7.5 150 mM, pH 7.5 150 mM, pH 7.5 
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Sucrose 17.5% (w/v) 15-60% (w/v) 17.5% (w/v) 17.5% (w/v) 
EDTA 10 mM 10 mM 10 mM 10 mM 
EGTA 10 mM 10 mM 10 mM 10 mM 
KCl 7.5 mM 7.5 mM 7.5 mM 7.5 mM 
DTT 10 mM 10 mM 10 mM 10 mM 
IGEPAL 
CA-630 
- - 0.01% (v/v) 0.01 or 0.1% (v/v) 
Protease 
inhibitors 
1% (v/v) 1% (v/v) 1% (v/v) 1% (v/v) 
NaMo - - - 1 mM 
NaF - - - 25 mM 
Calyculin A - - - 1 nM 
PVPP 0.5% (w/v) 0.5% (w/v) 0.5% (w/v) 0.5% (w/v) 
 
2.3.2.3 Plant protein extraction 
Plant tissue was frozen in liquid nitrogen and ground with a pestle and mortar to powder, 30-
50 g of total fresh weight was then used. Base buffer was added 2 ml to 1 g of fresh weight 
tissue was added. Homogenate was then filtered through one layer of miracloth (Millipore). 
All subsequent steps occurred on ice or at 4 0C 
2.3.2.4 Sucrose gradient fractionation 
Microsomes were prepared from a plant protein extract. The homogenate was centrifuged 
once at 6000 g for 10 min, the supernatant taken and centrifuged at 10 000 g for 20 min. 
Then the supernatant was centrifuged for 1 hour at 100 000 g and the pellet was taken as 
the microsome. The microsome was then re-suspended in 2 ml of sucrose gradient buffer 
with 25% sucrose and quantified to determine protein content. A 6 step sucrose gradient 
(30-55%) was prepared in a 12 ml ultracentrifuge tube (Sorvall), 1.71 ml of gradient buffer 
were overlaid in 5% steps. 9 mg of protein from the 25% sucrose (sucrose gradient buffer) 
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with re-suspended microsome was then overlaid on top of the 30% sucrose fraction to fill the 
tube. The gradient was centrifuged at 100 000 g for 18 hours and 1 ml fractions collected 
from the top of the gradient by pipetting. Protein concentration in each fraction was 
quantified by BCA assay. 
2.3.2.5 3 step sucrose cushion fractionation 
Plant protein was extracted in base buffer with 15% sucrose. The homogenate was layered 
onto a 2 step sucrose gradient in a 5 ml ultracentrifuge tube (Sorvall). 1.5 ml of sucrose 
gradient buffer (35% sucrose) was layered onto a 1.5 ml sucrose gradient buffer (45% 
sucrose) layer. Then 2 ml of plant protein homogenate was layered on top to fill the tube. 
The gradient was centrifuged for 1 hour at 100 000g. The gradient was extracted as two 
fractions per step and the interface layers by pipetting from the top. Protein concentration 
was then quantified with BCA. 
2.3.2.6 Sucrose cushion fractionation for immunoprecipitation 
Plant protein from 3 flasks of 8 day old A. thaliana seedlings was extracted in base buffer 
with 15% sucrose. The homogenate was layered onto a 2 step sucrose gradient in 6 x 35 ml 
ultracentrifuge tubes (Sorvall). 5 ml of sucrose gradient buffer (35% sucrose) was layered 
onto a 5 ml sucrose gradient buffer (45% sucrose) layer. Then 25 ml of plant protein 
homogenate was layered on top to fill the tube. The gradient was centrifuged for 1 hour at 
100 000g. The 15% sucrose layer was extracted by pipetting and discarded. The 35% 
sucrose layer was then extracted with a pipette and diluted 1:1 with IP buffer with 0.02% 
IGEPAL CA-630. 
2.3.2.7 Immunoprecipitation 
Eight day old seedlings,from 3 x 250 ml conical flasks, were frozen in liquid nitrogen and 
ground with a pestle and mortar to powder, 30-50 g of total fresh weight was then used. 
Protein extraction buffer (150 mM Na-HEPES pH7.5, 10 mM EDTA, 10 mM EGTA, 17.5% 
(w/v) sucrose, 7.5 mM KCl, 0.01% (v/v) Igepal CA-630, 10 mM DTT (Dithiothreitol), 1% (v/v) 
Protease inhibitors (Sigma), 0.5% (v/v) PVPP (polyvinylpolypyrrolidone) at 2 ml to 1 g of 
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fresh weight tissue was added. All subsequent steps were performed at 4 0C. Protein 
concentration was determined with BCA assay. Homogenate was filtered through two layers 
of miracloth and centrifuged at 6000 g for 20 min. 20 μl of chromotek GFP or RFP trap 
sepharose beads (as appropriate) were added per 50 ml homogenate and incubated for 3 
hours with shaking. The homogenate was then centrifuged at 500 g for 5 min and the 
supernatant discarded. The bead slurry was washed 5 times with fresh pre-chilled extraction 
buffer (no PVPP or protease inhibitors) with 3 min incubation. The slurry was collected after 
the last wash and protein eluted with incubation at 95 0C for 10 min in 2x SDS-PAGE loading 
buffer and taken for either LC-MS/MS or Western blotting. 
2.3.2.8 SDS-PAGE and immunoblotting 
10% poly-acrylamide SDS-gels were run at 100/200 V and proteins electroblotted onto 
Polyvinylidene fluoride (PVDF) membranes at 250 mA (Biorad). Membranes were rinsed in 
Tris buffered saline (TBS) and blocked in 5% (w/v) non-fat milk powder in TBS 0.1% tween 
(TBST) (w/v) for 1 hour. Primary antibodies were diluted in 0.5% (w/v) non-fat milk (unless 
otherwise stated in Table 2.2), TBST to the following concentrations and incubated at room 
temperature for 1 hour. Membranes were washed three times in TBST before 1 hour 
incubation with secondary antibodies Signals were visualized using chemiluminescent 
substrate (Lumigen ECL, GE Healthcare) and GE healthcare Image Quant LAS 3000. 
2.3.2.8.1 List of antibodies used  
Antibody Working stock Manufacturer Species 
α-AHA1 (H
+
ATPase 1) 1:2 000 Agrisera AS07 260 Rabbit 
α-BIP2 (luminal binding protein) 1:2 000  Agrisera AS09 614  Chicken 
α-RbcL (Rubisco Large Subunit) 1:10 000 Agrisera AS03 037 Rabbit 
α-COX2 (Cytochrome Oxidase 2) 1:5 000 Cytochrome Oxidase 2 Rabbit 
α-RFP 1:10 000 Abcam ab34771 Rabbit 
α-FLS2 1:5 000 Purified by Eurogentec  Rabbit 
α-pERK (p44/42 MAPK) 1:1 000 (3% BSA) Cell signalling #9102 Rabbit 
46 | P a g e  
 
α-SEC21  1:2 000 Agrisera AS08 327 Rabbit 
α-HSP70 (Heat shock protein 70)  1:5 000 Agrisera AS08 371 Rabbit 
α-GFP 1:4 000 Life Tech A-11122 Rabbit 
α-pS 1:1 000 (3% Gelatin) Invitrogen 61-8100 Rabbit 
α-Rabbit IgG- HRP 1:10 000 Sigma A6154 Goat 
α-Chicken IgG- HRP 1:10 000 Agrisera AS09 603 Goat 
 
2.3.2.9 Tryptic protein digestion from gel  
Affinity purified proteins were separted on 4-20% Tris-Glycine nUView pre-cast gradient gels 
(NuSep) and proteins stained with Simply BlueTM Safe Stain (Invitrogen). The SDS-PAGE 
gels were cut into 7 slices per affinity purification. Gel slices were washed for 30 min with 
50% ACN/ 25 mM ammonium bicarbonate (ABC) at 37 0C, twice. Then 100% ACN was 
added for 10 mins and the liquid removed. 10 mM DTT in 50 mM ABC was added to cover 
the gel pieces for 30 min at 560C shaking and the supernatant removed. 55mM 
iodoacetamide in ABC (in the dark) was applied for 20 min. The gel pieces were washed 
twice for 15 min with 50% ACN/ 25 mM ABC and dehydrated with 100% ACN for 10 mins. 
1μg of trypsin, 46 mM ABC, 5% ACN was applied at 37 0C overnight and the supernatant 
removed and retained. The gel pieces were washed three times by addition of 50% ACN, 
5% formic acid and sonicated for 10 min and the wash supernatants were then pooled with 
previous supernatants. The supernatants containing the peptides were then dehydrated to 
dryness. 
2.3.2.10 In solution tryptic protein digestion 
Following IP performed with the following modifications. An additional wash step was added 
of 3 min in dH2O at 4 
0C. Proteins were eluted from the IP beads with 100 μl of 0.1% TFA in 
dH2O followed by centrifugation for 1 min at 500 g. The supernatant was collected and the 
elution, centrifugation repeated four more times, the collective washes were pooled and 
dehydrated to dryness in a speedvac (MiniVac Duoconcentrator). Protein was then re-
solublised in 8 M urea. 50 μM DTT in 55 mM Triethylammonium bicarbonate (TEAB) was 
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added and the solution incubated for 1 hour at room temperature followed by 100 mM 
iodoacetamide in 55 mM TEAB incubated in the dark for 1 hour. 0.3 μg of trypsin was added 
and incubated at 37 0C overnight. 1 μl acetic acid in 55 mM TEAB was added to halt the 
digestion. The peptides were then dehydrated to dryness in a speedvac (MiniVac 
Duoconcentrator).LC-Orbitrap analysis of peptide solutions 
 
An Orbitrap (ThermoFisher Scientific) and a nanoflow-Ultra high performance liquid 
chromatography (UHPLC) system (nanoAcquity, Waters Corp.) was used to analyse peptide 
solutions. The generated peptides dissolved in 2% acetonitrile, 0.2% trifluoroacetic acid were 
applied to a reverse phase trap column (Symmetry C18, 5 m, 180 m x 20 mm, Waters 
Corp.) connected to an analytical column (BEH 130 C18, 1.7 m, 75 m x 250 mm, Waters 
Corp.) in vented configuration using nano-T coupling union. Peptides were eluted in a 
gradient of 3-40 % acetonitrile in 0.1 % formic (solvent B) acid over 50 min followed by 
gradient of 40-60 % B over 3 min at a flow rate of 250 nL min-1 at 40oC. The MS was 
operated in positive ion mode with nano-electrospray ion source with ID 0.02mm fussed 
silica emitter (New Objective). Voltage +2kV was applied via platinum wire held in PEEK T-
shaped coupling union. Transfer capillary temperature was set to 200 oC, no sheath gas, 
and the focusing voltages in factory default setting were used. The Orbitrap, MS scan 
resolution of 60,000 at 400 m/z, range 300 to 2000 m/z was used, and automatic gain 
control (AGC) target was set to 1000000 counts, and maximum inject time to 1 000 ms. In 
the LTQ, MS2 spectra were triggered with data dependent acquisition method for the 5 most 
intense ions. The threshold for CID was above 1000 counts, normal scan rate, AGC 
accumulation target was set to 30 000 counts, and maximum inject time to 150ms. A data 
dependent algorithm was used to collect as many tandem spectra as possible from all 
masses detected in master scan in the Orbitrap. For the latter, Orbitrap pre-scan 
functionality, isolation width 2 m/z and collision energy set to 35% were used. The selected 
ions were then fragmented in the ion trap using CID. Dynamic exclusion was enabled 
48 | P a g e  
 
allowing for 1 repeat only, with a 60 s exclusion time, and maximal size of dynamic exclusion 
list 500 items. Chromatography function to trigger an MS2 event close to the peak summit 
was used with correlation set to 0.9, and expected peak width 7s. Charge state screening 
enabled allowed only higher than 2+ charge states to be selected for MS2 fragmentation. 
2.3.2.11 iTRAQ labelling of peptides 
Briefly, peptides were digested with trypsin in 50mM triethylammoniumbicarbonate buffer, 
after reduction with DTT and carbamidomethylation with iodoacetamide. 35l of the digest 
was mixed with ethanolic solution of iTRAQ reagent, and incubated for 2 hours at RT. 
Samples were labelled using 4-plex iTRAQ labelling kit (AB Sciex Ltd., USA). Individual 
samples labelled the unique isotopic labels were combined, and evaporated to dryness in 
vacuum concentrator. 
2.3.2.12 Strong cation exchange chromatography 
Peptides were separated by two dimensional liquid chomatography. In the first dimension we 
used Strong cation-exchange chromatography (SCX) on 1 x 150mmPolySULFOETHYL A™( 
PolyLC Inc., USA) column. Mobile phase composition was 20mM potassium phosphate 
pH2.7 with 20% Actonitrile in the solvent A, and with 0.5M potassium chloride in the solvent 
B. Sample was dissolved in the solvent A, and injected on the column on U3000 (Thermo, 
USA) liquid chromatograph. When UV detector response (214nm) stabilized, 40min gradient 
dissolved in 0.1%TFA and 2%Acetonitrile for second dimension of LC separation.   
2.3.2.13 MS analysis of iTRAQ labelled peptides 
Samples were analysed by LC-MS/MS in data dependent mode on a Synapt G2 mass 
spectrometer (Waters) coupled to a nanoAcquity UPLC system(Waters Ltd, Manchester, 
UK). Peptides were trapped using a pre-column (Symmetry C18, 5µm, 180 µm x 20 mm, 
Waters Ltd) which was then switched in-line to an analytical column (BEH C18, 1.7 µm, 75 
µm x 250 mm, Waters Ltd) for separation. Peptides were eluted with a gradient of 3-40% 
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acetonitrile in water/0.1% formic acid at a rate of 0.75% min-1 with a flow rate of 250 nL min-
1. The column was connected to a 10 µm SilicaTip™ nanospray emitter (New Objective, 
Woburn, MA, USA) for infusion into the mass spectrometer. Glu-Fibrinogen peptide (1 pmole 
µl-1 , Sigma-Aldrich) was infused at 0.5 µl min-1 as a lock mass for recalibration and 
measured every 30 s. The mass spectrometer was controlled by the Masslynx 4.1 software 
(Waters) and operated in positive DDA and sensitivity mode with capillary voltage of 3 kV, 
cone voltage of 40 V. Scan time was 0.5 s over the range of 350-1800 m/z for full scans. 
MS2 was performed on the top 5 peptides per full scan (charge stages 2-4 +) and triggered 
by ion intensities above a threshold of 7000. Scan time was 1 s for the MS2 scan, and a 
charged stage dependent collision energy optimised for iTRAQ labelled peptides was 
applied in the trap cell. 
 
Peaklist (pkl) files were generated in ProteinLynx Gobal Server 2.5.2 (Waters) and used for 
protein identification and relative iTRAQ quantitation by a database search. The search and 
the quantitation were performed using an in-house Mascot Server 2.4 (Matrixscience, 
London, UK) on a TAIR protein database. The Mascot searches and quantification has been 
summarized in Scaffold-PTM (Proteome Software Inc., USA). Data was exported to excel for 
quantitative comparissons. 
2.4 Cell biology 
2.4.1 Transient protein expression by particle bombardment 
pUBQ10::YFP or pUBQ10::RFP-PRA1.B1/PRA1.B2/PRA1.F1 were coated onto 1 μm gold 
particles and bombarded into 4- to 5-week-old leaves of pUBQ10::RFP-RABF2b/ARA7, 
pUBQ10::YFP-GOT1 and pUBQ10::RABF1/ARA6-RFP using a Bio-Rad Biolistic PDS-
1000/He particle delivery system. Bombardment sites were imaged 16 hours after 
bombardment by confocal microscopy. Data were collected from at least two independent 
bombardment events and 5 independent plants. 
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2.4.2 Sub-cellular protein localisation 
Confocal laser microscopy was performed using the laser point scanning microscope Leica 
SP5. YFP was excited using the 514-nm argon laser, and fluorescence emissions were 
captured between 520 and 550 nm for YFP. RFP was excited at 561 nm, and emission was 
taken between 580 and 620 nm. The sequential scan mode was used for simultaneously 
imaging of YFP/RFP. Images were processed using the LeicaLite and Adobe Photoshop 
CS4 software packages. Images are maximum projections of a consecutive series of 
multiple Z planes 1 μm apart. Pearson’s Rank correlations were calculated using voxel 
intensity in the YFP and RFP channels with the software Imaris. 
2.5 Proteome analysis 
2.5.1 Spectrum matching with MASCOT 
Peak lists in format of Mascot generic files (.mgf files) were prepared from raw data using 
Proteome Discoverer v1.2 (ThermoFisher Scientific). Peak picking settings were as follows: 
m/z range set to 300-5000, minimum number of peaks in a spectrum was set to 1, S/N 
threshold for Orbitrap spectra set to 1.5, and automatic treatment of unrecognized charge 
states was used. Peak lists were searched on Mascot server v.2.4.1 (Matrix Science) 
against TAIR (version 10) database with GFP, RFP and common contaminants such as 
keratin added.Only tryptic peptides, were permitted with up to 2 possible miscleavages and 
charge states +2, +3, +4, were allowed in the search. The following modifications were 
included in the search: oxidized methionine (variable), carbamidomethylated cysteine 
(static). Data were searched with a monoisotopic precursor and fragment ions mass 
tolerance 10ppm and 0.8Da respectively. Mascot results were combined in Scaffold v. 4 
(Proteome Software) and exported in Excel (Microsoft Office). Peptide identifications were 
accepted if they could be established at greater than 95.0% probability by the Peptide 
Prophet algorithm (Searle 2010) with Scaffold delta-mass correction. 
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2.5.2 SAINT Analysis 
Protein identifications and total spectrum counts were exported from Scaffold and the fold 
enrichment over control samples (containing fluorescent protein baits) was calculated using 
SaintExpress {Teo et al. 2014). Default settings were used, where all three replicates 
counted equally and we did not use any known interaction information to weight interaction 
probabilities. Proteins were considered to be statically enriched if the SaintExpress 
probability score was greater or equal to 0.8 in keeping with recommendations (Teoet 
al.2014,Choiet al. 2011). At least three controls of mCherry, YFP and Col-0 enrichments 
were used. 
2.5.3 Proteome definition 
A finalised list of proteins identified in each proteome was created according to the following 
criteria: A minimum of two unique peptides were required to identify a protein and 
identifications were classified into three groups. Group 1 proteins have spectrum matches in 
the affinity enrichments and none in the controls in two or more replicate affinity purifications. 
Group 2 proteins have spectrum matches in both control and affinity enrichments but have at 
least two times more spectrum matches in the affinity purifications than in the control in two 
or more replicates. Group 3 proteins have spectrum matches in only one out of three 
replicates affinity purifications and so have only weak evidence supporting their assignment 
to a proteome and are reported for completeness. I present proteins in groups 1 and 2 for 
each affinity purification bait as being identified in that proteome.The Sungear diagram was 
generated in virtual plant (Poultney et al. 2007). Venn diagrams were produced in R (File 
S1). 
2.5.4 Electronic annotation of identified proteins 
To identify transmembrane domains and putative signal peptides in our proteomic data I 
parsed a bulk download of protein data from Swiss-Prot and pTREMBL 
(http://web.expasy.org/docs/swiss-prot_guideline.html) using the Perl script (File S2). I also 
extracted protein name information and number of transmembrane domains from TAIR10 by 
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direct download of proteins with transmembrane domains from (http://www.arabidopsis.org/ 
and http://www.uniprot.org). Transmembrane domain information from TAIR10 was used 
preferentially to that from Swiss-Prot, and protein records from the manually curated Swiss-
Prot preferentially to data from electronically annotated pTREMBL. Data was then 
amalgamated with information of acylaton (Hemsley et al. 2013) and comparison to 
published proteomic data(Dunkley et al. 2006, Sadowski et al. 2008, Drakakaki et al. 2012, 
Nikolovski et al. 2012, Parsons et al. 2013, Groen et al. 2014) in Excel. 
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3 Development of a method for the affinity enrichment of 
proteins associating with endomembrane markers. 
Acknowledgements: All LC-MS/MS analysis was performed by Dr Jan Sklenar, analysis of 
data generated through LC-MS/MS analysis was partially analysed by Dr Jan Sklenar and 
partially by William Heard. SAINT analysis was performed by Dr Alex Jones. All other 
techniques were performed by William Heard. Sections 3.2.3, 3.2.5, 3.2.6, 3.2.7, 3.2.8, 3.2.9 
contain data submitted in a paper to Molecular and cellular proteomics. 
3.1 Introduction and objectives 
3.1.1 Proteomic characterisation of LE/MVBs is the essential first step to 
understanding the role of LE/MVBs in signalling 
Endomembranes are integral to cellular function, as demonstrated by the severe 
developmental phenotypes that frequently occur in mutants lacking endomembrane 
regulators, for examples see Mayer et al. 1993; Assaad et al. 2004; Cai et al. 2005; Gendre 
et al. 2013[166]. Yet our knowledge of the plant endomembrane system, and the proteins 
both regulating and trafficking through it, is limited because of lack of study and low 
homology to mammalian and yeast systems (discussed in Section 1.2.1). 
 
Great advances have been made in localising proteins to endomembrane compartments, 
using confocal and electron microscopy. More recently, excellent progress has been made in 
the plant field with characterising the proteomes of the ER, the vacuole, PM, mitochondria 
and chloroplasts, and smaller vesicle-like compartments such as peroxisomes and Golgi 
(Carter et al. 2004, Kleffmann et al. 2004, Dunkley et al. 2006, Eubel et al. 2007, Jaquinod et 
al. 2007, Schmidt et al. 2007, Eubel et al. 2008, Ito et al. 2010, Drakakaki et al. 2012, Elmore 
et al. 2012, Nikolovski et al. 2012, Parsons et al. 2012, Groen et al. 2014). However, basic 
proteomic data is minimal for compartments such as LE/MVBs in plants.  
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The innovative use of proteomic data has led to discoveries that would otherwise not have 
been possible. For example, using proteomic data of the Golgi and structure-based 
homology analysis, Nikolovski and colleagues (Nikolovski et al. 2012) could identify 12 
previously uncharacterised Golgi glycosyltransferase (GT) families. This revealed that there 
could be up to 30% more GTs in plants than previously estimated. Furthermore it highlights 
the importance of organelle proteomics in deciphering the biochemical functionality of a 
compartment.  
 
To better understand the wider functions of LE/MVBs within a cell, we first need a proteome 
of these compartments. Therefore, my first objective was to develop a method to allow 
proteomic analysis of LE/MVBs. 
3.1.2 RABF2b/ARA7 is a good model for studying LE/MVBs 
The term LE/MVB represents a group of endomembrane compartments comprised of 
membranes and proteins on the endocytic route to the lysosome, or the vacuole in plants 
(Alberts et al. 2008). The identity of a LE/MVB is dictated by the presence of RAB GTPases 
on the cytosolic face of the membrane that regulate its protein and lipid composition (Saito 
and Ueda 2009). In plants, late endosome identity is conferred by the RAB5 GTPase family, 
RABF1/ARA6, RABF2b/ARA7 and RABF2a/RHA1 (Ueda et al. 2001, Rutherford and Moore 
2002, Lee et al. 2004, Ueda et al. 2004), and the RAB7 GTPase family, RABG1, RABG2 
and RABG3a-f (Rutherford and Moore 2002, Geldner et al. 2009). RAB7 family GTPases 
also have a role at the tonoplast membrane (Nielsen et al. 2008). Amongst the LE/MVB 
population there is a clear distinction between RAB5 and RAB7 labelled structures 
(Bottanelli et al. 2012). The RAB5 family label the earlier ‘late’ endosome and as the 
endosome matures, the RAB7 family GTPases are brought onto the membrane by RAB5 
family GTPases and their effectors (Cui et al. 2014, Lawrence et al. 2014). The RAB7 family 
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GTPases, through the action of their effectors, then prevent association of the RAB5 family 
GTPases, following the RAB cascade hypothesis (Markgraf et al. 2007).  
 
In addition to the distinction between the RAB5 and RAB7 family GTPase labelled 
endosomes, it is clear that there is diversity between RAB5 family GTPase labelled 
endosomes. The different RAB5 family GTPases are expressed in different tissues, but they 
are also functionally distinct (Ueda et al. 2004, Ebine et al. 2011). Several cargos of the 
endocytic route pass through these endosome populations and this highlights the functional 
differences between them. The RLK FLS2 co-localises with both RFP-RABF2b/ARA7 and 
RABF1/ARA6-RFP after ligand induced endocytosis, but displays up to 90% co-localisation 
with RFP-RABF2b/ARA7, and only up to 60% co-localisation with RABF1/ARA6-RFP (Beck 
et al. 2012). Similarly, peak co-localisation of FLS2-GFP with RFP-RABF2b/ARA7 occurs at 
30 minutes of ligand treatment, whereas for RABF1/ARA6-RFP co-localisation is delayed to 
60 minutes of flg22 induced endocytosis (Beck et al. 2012). 
 
Despite these differences in functionality of endosomes, for this study I followed the 
assumption that compartments would be sufficiently biophysically and biochemically similar 
that RFP-RABF2b/ARA7 endosomes could be used as a model to optimise the protocol for 
endosome enrichment for proteomic analysis. 
3.1.3 Approaches for the preparation of endomembrane compartment proteins for 
proteomic analysis 
Historically the preparation of endomembrane compartments for proteomic analysis has 
made extensive use of the biophysical properties of a compartment. One of the most 
common methods for the enrichment of endomembranes for proteomic analysis is in the 
enrichment of microsomes. This method helps define proteins associating with membranes, 
reviewed Abas and Luschnig (2010). Microsomes are commonly defined as the membrane 
fraction spun down at 100,000g from a post-mitochondrial fraction(De Duve 1971, Dallner 
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1974). This includes a mixture of the endomembrane organelles of the cells studied (varying 
by species), but predominantly vesicles derived from lysed ER (reviewed in (Abas and 
Luschnig 2010). Microsome preparations rely on the greater density of endomembrane 
organelles than the extraction buffer in which they are suspended. Therefore upon a 
centrifugation (usually ultra-centrifugation of >100 000 g) step, they are pelleted and form a 
microsome fraction (Abas and Luschnig 2010). Typically there is also a single pre-clearing 
step to remove unwanted organelles and cell debris e.g. cell walls, nuclei (Abas and 
Luschnig 2010). There is a subsequent stronger centrifugation step which can be varied 
depending on the cells analysed. This is a relatively crude preparation, as the aim is to pellet 
all endomembranes, and compartment specific (amongst the microsome organelles) protein 
localisation cannot be determined. Furthermore, the microsomal fraction is frequently very 
difficult to re-suspend, due to the ultracentrifugation steps, and frequently organelles are 
damaged by the required agitation to re-suspend the microsomal pellet (Abas and Luschnig 
2010). 
 
To provide greater organelle resolution to the identification of proteins than a microsomal 
fractionation, methods of organelle preparation for proteomic analysis were improved, 
exploiting differences in compartment properties. Endomembrane compartments have 
different biophysical properties. Different densities and surface charge from lipid 
composition, protein content and shape provide the opportunity to selectively isolate or 
enrich compartments using their different biophysical properties. Centrifugation in varying 
densities of extraction media (often sucrose but other media have been used more recently) 
allowed the proteomic characterisation of a variety of endomembrane compartments 
including animal clathrin coated vesicles and synaptic vesicles (reviewed (Castle 2001). 
Whilst this approach has been successful in some cases, difficulties have been encountered 
in isolating pure organelles, especially for delicate compartments and those with significant 
similarities in biophysical properties to other organelles (Dunkley et al. 2004, Sadowski et al. 
2008, Groen and Lilley 2010, Nikolovski et al. 2012). This has stimulated the development of 
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novel approaches employing statistical methods to extract data against a background of 
noise, circumventing the need for purification entirely.  
3.1.4 Statistical methods to identify organelle proteins 
Statistical approaches include the Localization of Organelle Proteins by Isotope Tagging 
(LOPIT) technique (Dunkley et al. 2004, Dunkley et al. 2006, Sadowski et al. 2008, 
Nikolovski et al. 2012) or protein correlation profiling (PCP) (Foster et al. 2006). Both 
techniques assess the co-migration of proteins down a density gradient after centrifugation 
with known marker proteins from a specified organelle but use different methods for protein 
quantitation. A protein that co-migrates with a marker protein for a specific organelle is then 
assigned to that compartment proteome. For these techniques, good quality marker proteins 
and careful statistical analysis is essential, but specific compartment purification is not. 
When there were insufficient marker proteins known for an organelle, IP of a known marker 
(Vacuolar H+ ATPase-A1 - VHA-A1) was used to preliminarily characterise the proteome of 
the  plant TGN/EE to allow successful analysis with LOPIT (Groen et al. 2013). 
3.1.5 Novel purification techniques for organelle proteomics 
To improve purity of isolated organelles and as an alternative to density gradient 
centrifugation, surface charge properties can be used to isolate membrane structures such 
as the PM (Widell et al. 1982, Lund and Fuglsang 2012). In these studies, aqueous polymer 
solutions are used to separate the membrane structures based on hydrophobicity, a property 
defined by phospholipid composition etc. (Schindler and Nothwang 2006). The PM is 
preferentially enriched in the hydrophobic top phase comprised of the aqueous polymer 
PEG, rather than the lower phase of the aqueous polymer solution of dextran (Schindler and 
Nothwang 2006). Surface charge was also used in addition to migration in density medium 
to great effect by Parsons et al. 2012 for enrichment and proteomic analysis of the Golgi. 
Here, an electrical current was applied to a Golgi enriched fraction obtained by sucrose 
gradient separation to further purify the Golgi. This purification method allowed proteomic 
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analysis of the plant Golgi and led to elucidation of Apyrase 1(ATAPY1)’s novel function as 
an NDPase in the Golgi (Parsons et al. 2012). 
 
An analogous approach uses the protein identity of a compartment to selectively enrich for 
the organelle, whereby an affinity binding protein and a corresponding target associated with 
the membrane of choice are used to target and precipitate the organelle. This can be 
described as IP of an organelle. The organelle properties (usually density with agarose 
beads or magnetism with iron beads) of an organelle are changed through binding to a bead 
through an antibody. The organelle can then be more easily precipitated from solution. This 
technique has been used to enrich mitochondria  (Hornig-Do et al. 2009) and even cell line 
specific nuclei (Deal and Henikoff 2011). Furthermore the technique was more recently 
established for endomembrane organelles in animals (Morciano et al. 2005, Steuble et al. 
2010) and then plants (Drakakaki et al. 2012) to prepare intact CFP-SYP61 labelled TGN 
vesicles. All of these techniques could be used individually or in combination to enrich 
LE/MVBs for proteomic analysis.  
 
These IP techniques can yield intact compartments, or at least membrane structures 
resembling the desired organelles, as determined by electron microscopy (Morciano et al. 
2005, Steuble et al. 2010, Drakakaki et al. 2012). It is not necessary, however, to isolate 
intact compartments to define an organellar proteome. IP of PM membranesfrom animal cell 
cultures, obviously disrupts the normal structure of the organelle (as the PM is broken) 
(Zhang et al. 2006) or indeed any enrichment of the PM (Benschop et al. 2007, Nühse et al. 
2007, Tang et al. 2008, Keinath et al. 2010). Yet biologically relevant proteomic data was 
obtained through these methods. As long as the protein target is suitably localised and 
important in the functioning of an organelle, IP will enrich for proteins associating with the 
target and so localising to the organelle, as demonstrated by IP of VHA-A1 for the 
description of the TGN proteome (Groen et al. 2014). In a similar approach to Groen et al. 
2014, Fujiwara et al. (2014) utilised an IP based method to assess the interactome of 
59 | P a g e  
 
SNAREs. As several SNAREs have defined localisations within the cell, this methodology 
allows for inference of the proteomes of the compartment to which the SNARE localises 
(Fujiwara et al. 2014). For this approach to be successful, careful choice of marker proteins 
as IP targets is essential. 
3.1.6 Markers have significantly aided research into endomembranes 
Marker proteins have proven essential to our understanding of the endomembrane system; 
identification of diagnostic residents of a compartment allow the definition of that 
compartment microscopically, biochemically or biophysically. Such markers usually have 
putative or defined regulatory or structural roles within a compartment. I selected markers 
that meet these criteria for this study: Golgi transport 1 (GOT1) has a putative role in un-
coating Coat protein 2 (COPII) vesicles and is located at the Golgi (Conchon et al. 1999, 
Lorente-Rodríguez et al. 2009)); VAMP711 (vacuolar SNARE) marks the tonoplast (Geldner 
et al. 2009); RABD2a/ARA5 (RAB GTPase) labels the secretory route from the Golgi to the 
TGN to post Golgi vesicles; Clathrin light chain 2 (CLC2) is an integral component of clathrin 
coated structures trafficking from the PM and the TGN/EE. To label endosomal 
compartments, RABF2b/ARA7 and RABF1/ARA6 (both RAB 5 GTPases) are used as 
LE/MVB markers, whilst RABG3f (RAB 7 GTPase) labels both the LE/MVB and tonoplast. 
Collectively, these markers act as a powerful suite of tools to assess diverse endomembrane 
organelles.  
 
None of these markers have been tested for complementation. Without this data, it cannot 
be concluded as to whether the compartments labelled are biologically relevant. These 
markers are, however, frequently used for co-localisation studies and so proteomic data 
obtained using these markers is useful as it directly applies to the markers used, rather than 
the represented biological compartments. Furthermore, these markers are being expressed 
under a constitutive promoter. The UBQ10 promoter expresses to lower levels than the 35s 
promoter but there is still overexpression (Grefen et al. 2010). This can also result in 
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artefacts, for example overexpression of RAB GTPases results in enlargement of the 
labelled compartments (Spallek et al. 2013). 
3.1.7 Objectives 
In order to meet my overall aims of assessing the role of endosomes in signal transduction, I 
required proteomic data for endosomes. Therefore, in this chapter, I aim to develop a 
method to suitably enrich endosome proteins, using RABF2b/ARA7 initially as a marker, and 
expanding to other endosome markers. Then I will utilise this method to proteomically 
characterise other endomembrane compartments. 
3.2 Results 
3.2.1 RFP-RABF2b/ARA7 co-fractionates with the ER and PM on a sucrose gradient 
In order to biophysically characterise the RFP-RABF2b/ARA7 endosomes in relation to other 
endomembrane compartments, I tested their migration on a sucrose gradient. Microsomes 
were prepared, re-suspended in 25% sucrose gradient buffer, quantified with BCA assay 
and 9 mg of protein was layered on a sucrose gradient (30-55% sucrose) and centrifuged at 
100 000 g x 18 hrs. I collected 12, 1 ml fractions from the bottom of the gradient, and took 
12.5 μl of each fraction with 6 μg of microsomal and cytosolic protein for SDS-PAGE. 
Distribution of RFP-RABF2b/ARA7 endosomes, PM, ER, chloroplasts/cytosol and Golgi 
vesicles was then assessed with immunoblot using αRFP, αFLS2/αAHA1, αBIP2, αRbcL 
and αSEC21 respectively (Figure 3.1). RFP-RABF2b/ARA7 co-fractionated partially with the 
PM, ER and cytosol. However, the majority of the RFP-RABF2b/ARA7 appears in lighter 
fractions of around 35% sucrose, whilst the majority of the ER and PM were found in the 
denser fractions of >40% sucrose.  
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3.2.2 RFP-RABF2b/ARA7 endosomes can be biochemically separated from the 
cytosol and ER but not the PM 
Using the knowledge of ER, PM and RFP-RABF2b/ARA7 migration in sucrose gradients, I 
developed a modified microsome production protocol to deplete ER, cytosol and PM from 
the RFP-RABF2b/ARA7 enriched microsome. A crude extract of protein was prepared from 
A. thaliana expressing RFP-RABF2b/ARA7 in 15% sucrose gradient buffer and loaded onto 
a 35%, 45% stepped sucrose gradient and centrifuged at 100 000 g x 1 hr. I used a single 
step purification strategy, rather than a two-step microsome preparation, for simplicity, and to 
avoid the need for re-suspension of the microsomal pellet.  
 
Fractions were collected from the 15%, 35%, 45% sucrose steps and from the interfaces, 
and 12.5 μl analysed with SDS-PAGE and immunoblot (Figure 3.2). I tested for abundance 
of RFP-RABF2b/ARA7, PM, ER, cytosol and Golgi vesicles using αRFP, αFLS2/αAHA1, 
αBIP2, αHSP70 and αSEC21 respectively. The majority of the RFP-RABF2b/ARA7 was 
Figure 3.1.Co-fractionation of organelles on a sucrose gradient. A microsome 
fraction from A. thaliana stably expressing RFP-RABF2b/ARA7, was fractionated on a 
25-55% sucrose gradient followed by immunoblot, along with total microsomal and 
cytosolic fractions with αRFP, BIP2, Sec21, FLS2, RbcL, AHA1 as indicated. 
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detected in the 35% fraction and the associated interfaces. In addition, there was a depletion 
of ER in the 35% and interface fractions, however, the PM was also predominantly detected 
in the 35% fraction. Therefore I concluded it was unlikely that I could achieve a pure fraction 
of RFP-RABF2b/ARA7 labelled endosomes using biophysical properties alone.  
 
The identification of BIP2 (a soluble ER marker protein) only in the most dense pellet of the 
gradient also demonstrates that this method of tissue lysis (pestle and mortar grinding on 
liquid nitrogen) can yield intact organelles. If the ER was broken, then BIP2 should be 
identified in the predominantly cytosolic top 15% fraction, which it is not (Figure 3.2). As the 
ER’s structure is substantially more elaborate than those of vesicular endosomes, it is likely 
that the LE/MVBs are intact as well. 
 
Figure 3.2.A 3 step sucrose gradient to remove cytosol and ER from crude 
extract. A crude extract (in 15% sucrose) from A. thaliana stably expressing 
RFP-RABF2b/ARA7, was fractionated on  two 35%-45% sucrose steps followed 
by immunoblot with αRFP, BIP2, Sec21, FLS2, Hsp70, AHA1 as indicated.b. is 
a photograph of the resulting gradient after centrifugation. Percentages 
represent sucrose concentration (w/v). 
 
a. b. 
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3.2.3 Immuno-purification gives a significant enrichment of endosome markers with 
minimal endoplasmic reticulum and plasma membrane contamination 
To test whether I could use IP of RFP to enrich for RFP-RABF2b/ARA7, and associating 
proteins, whilst depleting other contaminating organelles, I analysed a variety of IP buffers 
with different additives. IPs of RFP-RABF2b/ARA7 and Col-0 as a control were analysed 
with SDS-PAGE and colloidal Coomassie stain (Figure 3.3). Visual inspection shows that an 
addition of 0.01% (v/v) IGEPAL CA-630 yields a good enrichment of RFP-RABF2b/ARA7, 
and other proteins, with the least contamination in the control lane. This concentration of 
IGEPAL CA-630 was used as it is below the critical micelle concentration 0.29 mM or 
0.0179%, v/v (Piercenet.com) of this detergent and so should prevent the lysis of membrane 
structures. 
 
To further interrogate the level of contamination of our IP protocol, I used IP of RFP and YFP 
to enrich RFP-RABF2b/ARA7 (IP - RFP) and a LE/MVB/tonoplast marker YFP-RABG3f (IP - 
YFP) from A. thaliana expressing the relevant fusion proteins and Col-0 as a control. 10% of 
Figure 3.3.SDS-PAGE comparison of immune-purifications with different 
additives. Total extracts from A. thaliana, stably expressing RFP-
RABF2b/ARA7 were subjected to immuno-affinity enrichment of RFP followed 
by SDS-PAGE and coomassie stain.  
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the IP in each case was used for SDS-PAGE and immunoblot for RFP-RABF2b/ARA7, 
RABG3f and markers for the ER, Mitochondria, chloroplasts/cytosol and PM (αRFP, αGFP, 
αER, αCOXII, αRbcL and αAHA1 respectively). Whilst all organelles could be easily 
detected in the inputs of Col-0, RFP-RABF2b/ARA7 and YFP-RABG3f (Figure 3.4), they 
could not be detected with this system in the IPs. Whilst these immunoblots demonstrate 
that the endosome marker alone can be enriched with IP, I was unable to assess the co-
enrichment of other known associating proteins, e.g. Vacuolar protein sorting 9a (VPS9a), 
VAMP727, Suppressor of K+ Transport Growth Defect1 (SKD1) for RABF2b/ARA7, as no 
suitable antibodies could be obtained. However, based on this data, I concluded that a good 
enrichment of an endosomal marker can be achieved with IP and a much greater depletion 
of contaminating organelles, compared to using sucrose gradients alone.  
 
Figure 3.4.Immunoblotting of RFP-RABF2b/ARA7 and YFP-RABG3f 
enrichments to determine organelle contamination. Total protein extracts, 
from A. thaliana Col-0 or stably expressing RFP-RABF2b/ARA7 or YFP-
RABG3f, were subjected to immunoaffinity enrichment of RFP or YFP followed 
by immunoblot with αRFP, GFP, BIP2, COXII, RbcL, AHA1 as indicated. 
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3.2.4 Pre-fractionated input to an IP does not reduce contamination with unwanted 
proteins 
To determine whether RABF2b/ARA7 associating proteins could be co enriched with our IP 
method I performed IP of YFP-RABF2b/ARA7 (Col-0 seedlings as a control) from a crude 
extract followed by SDS-PAGE fractionation, tryptic digest and LC-MS/MS. Strikingly 
undesirable organelle proteins (e.g. from the ER and cytosol) could be detected, even 
though they were not detected with immunoblot. Therefore, I also performed IP of GFP from 
a fractionated input from the 35% and interface fractions (Figure 3.2) of Col-0 and YFP-
RABF2b/ARA7 expressing seedlings followed by SDS-PAGE fractionation, tryptic digest and 
LC-MS/MS. A brief summary of the MS data is presented in Figure 3.5. Known 
RABF2b/ARA7 proteome proteins are detected in both IPs from crude and a fractionated 
input (Figure 3.5a). The fractionated IP yielded a smaller percentage of spectra assigned to 
RABF2b/ARA7 proteome proteins and a larger percentage of spectra assigned to ER 
proteins. Furthermore there were roughly equal numbers of spectra assigned to 
keratin,trypsin and ribosomes (I assumed these to be contaminants) in the IPs from crude 
and fractionated inputs. Therefore I surmised that there was no benefit to IP from a pre-
fractionated sample and all further IPs are from crude extract. Furthermore, the 
contaminating proteins examined with Figure 3.5 are present at similar abundances in both 
Col-0 control and YFP-RABF2b/ARA7 IPs, therefore are likely to be sticking to the affinity 
beads. This demonstrates the need for good controls when using this protocol for organelle 
proteomics. 
 
3.2.5 Affinity purification of seven different endomembrane compartment markers 
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To provide adequate controls for my survey of endosomal proteomes, I chose seven 
endomembrane marker proteins for numerous different endomembrane organelles 
(Figure3.6a). Details of the marker proteins, their mammalian and yeast homologs are 
presented in Table 3.1 and in Section 3.1.6. All of these markers were under the control of 
constitutive promoters to ensure expression in all plant tissues - UBQ10 (Ueda et al. 2001, 
Ueda et al. 2004, Grefen et al. 2010) or 35s for CLC2-GFP (Konopka et al. 2008). 
Expression of protein markers was confirmed in leaf epidermal cells using CLSM (Figure 
3.6b). RFP-RABF2b/ARA7, YFP-RABF2b/ARA7, RABF1/ARA6-RFP, YFP-RABD2a/ARA5, 
CLC2-GFP and YFP-GOT1 localise predominantly to motile cytoplasmic structures. YFP-
RABG3f localises to both cytoplasmic structures and a membrane resembling the tonoplast. 
YFP-VAMP711 localises to a membrane structure resembling the tonoplast. These data are 
Figure 3.5.MS assessment of pre-fractionation on levels of contaminating 
proteins in IP of YFP-RABF2b/ARA7. Crude extracts of proteins from 
A.thaliana stably expressing YFP-ARA7 were subjected immuno-affinity 
enrichment of YFP, run on SDS-PAGE, tryptically digested and subsequently 
analysed with LC-MS/MS. A. Comparison of percentage of total spectra 
assigned to the ER or RABF2b/ARA7 endosomes in affinity enrichments of 
YFP-RABF2b/ARA7 from A. thaliana. B. Comparison of total number of spectra 
assigned keratin/trypsin, ribosomal proteins and other proteins. 
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in accordance with their reported localisations (Ueda et al. 2001, Ueda et al. 2004, Konopka 
et al. 2008, Geldner et al. 2009). 
ATG 
A.thalian
a 
Mam
mals 
S.cerevis
ae 
S.po
mbe Construct 
Localisati
on 
AT3G18820   RABG3f RAB7 YPT7 YPT7 
YFP-
RabG3f 
Vac/LE/
MVB 
AT4G19640 
ARA7/RA
BF2b RAB5 
YPT51/5
2/53 YPT5 
RFP-
RABF2b/
ARA7 LE/MVB 
AT3G54840 
ARA6/RA
BF1 RAB22     
RABF1/A
RA6-RFP LE/MVB 
AT1G02130 
ARA5/RA
BD2a RAB1 YPT1 YPT1 
YFP-
RABD2a/
ARA5 
Golgi/TG
N/SV 
AT4G32150 VAMP711 
VAMP
7 YKT6 sec22 
YFP-
VAMP711 Vac 
AT2G40060 CLC2 CLTB CLC1 CLC CLC2-GFP CCV 
AT3G03180 GOT1 
GOT1
A GOT1p GOT1 YFP-GOT1 Golgi 
To evaluate the proteomes of the various endomembrane compartments, I utilised the IP 
approach detailed above (Section 3.2.3) for the affinity purification of endomembrane 
markers (Figure 3.6) canonical of several endomembrane compartments. For this, crude 
protein extracts from sterile grown A. thaliana seedlings stably expressing the different 
endomembrane markers listed (YFP-RABG3f, YFP-GOT1, YFP-VAMP711, YFP-
RABD2a/ARA5, CLC-GFP, RFP-RABF2b/ARA7, RABF1/ARA6-RFP) above were subjected 
to IP for YFP/RFP/GFP as appropriate, proteins fractionated by SDS-PAGE, gel slices 
tryptically digested,and analysed with LC-MS/MS. The IP, SDS-PAGE, digestion and LC-
MS/MS (Orbitrap XL) analysis for each protein was repeat three times. Supplemental 
controls were also added using IP of YFP and mCherry, digested in solution and analysed 
with an Orbitrap Fusion. 
Table 3.1. Affinity purification baits and their homologs in Mammals and Yeasts. 
ATG numbers and A.thaliana short names are from TAIR. Homologs were identified from 
published works.  
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Figure 3.6.Endomembrane targets.a. Schematic overview of the endomembrane marker 
proteins used in this study and their localisations. RABD2a/ARA5 – post-
Golgi/Golgi/TGN/Secretory vesicles (SV), RABF1/ARA6 – LE/MVBs, RABF2b/ARA7 – 
LE/MVBs, CLC2 – Clathrin Coated Vesicles, GOT1 – Golgi, RABG3f – LE/MVB/Vacuole, 
VAMP711 – Vacuole. b. Localisation of fluorescent-tagged marker proteins. Standard 
confocal micrographs of leaf epidermal cells of A. thaliana transgenic plants stably 
expressing the indicated recombinant proteins. Scale bars 10µM. Pattern of localisation was 
observed in all 8 of 8 images per genotype. References: pUBQ10:YFP-RabG3f, YFP-
RABD2a/ARA5, YFP-VAMP711, YFP-Got1 [11], RABF1/ARA6-RFP, RFP-RABF2b/ARA7 
(provided by K. Schumacher, Heidelberg, Germany), p35S:CLC-GFP (provided by S. 
Bednarek, Madison WI, USA). 
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Total number 
of proteins 
Number of 
unique proteins 
% previously identified 
% membrane 
associated 
YFP-
RABD2a/ARA5 
120 22 18% 34% 
RABF1/ARA6-
RFP 
63 9 14% 33% 
RFP-
RABF2b/ARA7 
279 121 43% 33% 
CLC2-GFP 49 15 31% 24% 
YFP-GOT1 62 30 48% 77% 
YFP-RABG3f 136 42 31% 22% 
YFP-VAMP711 51 12 24% 41% 
3.2.6 Proteomic analysis reveals a large degree of overlap between proteomes 
To determine whether the proteomic data from all 21 IPs was suitable for further analysis, I 
examined the combined dataset.  Using LC-MS/MS we identified a total of 159903 peptides 
corresponding to 2526 proteins; the respective proteins, peptides and spectrum counts for 
each affinity based purification are listed in Table S1. The reproducibility of the identification 
of each protein, using analysis by SAINT (Choi et al. 2011) Table S2. Proteins were 
accepted as enriched by a specific affinity bait if the protein was identified in at least two of 
three replicate affinity purifications. This criterion substantially reduced the total number of 
accepted proteins to 433 (Table 3.2). Most proteins were identified from RFP-RABF2b/ARA7 
affinity-purifications, with 279 proteins assigned. This bait also had the highest number of 
unique proteins assigned to its proteome; 121. The CLC2-GFP proteome had the smallest 
number of total proteins, 49, of which 15 were unique to that bait (Table 3.2).  
 
Table 3.2. Numbers of proteins identified in affinity purifications. Proteins that 
were identified in and unique to (according to criteria in materials and methods) 
each affinity purification. Percentage of proteins identified in selected previous 
proteomic studies was calculated from whether a protein was identified in 
Nikolovski et al. 2012, Parsons et al. 2012, Sadowski et al. 2008, Dunkley et al. 
2006, Drakakaki et al. 2012. Percentage of proteins with membrane associations 
was calculated using annotations from Uniprot (http://www.uniprot.org) and TAIR 
(http://www.arabidopsis.org/) as described in the materials and methods. 
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To visualise the differences and commonalities in the seven affinity enrichments I used the 
Sungear tool from Virtual plant (Poultney et al. 2007) (Figure3.7). The CLC2-GFP and YFP-
VAMP711 proteomes are clearly distinct from the other proteome. There are also substantial 
pair wise and collective overlaps between the RFP-RABF2b/ARA7, RABF1/ARA6-RFP and 
YFP-RABG3f. However, complex comparisons between all groups can be drawn, therefore, 
in addition to the analysis below, the full set of proteins associated with each group in the 
Sungear diagram can be explored using filters in Table S3.  
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3.2.7 YFP-GOT1 is not amenable to tryptic digests 
All affinity purifications had many assigned spectra to the relevant fluorescent protein tag 
and most have assigned spectra to the target protein in the corresponding enrichment 
Figure 3.7. Sungear diagram of proteins assigned to the different 
proteomes.Sungear diagrams generated in virtual plant (http://virtualplant-
prod.bio.nyu.edu/cgi-bin/sungear/index.cgi)(Poultney et al. 2007). Groups of 
proteins are indicated by the black dots, with a size proportional to the number of 
proteins in the group. The arrows on each dot point to the proteome assignment of 
a group of proteins. Enrichments were performed three times for each bait, proteins 
were accepted when they were more than two times more abundant, or unique to, 
the marker enrichment compared to the control. 
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except for YFP-GOT1. This is probably because GOT1 is less amenable to tryptic digests, 
with only two potential peptides between 4 and 24 amino acids in length (Figure3.8), making 
peptides from YFP-GOT1 unlikely to be detected. In each of the YFP-GOT1 
enrichmentsthere are over 100 spectra detected from YFP, indicating the enrichment was 
successful for this bait as well (Table 3.3).  
3.2.8 Endomembrane regulators and suspected contaminants found in six or more 
enrichments 
To provide a mechanistic overview of proteins with known functions in endomembrane 
trafficking identified in our affinity enrichments, I manually curated a database of 
endomembrane regulators from a literature survey (Table S4) and present the spectral 
counts assigned to each enrichment (Table 3.3). Five proteins were identified in all affinity 
purifications and nine proteins were enriched with six of the seven baits. These include 
PEN3 (AT1G59870), and it is likely that these proteins are present throughout the 
endomembrane system (Sanderfoot et al. 2000, Anders and Jürgens 2008). Other 
commonly detected proteins are CPN60A and CPN60B (AT1G55490, AT2G28000) these 
chaperones are commonly considered to be contaminants in affinity purifications. 
Figure 3.8. Amino acid sequence of GOT1 with annotated potential trypsin 
cleavage sites. 
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ATG Group Short name 
YFP-
RABD2a/ARA5 
RABF1/ARA6-
RFP 
RFP-
RABF2b/ARA7 
CLC2-
GFP 
YFP-
GOT1 
YFP-
RABG3f 
YFP-
VAMP711 
AT5G22780 
C
C
V
 
Adaptin α2 NS NS 11 NS NS A A 
AT2G25430 ECA4 NS NS NS 73 A 43 NS 
AT4G32285 CAP1 NS NS 60 NS A A A 
AT3G11130 CHC1 NS NS NS 29 NS NS NS 
AT3G08530 CHC2 NS NS NS 60 NS A A 
AT2G20760 CLC1 A NS NS 18 A A A 
AT2G40060 CLC2 NS NS A 110 NS A A 
AT4G33650 DRP3A 8 NS 10 7 NS NS NS 
AT1G10290 DRP2A NS NS NS NS NS NS 3 
AT4G34660 SH3PH A A NS 40 A A A 
AT1G52360 
C
o
a
to
m
e
r 
Coatomer ß ' 
(SEC27p) 5 4 10 NS NS 7 NS 
AT4G31480 
Coatomer ß 
(SEC26p) NS A A NS A 11 NS 
AT4G31490 
Coatomer ß 
(SEC26p) NS NS 13 NS NS A A 
AT1G62020 
Coatomer α 
(RET1p) 16 16 21 NS NS 12 7 
AT2G21390 
Coatomer α 
(RET1p) 6 7 9 NS NS 6 NS 
AT5G05010 
Coatomer δ 
(RET2p) 10 NS 10 NS NS NS NS 
AT3G63460 SEC31B 8 6 10 NS NS NS NS 
AT5G16300 
C
O
G
 
COG1/VPS51 33 NS 120 NS NS NS NS 
AT4G24840 COG2 NS NS 37 NS NS NS A 
AT1G67930 COG5 NS NS 20 A NS A A 
AT5G51430 COG7 27 NS 50 NS A NS NS 
AT5G11980 COG8 30 NS 47 NS NS NS A 
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AT2G27600 ESCRT VPS4 NS NS 7 A NS 8 A 
AT5G03540 
EXOCYST 
EXO70A1 NS NS 60 NS A NS A 
AT5G59730 EXO70H7 NS NS 30 NS A A A 
AT5G49830 EXO84B/VPS51 NS NS 40 NS NS 23 NS 
AT5G12370 SEC10 9 NS 12 NS NS NS NS 
AT1G47550 SEC3A NS NS NS NS NS 33 NS 
AT1G76850 SEC5A NS NS 107 NS NS NS NS 
AT3G10380 SEC8 20 12 29 10 NS 12 NS 
AT4G02030 
G
A
R
P
 VPS51 NS NS 8 NS A NS A 
AT1G71270 VPS52 33 40 50 40 NS 37 NS 
AT1G50500 VPS53 37 NS 87 NS NS 60 NS 
AT4G19490 VPS54 15 NS 46 NS NS NS NS 
AT3G60860 
G
E
F
 
BIG2  24 NS 60 NS A NS NS 
AT1G01960 BIG3 15 NS 33 8 NS 9 NS 
AT3G43300 BIG5/MIN7 16 NS 23 NS NS 11 NS 
AT1G13980 GNOM 53 NS 97 NS NS NS A 
AT2G01470 SEC12 NS NS NS A NS NS 33 
AT1G16920 
G
T
P
a
s
e
 
AtRABA1b 7 NS 5 NS NS NS NS 
AT4G18800 AtRABA1d NS NS 33 NS NS NS 117 
AT3G46830 AtRABA2c 14 NS NS A NS 38 NS 
AT4G17170 AtRABB1c NS NS NS NS NS 6 4 
AT1G43890 AtRABC1 NS 12 NS NS NS 7 A 
AT3G11730 AtRABD1 A NS NS NS NS 30 NS 
AT1G02130 AtRABD2a 56 NS NS NS NS NS NS 
AT5G47200 AtRABD2b NS NS 10 NS NS 11 7 
AT3G54840 AtRABF1 NS 195 NS NS A NS A 
AT4G19640 AtRABF2b 100 272 2330 NS NS 76 NS 
AT3G18820 AtRABG3f NS NS NS A NS 120 9 
AT2G44610 AtRABH1b NS NS NS NS NS 6 NS 
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AT3G56110 
RAB 
regulator 
AtPRA1.B1 NS A 117 A 53 NS A 
AT2G40380 AtPRA1.B2 NS A NS A 60 NS A 
AT2G38360 AtPRA1.B4 NS NS 110 A NS NS NS 
AT2G44100 GDI1 NS A 57 A A 657 A 
AT3G59920 GDI2 NS A NS A A 177 A 
AT3G19770 VPS9a A NS 130 A A A A 
AT4G30260 YIP4b 62 NS 104 A A NS NS 
AT3G05280 YIP5b 80 A NS A NS NS 60 
AT1G75850 
Retromer 
VPS35A NS A NS A A 40 A 
AT2G17790 VPS35B NS NS NS A A 43 A 
AT5G06140 SNX1 NS NS 53 NS A NS NS 
AT2G45200 
S
N
A
R
E
 
GOS12 NS A A NS 40 A A 
AT4G04910 NSF 70 NS 113 NS 70 NS 93 
AT3G05710 SYP43 NS A 23 A A A NS 
AT1G16240 SYP51 NS NS NS A A NS 53 
AT4G32150 VAMP711 A NS NS A NS A 1713 
AT1G04750 VAMP721 A A A A A A 167 
AT2G33120 VAMP722 33 9 16 NS 6 18 A 
AT3G54300 VAMP727 NS NS 40 A A A A 
AT3G27530 Tether GC6 NS NS 17 NS NS NS A 
AT1G21630 
T
P
L
A
T
E
 c
o
m
p
le
x
 
EH2 NS NS NS 20 A A A 
AT2G07360 TASH3 8 NS 6 5 A A NS 
AT5G57460 TML 23 NS NS NS A A A 
AT3G01780 TPLATE NS 7 10 NS NS NS NS 
AT3G50590 TWD40-1 6 NS 8 NS NS A A 
AT5G24710 TWD40-2 NS NS NS 10 A NS A 
AT5G11040 
TRAPP 
TRS120 NS 23 NS A A NS NS 
AT5G16280 TRS85 417 NS NS A NS 53 NS 
AT3G52850 VSR VSR1 NS NS 52 A NS A NS 
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AT2G14740 VSR3 A A A A A A 47 
AT2G14720 VSR4 NS NS 147 A A NS A 
 
  
Table 3.3.Endomembrane regulators identified in affinity purifications.Summed spectrum counts (over each replicate) of each 
affinity purification.Cells are highlighted when the protein was significantly enriched (using the SAINT analysis described in materials 
and methods) in an affinity purification. If a protein was absent in an IP it is annotated as A, if a protein was detected but not 
significantly enriched it is annotated as NS. Annotations for inclusion in a complex were manually curated from literature (Vernoud et al. 
2003, Uemura et al. 2004, Latijnhouwers et al. 2005, Masclaux et al. 2005, Latijnhouwers et al. 2007, Robinson et al. 2007, Alvim 
Kamei et al. 2008, Geldner et al. 2009, Schellmann and Pimpl 2009, Thellmann et al. 2010, Zhang et al. 2010, Chen et al. 2011, 
Shahriari et al. 2011, Gendre et al. 2013, Gadeyne et al. 2014). 
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3.2.9 This IP approach identifies more proteins transiently associating with 
endomembranes than identified in other proteomic studies 
To compare the proteomes defined in this study with those of other published proteomic 
studies, I complied a database of proteins identified in six proteomic studies. These are: the 
CFP-SYP61 proteome (TGN/EE) (Drakakaki et al. 2012), VHA-a1-GFP (TGN/EE) (Groen et 
al. 2014), ER, Golgi, Mitochondria/Plastid, PM, Vacuole (Nikolovski et al. 2012), Golgi 
(Parsons et al. 2012), ER, Golgi, Mitochondria/Plastid/PM/Vacuole (combined from (Dunkley 
et al. 2006, Sadowski et al. 2008). For each of the proteins identified in all studies I curated 
the annotations from the Uniprot database (http://www.uniprot.org)and the TAIR10 database 
(http://www.arabidopsis.org). Using this data, I extended the analysis to include predicted 
transmembrane domains and membrane associated modifications (Table 3.2, Table S3). 
Overall, I identified 64proteins with one transmembrane domain and 58 with multiple 
transmembrane domains, 12 proteins with membrane association lipid modifications (these 
were predominantly RAB GTPase proteins of various classes that are commonly 
prenylated), and a diverse set of 63 potentially S-acylated proteins (Table S3). The 
remaining 63% of our dataset did not have any membrane association motifs. This suggests 
that my IP method preferentially enriches for proteins transiently associating with 
compartments, when compared to other methods.  
 
The proportions of proteins in each proteome with membrane association motifs varied 
across the enrichments; YFP-GOT1 had the greatest at 77%, whilst YFP-RABG3f  has the 
smallest proportion of membrane-associated proteins, 22% (Table 3.2). The proportion of 
YFP-GOT1 membrane associated proteins is comparable to specific Golgi or TGN/EE 
proteomic studies such as 77% (Drakakaki et al. 2012) or 65% (Parsons et al. 2012). That 
the other affinity baits, such as RFP-RABF2b/ARA7 endosomes, show a lower proportion of 
membrane associated proteins is likely to be a consequence of the choice of bait protein for 
IP and my methodology.  
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The lower proportion (compared to Drakakaki et al. 2012 and Parsons et al. 2012) of 
membrane associated proteins in my proteomic dataset raises the possibility thatthis 
approachidentifies more proteins with transient membrane interactions, such as vesicle 
coats (e.g. COPI and COPII), motor proteins (e.g. myosins), and endomembrane tethers 
(Table 3.3), cargo proteins. This is to be expected with my choice of baits, which are 
regulators that affect cytosolic protein recruitment, e.g. RAB GTPases. In addition this 
protocol does not contain long centrifugation steps or carbonate washes, as used in other 
protocols. Both of these steps will reduce the number of transiently associating proteins 
identified in the enrichment and may explain why I observe an enhanced number of these 
proteins using this IP method. 
3.3 Discussion 
I have developed a methodology for the purification of endomembrane compartments that 
share biophysical and biochemical characteristics in a single cell. Targeted IP of marker 
proteins allows for distinct proteomic characterisation of these compartments. The proteomic 
data produced with this method is relatively free from contaminating organelle markers and 
enhances the number of peripherally associated proteins relative to other methods. Thus, 
the data obtained by application of this method provides a valuable list of candidate proteins 
associated with the function and regulation of each organelle.  Using these lists as a starting 
point, in depth analysis and predictions will validate the specificity of the data and provide 
the framework for comprehensive proteomic characterisation of endomembrane proteomes. 
3.3.1 Endomembrane compartments require extensive biophysical knowledge to 
purify 
The preliminary work presented in Section 3.2.1 and 3.2.2 (Figures 3.1 and 3.2) 
demonstrates that RFP-RABF2b/ARA7 labelled endosomes cannot be purified by density 
gradient centrifugation alone. It is likely that this principle applies to most endosomal 
compartments. Therefore I concluded that an alternative approach was necessary to achieve 
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our aims of a simple, broadly applicable, high throughput method to provide an insight into 
these, largely uncharacterised, proteomes.  
 
I made use of extensive in department experience (Schwessinger et al. 2011, Kadota et al. 
2014) and literature survey of IP methods to develop a protocol for the selective IP of marker 
proteins; affinity purification of proteins associating with the diagnostic marker proteins for 
given endomembrane compartments. The use of 0.01% IGEPAL CA-630 as an additive to 
the extraction buffer reduces the non-specific binding of proteins to the beads (Figure 3.3) 
and this is true for YFP tagged RAB GTPases (YFP-RABG3f) as well as RFP-
RABF2b/ARA7. In addition, IP directly from a crude extraction of proteins is the best 
compromise between relevant protein yield and purity.  
3.3.2 Limitations of this IP method 
In this method I did not remove the cytoplasm prior to IP. Not removing the cytosol from the 
extraction procedure will change the nature of the enrichment. IP of RAB GTPases will 
extract proteins interacting with the bait whilst it in the cytosol as well as on membranes. 
However, current knowledge of RAB GTPases suggests that, with the exception of RAB 
activation suppressors (GDP dissociation inhibitors - GDIs) (Saito and Ueda 2009), they 
have minimal interaction with other proteins in the cytosol while in their inactive state. 
Following this assumption, both GDIs and RAB activators are identified in my proteomic 
data. Therefore, on balance, the benefits yielded by reduced contamination in the fractions, 
and the increased yield and speed of the preparation, I determined that this method was 
suitable for further analysis of endosome, and other endomembrane compartment, 
proteomes. 
 
One principal question is whether intact compartments can be enriched with this method. 
Whilst not relevant to the aims of this thesis, as discussed in section 3.1.5, this is a pertinent 
question. Extracting plant membranes after lysis of cells with a pestle and mortar and liquid 
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nitrogen can be optimised to not lyse the ER (Section 3.2.2). This optimised method was 
used to all subsequent IPs. Detergents are also an additive that can cause membrane lysis. 
The major contrast between my IP method and those used for IP of transmembrane proteins 
or cytosolic proteins is the concentration of detergent used. For IP of PM resident proteins, 
high concentrations of detergent (for IGEPAL CA-630 >1%) are necessary to cause mycelle 
formation of the lipids and so extract the protein from the membrane (Schwessinger et al. 
2011, Kadota et al. 2014). The detergent concentration used in this study (0.01% IGEPAL 
CA-630) does not lyse membranes as it is below the Critical mycelle concentration (CMC) 
for IGEPAL CA-630. Therefore it is likely that endomembrane compartments are intact. 
However, the large number of proteins identified that transiently interact with membranes is 
likely to reduce the numbers of potential cargos detected. Therefore, whilst compartments 
are likely to be intact, cargos are less likely to be detected. 
3.3.3 Affinity purification using marker proteins allows distinction of biophysically 
similar compartments 
RABF2b/ARA7 and RABG3f label multiple compartments. Whilst RABF2b/ARA7 is usually 
used as a marker for LE/MVBs it has been localised to the endocytic route from the TGN to 
the vacuole depending on expression levels (Lee et al. 2004, Ueda et al. 2004 and 
conference communication Carine de Marcos Lousa). Similarly RABG3f clearly labels both 
the tonoplast and an endosomal population (Geldner et al. 2009). Thus, it is possible that by 
extracting membranes by IP of RAB GTPases that compartment specificity will be difficult to 
define. However, by using multiple markers for endosomes, comparisons can be made 
between compartments to allocate proteins to specific compartments. Accordingly, a more 
detailed, compartment specific comparison is detailed in Chapter 4. 
 
This approach allows dissection of trafficking routes that are biophysically very similar but 
known to be functionally different. For example, RABF2b/ARA7 and RABF1/ARA6 label 
partially overlapping but functionally distinct endosome populations (Ueda et al. 2004, 
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Ebineet al. 2011).Hence, data generated from this IP method has the potential to be 
incredibly useful for the scientific community to elucidate highly overlapping and similar, but 
distinct endomembrane compartments such as the TGN/EE, endosomes and ER-Golgi 
traffic. The distinctions between highly overlapping compartments and organelles will be 
explored in Chapter 4. 
3.3.4 Affinity purification is a necessary complement to other proteomic methods 
The differences between proteomic datasets derived from affinity purification and those from 
other methods of enrichment/isolation mean there are subtle, but important differences in the 
conclusions that can be made from the data, as discussed above. Both approaches are 
useful and have been combined with great success to characterise the proteome of the 
TGN/EE, reviewed (Groen et al. 2013). Therefore, I emphasise that data generated from this 
method is a starting point to help initially characterise the proteome of the labelled 
compartments, not a definitive proteome in itself. Data generated from this approach will be 
useful to my further work and the community. The data can be used to make inferences 
about compartment function (as will be explored in Chapter 4). Furthermore proteins 
identified in this study could be used as organelle markers for CLSM or to optimise large 
scale organelle proteomic studies such as PCP or LOPIT (Dunkley et al. 2004, Foster et al. 
2006) as was demonstrated recently (Groen et al. 2013). Whilst this approach is not unique 
as demonstrated by Groen et al. 2014 and Fujiwara et al. 2014, who also use IP based 
methods. This is the first method to utilise RAB GTPases.  
3.3.5 Conclusions and further work 
I developed a method that allows for the enrichment of proteins associating with an 
endomembrane compartment marker, and thus the given compartment. This method is 
applicable to numerous different endomembrane compartments, regardless of biophysical 
properties. My ultimate objective is to elucidate the role of endosomes in signalling in the 
context of pathogen induced endocytosis. For this I must assess the proteomes of multiple 
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endosome populations and the methodology I have established and the dataset from 
Section 3.2.6 is an excellent starting place.   
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4 Validation and characterisation of a LE/MVB proteome 
All techniques were performed by William Heard. Sections 4.2.2-4.2.7 contain data 
submitted in a paper to Molecular and Cellular Proteomics. 
4.1 Introduction and Objectives 
The quality of proteomic data rests on the discriminatory power of the methods used for 
protein extraction and purification. Any dataset acquired by a novel method requires 
validation to determine whether it is representative of the intended target. Thus, this chapter 
addresses the biological relevance of the data obtained in Section 3.2.6 with the particular 
aim of characterising a LE/MVB proteome in accordance with my overall aims of elucidating 
the role of LE/MVBs in signalling.  
4.1.1 The Golgi has been extensively proteomically characterised and is an ideal 
bench mark against which to compare proteomic data 
The Golgi is perhaps the best proteomically characterised endomembrane organelle in 
plants (as discussed in Sections 3.1.4 and 3.2.9) and has been successfully analysed using 
a variety of techniques (Dunkley et al. 2004, Dunkley et al. 2006, Sadowski et al. 2008, 
Nikolovski et al. 2012, Parsons et al. 2012). The extensive proteomic knowledge of the 
Golgi, makes it an ideal standard against which to compare my proteomic data. Attempts to 
purify the Golgi were unsuccessful with density gradient centrifugation alone, however the 
LOPIT technique was used to identify Golgi resident proteins (Dunkley et al. 2004, Dunkley 
et al. 2006, Sadowski et al. 2008, Nikolovski et al. 2012). Each of these studies used slightly 
different gradients or statistical analyses to identify novel proteins and provide new insights 
into the plant Golgi. Furthermore, surface charge was used in addition to migration in density 
medium to great effect by Parsons et al. 2012 for enrichment and further proteomic analysis 
of the Golgi (Section 3.1.5). Interestingly, the similarity of proteomic data obtained is very 
closely linked to the method used to obtain it. The proteomes generated from LOPIT 
analysis are more similar to each other than to those obtained by affinity purification or 
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surface charge purification, highlighting the need for combined approaches to elucidate 
proteomes (Parsons et al. 2013). All of these studies contribute to our knowledge of the 
Golgi and provide unique insights into its proteome (reviewed Parsons et al. 2013).  
4.1.2 The TGN is a suitable comparison organelle for my LE/MVB proteomic data 
The TGN is a multi-functional organelle within the cell, and is defined by its association with 
the Golgi in planta (Gendre et al. 2014).The TGN in plants is formed from the most trans-
Golgi cisternae(Staehelin and Kang 2008, Kang et al. 2011), and has been implicated in 
secretion to the PM, secretion to the cell plate, endocytic trafficking and trafficking to the 
vacuole (reviewed Gendre et al. 2014). One specific role for the TGN in endocytic trafficking 
is in the formation of LE/MVBs (Scheuring et al. 2011). The term TGN/EE is commonly used 
in plant literature but this is based on a long standing and incorrect assumption that TGN will 
always act as an EE. As I will explore later not all TGN acts an EE and so the term is 
misleading. I will therefore use only TGN. 
 
To date there are no published LE/MVB proteomes against which to compare my RFP-
RABF2b/ARA7, RABF1/ARA6-RFP and YFP-RABG3f data. Therefore, proteomic data from 
the TGN compartment could be compared against my LE/MVB marker proteomes to assess 
the quality of the dataset. LE/MVBs are on the endocytic route along with the TGN. 
Moreover, the interaction between LE/MVBs and the TGN has been partially characterised. 
Current knowledge of the nature of the interaction between LE/MVBs and the TGN will now 
be explored. 
4.1.3 The name TGN describes a population of heterogenous endomembrane 
compartments 
Although the TGN is typically regarded as one organelle, not all of the TGN is involved in all 
of the functions ascribed to the TGN. The TGN is a name for a population of morphologically 
distinct endomembrane structures, and it is not a homogeneous organelle. Determining 
which of these populations are directly involved in the formation of LE/MVBs is essential to 
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further understand the endocytic route. Initially a TGN will be closely associated with the rest 
of the Golgi and is known as Golgi Associated-TGN (GA-TGN) (Kang 2011, Kang et al. 
2011). As a TGN matures it associates less with the Golgi until it becomes a Golgi 
Independent (GI-TGN) (Uemura et al. 2014). This process is known as “cisternal peeling” 
and is accompanied by a decrease in TGN size(Kang 2011, Kang et al. 2011). A GA-TGN is 
around 30% smaller than the most trans-Golgi cisternae, and a GI-TGN is smaller still(Kang 
2011, Kang et al. 2011). As there are striking morphological differences between the GA and 
GI-TGN (Kang et al. 2011), they must proteomically differ to some extent. Interestingly, 
however, there are no proteins that have been defined as GA or GI-TGN specific. There are, 
however, defined proteomically different populations of the TGN (reviewed Gendre et al. 
2014). 
4.1.4 The TGN is a proteomically diverse population of endomembrane 
compartments. 
There are two broad populations of the TGN, one labelled with VHA-A1/SYP61/SYP43, and 
one labelled with RABA2a/RABA1b/VAMP721 (Chow et al. 2008, Asaoka et al. 2012, Feraru 
et al. 2012). These two populations are generally overlapping but partially 
distinct.Furthermore, these populations within the TGN are functionally specialised. TGN 
populations labelled with different markers show demonstrably different biological 
characteristics. The functionality of different TGN populations has been investigated with two 
drugs. Endosidin 1(ES1) stabilises the actin cytoskeleton (Toth et al. 2012) and the drug 
Concanamycin A (Conc A) interferes with the function of vacuolar ATPases, especially the 
TGN localised VHA-A1 and so disrupts MVB formation(Scheuring et al. 2011). ES1 
specifically disrupts the VHA1-A1 and SYP61 compartments labelled TGN but not the TGN 
compartments labelled by SYP41 (Robert et al. 2008). These data support the hypothesis 
that there are at least two different populations of TGN compartments (Figure 4.1). 
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In addition to drugs, fluorescent endocytic tracer dyes, such as FM4-64, can be used to 
elucidate the involvement of different populations of the TGN in endocytosis. The 
SYP61/VHA-A1 labelled TGN are the principal TGN population involved in endocytosis. 
SYP61/VHA-A1 labelled TGN show extensive labelling with the endocytic tracer dye FM4-64 
(Zouhar et al. 2009), whilst RABA2a labelled TGN do not (Chow et al. 2008). Transiently 
expressed atSYP61 in N. benthamiana co-localises with endocytosed atFLS2 (Choi et al. 
2013), presumably at the TGN although the localisation of atSYP61 in N. benthamiana has 
not been characterised. Furthermore, other RAB GTPases, such as RABD2a/ARA5 localise 
to the Golgi as well as compartments labelled by FM4-64 (Geldner et al. 2009). The Golgi 
apparatus is not usually labelled by FM4-64 except after very long exposure. This, therefore, 
Figure 4.1.TGN populations and their functions.Schematic overview of the 
TGN populations, their protein markers and the principal biological functions in 
which they are involved. VHA-A1, SYP61 and SYP43 label one TGN population 
that is principally involved in secretion to the PM, endocytosis to the TGN and to 
the Vacuole. The RABA1b/RABA2a/VAMP721 labelled TGN is predominantly 
involved in secretion to the cell plate and to the PM. These populations are not 
totally distinct but exhibit a preference in biological function. Adapted from 
Gendre et al. 2014. 
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suggests that RABD2a/ARA5 labels some non-Golgi structures, likely to be the TGN, as well 
as the Golgi, although this has not been conclusively demonstrated. 
 
Generally the VHA1-A1/SYP61/SYP43 labelled TGN has been implicated in secretion to the 
PM, endocytic trafficking and trafficking to the vacuole (Gendre et al. 2014). The 
RABA2a/RABA1b/VAMP721 TGN are thought to be involved in secretion to the cell plate 
and the PM (Gendre et al. 2014). The generalised roles of the two TGN populations are 
summarised in Figure 4.1. It is clear that these populations have different characteristics and 
Gendre et al. (2014) suggest that two populations is the minimum for the TGN, however 
properly defining them has proven difficult. 
4.1.5 Higher throughput proteomic approaches are essential to elucidate protein 
content of the different TGN populations 
One of the principal problems in with our understanding of the TGN has been throughput. 
Microscopy limits the throughput of proteins that can be studied at one time, studies of three 
or more proteins simultaneously are rare. Therefore, for example, the relationship between 
VHA1-A1, SYP61, SYP43 and the Golgi cannot be compared simultaneously in one 
experiment. Instead complicated relationships must be analysed in a pairwise manner, 
dramatically inflating the work required. Furthermore, microscopyis inherently biased to the 
proteins selected for study. The work in defining GA and GI-TGN was performed using the 
SYP43 and VHA-A1 TGN marker proteins(Uemura et al. 2014). Therefore the localisation of 
other TGN markers to GA or GI-TGN has not been tested. Perhaps the 
RABA2a/RABA1b/VAMP721 labelled TGN is only GA or GI. This is unlikely, but must be 
tested. 
 
Proteomic approaches have started to be used to understand the TGN as a higher 
throughput method for studying protein localisation. One recent study analysed the VHA-A1 
labelled TGN. In this study, IP of the VHA-A1 marker was used to preliminarily characterise 
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the TGN proteome, followed by LOPIT (Groen et al. 2014). As expected, the IP of VHA-A1 
identified SYP61 but not the VAMP721 marker. In addition, the other TGN population 
markers RABA1b/RABA2a were not identified. Although, no RAB GTPases were detected at 
all presumably due to the use of carbonate washes to remove peripheral membrane 
proteins. Strikingly, LE/MVB marker proteins such as the SNARE VAMP727 and LE/MVB 
RAB5 regulator VPS9a were also identified. This suggests a strong link between the VHA-
A1 labelled TGN and LE/MVBs due to the presence of respective markers associating with 
VHA-A1.  
 
Proteomic analysis of the TGN using IP of the SYP61 marker protein identified numerous 
secreted cargos, confirming the role of the SYP61 labelled TGN in secretion to the PM 
(Drakakaki et al. 2012). Moreover, a plethora of other TGN markers were also identified 
including RABA2a, RABA1b, VHA-A1 and Echidna (ECH). The latter has since been 
developed as a TGN marker and is implicated in secretion to the PM and cell plate (Gendre 
et al. 2011, Drakakaki et al. 2012, Boutté et al. 2013, Gendre et al. 2013). Interestingly, 
VAMP721 was identified, no LE/MVB regulators were found. This suggests that the VHA-A1 
labelled TGN is more closely associated to LE/MVBs than the SYP61 labelled TGN.  
 
Additional genetic evidence supports the division between VHA-A1 and SYP61 labelled 
TGN.In ech mutants (a TGN marker closely associating with SYP61) Auxin resistant 1 
(AUX1) secretion is inhibited(Boutté et al. 2013). By contrast, VHA-A1 functionality is not 
required for AUX1 localisation as Conc A does not inhibit AUX1 secretion (Brux et al. 2008). 
These data suggest further functional division between the SYP61 and VHA-A1 labelled 
TGN and support the hypothesis that VHA-A1 labelled TGN more closely interacts with 
MVBs than SYP61 labelled TGN. Whilst these markers may be on the same compartment, 
the compartment is likely to be subdivided. Exactly how similar the SYP61 and VHA-A1 
labelled TGN are, and how they interact with LE/MVBs are crucial questions in our 
understanding of the TGN-LE/MVB interaction. 
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4.1.6 The TGN compartments are directed to be secretory vesicles or LE/MVBs 
The relationship between the TGN and the LE/MVB is complex. The ultimate fate of a TGN 
compartment is hypothesised to be the depletion of membrane, by vesicle budding, until the 
compartment breaks up to form yet more secretory vesicles (Kang 2011, Kang et al. 2011, 
Scheuring et al. 2011). This is certainly the fate of some TGN compartments, but relies on 
the assumption of no membrane replenishment. It was demonstrated that GFP-SYP43 
recovers in the GA-TGN after photobleaching, showing that membrane replenishment 
occurs in the GA-TGN at least (Scheuring et al. 2011, Uemura et al. 2014). Perhaps GI-TGN 
are unable to replenish membrane and so are condemned to be depleted and form SVs 
(Kang 2011, Kang et al. 2011). LE/MVBs are also generated from TGN bodies (Scheuring et 
al. 2011). LE/MVB formation is distinct from the production of SVs and is a maturation 
process, whereby a portion of a TGN body is altered in identity to an LE/MVB. So there is 
clearly a bifurcation in the fate of the TGN between an ultimately secretory vesicle fate and 
an LE/MVB fate. 
 
Entire TGN compartments could be destined to be either LE/MVBs or secretory vesicles. 
Alternatively, it could be that there are distinct subdomains within each TGN body that have 
different fates. This mechanism has been shown for the grouping of cargos into specific 
regions of the TGN for onward transport (reviewed Surma et al. 2012; Gendre et al. 2014) 
and is supported by the observations of subdomains of VHA-A1 and SYP61 within a TGN 
compartment (Robert et al. 2008). 
4.1.7 RAB GTPases dictate compartment identity 
To understand the process, by which compartment identity is modified from one to another, 
we need to understand the mechanisms by which the compartment identity regulators are 
regulated themselves. The principal regulators of compartment identity are the RAB 
GTPases. RAB GTPases are molecular switches that are active when GTP bound 
(membrane bound) and inactive when GDP bound (cytosolic), (Saito and Ueda 2009). RAB 
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GTPases recruit proteins (RAB effectors) to a membrane to alter or reinforce an identity on 
the endomembrane structure (Saito and Ueda 2009). 
 
RAB effectors implement compartment identity directly. Some, such as the mammalian 
RAB5 effector Early endosome associated 1 (EEA1), are tethering factors that direct the 
interactions a compartment has with other organelles over a long range (Christoforidis et al. 
1999). Alternatively, RAB effectors can be SNAREs that mediate inter-compartment 
interactions over a shorter range (SNAREs mediate membrane fusion). Syntaxin 13 is 
another RAB5 effector and together with EEA1 drives endosome fusion in mammals 
(McBride et al. 1999). Another well characterised role of RAB effectors is facilitating the 
maturation of a compartment from one identity to another in a RAB cascade. For example, 
the A.thaliana RAB5 GTPases recruit the Monensin sensitivity 1 (MON1)-Calcium caffeine 
zinc sensitivity 1 (CCZ1) complex, activators of RAB7s, to LE/MVBs (Cui et al. 2014, 
Lawrence et al. 2014). MON1-CCZ1 activate RAB7s on LE/MVBs and promote a more 
vacuole like identity, which in turn pushes off the RAB5 GTPases (Bottanelli et al. 2012). 
Thus the RAB cascade promotes compartment maturation in the late endocytic route.  
 
The process of MVB formation starts at the TGN and so there must be TGN membranes 
with partial LE/MVB identity. Whilst RAB GTPases may dictate overall compartment identity, 
the MVB membrane structures are generated by the ESCRT machinery. The Endosomal 
sorting complexes required for transport (ESCRT) components (ESCRT-0, ESCRT-I, 
ESCRT-II and ESCRT-III) act sequentially to induce intraluminal vesicle formation (reviewed 
Hurley 2008). Plants do not have clear homologs of the recognised animal ESCRT-0, but the 
Ton1 recruiting motif 33 like (TOL) proteins and FYVE domain protein required for 
endosomal sorting 1 (FREE1) were recently shown to fulfil a similar role in higher plants 
(Korbei et al. 2013, Gao et al. 2014). ESCRT-0 is now commonly used as a term for the 
ESCRT-0 function and not solely for the homologs of the animal ESCRT-0.  
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Together with the ESCRT machinery, other LE/MVB identity specifiers such as the RAB5 
GTPases (RABF1/ARA6, RABF2a/RHA1 and RABF2b/ARA7) are likely to be present on the 
TGN to specify LE/MVB identity. RAB GTPases regulate membrane identity by recruiting 
proteins (RAB effectors) to the membranes on which they are located (Saito and Ueda 
2009). Upon Conc A treatment, LE/MVB identity proteins (RABF1/ARA6 and RABF2b/ARA7) 
accumulate on the TGN, displaying strong co-localisation with SYP61 and VHA-A1 
(Scheuring et al. 2011). This data supports the observation that RAB5 GTPases are present 
on the TGN/EE membranes as does low level co-localisation with the TGN marker VHA-A1 
(Ueda et al. 2004).   
 
Furthermore, RFP-RABF2b/ARA7 is frequently cited in literature as a LE/MVB marker, 
however initial characterisation of this protein suggested a partially early endosome function 
as well. Assessing the similarity between the published TGN proteomes and the RFP-
RABF2b/ARA7 proteome will help elucidate the role of RABf2b/ARA7 within the cell. 
4.1.8 PRA1 and YIP proteins control the regulatory RAB GTPases 
RAB GTPases regulate the identity of a membrane but, as mentioned above, they are 
controlled in several ways themselves (Summarised in Figure 4.2). They are poor GTPases 
and require a GAP to hydrolyse GTP and be inactivated, and a GEF to switch the GDP for 
GTP and be activated, (reviewed Saito and Ueda 2009). The CCZ1-MON1 complex acts as 
a GEF for RAB7 GTPases whilst VPS9a acts as a GEF for RAB5 GTPases. RAB GTPases 
have an additional layer of regulation, by altering their affinity for membranes. All RAB 
GTPases have a hydrophobic membrane association modification, which is usually 
prenylation on one or more conserved cysteine residues on their C-terminus (Saito and 
Ueda 2009). In A. thaliana there are three proteins that bind this prenylation motif and so 
prevent the RAB from associating with the membrane, (reviewedSaito and Ueda 2009). As 
membrane association is a pre-requisite for RAB GTPase activation by exchange of GDP for 
GTP, these proteins are known as GDP dissociation inhibitors (GDIs)- GDI, GDI1 and GDI2 
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(Ueda et al. 1996, Žárský et al. 1997). The GDIs are removed and the RAB GTPase 
associates with the membrane via the function of a GDI dissociation Factor (GDF) (Sivars et 
al. 2003, Chen and Collins 2005, Kano et al. 2009, Lorente-Rodríguez et al. 2009). The 
homologs of yeast GDFs in A.thaliana are the Ypt Interacting protein (YIP) and Prenylated 
Rab GTPase acceptor 1 (PRA1) family (Alvim Kamei et al. 2008, Gendre et al. 2013). 
There is clearly tight regulation of RAB GTPase activity, especially through GDF/GDI activity. 
In A. thaliana, there has been a radiation of the PRA1 and YIP1 proteins into two families of 
GDFs, 19 in the PRA1 family and seven in the YIP family (Alvim Kamei et al. 2008, Gendre 
et al. 2013). The PRA1 family are co-expressed with RAB GTPases and a few select 
members have been localised to a variety of endomembrane compartments (Alvim Kamei et 
al. 2008). With so many different GDFs (compared to the three GDIs) it is likely that they 
Figure 4.2.Regulation of RAB GTPases.Known and suspected RAB GTPase regulators are 
detailed. VPS9a is the regulator of the RAB5 GTPases (Goh et al. 2007) and the CCZ1/MON1 
dimer is the GEF for RAB7 GTPases (Cui et al. 2014, Lawrence et al. 2014). The PRA1 and 
YIP1 family have been implicated as GDFs (Alvim Kamei et al. 2008, Gendre et al. 2013). 
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dictate the membranes with which a RAB GTPase associates. One pressing question is, 
therefore, where do these GDFs localise in planta?  
 
Intriguingly the plant unique RAB GTPase RABF1/ARA6, associates with membranes by N-
myristolylation and lacks the C-terminal cysteine motif for prenylation, (Ueda et al. 2001). As 
GDIs bind to RAB GTPases through the C-terminal prenylation modification, it remains open 
whether GDIs can bind to RABF1/ARA6. Whilst RABF1/ARA6 binding to membranes is not 
reduced in single gdi1 mutants, the association of GDIs to RABF1/ARA6 has not been 
investigated directly (Ueda et al. 2001). Furthermore, it remains unknown how RABF1/ARA6 
is directed to the appropriate membranes. The GEF for RABF1/ARA6 is VPS9a (Goh et al. 
2007), but literature knowledge of RAB GTPases indicates GEFs function downstream of 
membrane association of a RAB GTPase. Therefore it is still unknown whether 
RABF1/ARA6 associates with canonical GDFs to promote association with the correct 
membranes.  
4.1.9 LE/MVBs exist as a diverse population 
RABF1/ARA6 and RABF2b/ARA7 labelled LE/MVBs are distinct. RABF2b/ARA7 LE/MVBs 
are more susceptible to application of the drug BFA than RABF1/ARA6 LE/MVBs (Ueda et 
al. 2004). Furthermore, RABF2b/ARA7 co-localises to a greater extent with the SNARE 
VAMP727 whilst RABF1/ARA6 co-localises to a greater extent with the SNAREs SYP21 and 
SYP22 (Ueda et al. 2004). The two populations of RAB GTPases also have different 
biological functions. Mutant rabf2b/ara7 and rabf2a/rha1 exaggerate the developmental 
phenotype of syp22-1knock out plants, whilerabf1/ara6 loss of function mutantssupress 
thesyp22-1 phenotype (Ebine et al. 2011, Ebine et al. 2012).Also, RABF1/ARA6 has been 
implicated in salt stress tolerance and rabf1/ara6 mutants accumulate more Flowering Locus 
T (FLT), whereas in both cases, RABF2b/ARA7 is not involved (Ebine et al. 2012). These 
data demonstrate that whilst the RAB5 GTPases label morphologically similar 
compartments, they have very different biological functions. These differences must relate to 
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differences at the proteome level too. It will be interesting to determine which tethering 
factors or other RAB effectors are RABF1/ARA6 or RABF2b/ARA7 specific.  
4.1.10 Objectives 
My objectives for this chapter are to provide independent experimental evidence to test the 
biological significance of my proteomic data by comparison with literature and validate the 
predicted localisation (based on my proteomic data) of PRA1.B1, PRA1.B2 and PRA1.F1 
(GDF) proteins with CLSM. The analysis of GDFs will help elucidate the functional specificity 
of these proteins and how RAB GTPases are generally regulated. Secondarily, I can use 
these data to make inferences about the biology of the endomembrane system. My 
comparisons between the LE/MVB proteomes and the TGN will also be used to make 
inferences about the interaction between the TGN and LE/MVBs. These experiments and 
comparisons will dictate whether this data can be used for further study of endosomes and 
their roles in signalling. 
4.2 Results 
4.2.1 The proteomic data is not suitable for direct quantitative comparisons between 
proteomes 
The efficiency of the IP method (Section 3.2.6) to enrich for proteins associating with an 
endomembrane marker varied according to the bait protein used. Whilst input protein was 
carefully balanced (after quantification with BCA assay to ensure equal input into the IP) the 
yield of bait proteins and co-enriched proteins varied between marker protein bait (Table 
S3). Therefore conclusions made by numbers of proteins identified or quantity of protein 
identified in each IP must be made with caution. I can, however, make conclusions about the 
identity of proteins that are identified with each bait, but analyses need to reflect the relative 
number of proteins in each proteome. 
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4.2.2 The proteomic data recapitulates known differences between the Golgi and the 
tonoplast and the similarity between two LE/MVB markers 
In order to confirm the power of my IP method (Section 3.2.6) to discriminate between 
compartments, I tested whether known biological differences between compartments (the 
tonoplast and the Golgi) were reflected in the data. A comparison between the YFP-GOT1 
(Golgi) and the YFP-VAMP711 (tonoplast) proteomes revealed a modest overlap of 46 
proteins (Figure 4.3a). In order to test the significance of this overlap, I tested the H0 of 
independent assignment of proteins between the two proteomes with a χ2analysis. Based on 
these data, the H0cannot be rejected(P~0.5), demonstrating that proteomic data obtained 
with this method can discriminate between the Golgi and the tonoplast.  
 
In order to test whether the proteomic data obtained with this method could also recapitulate 
a published biological similarity, I compared the RFP-RABF2b/ARA7 (LE/MVB) proteome to 
the RABF1/ARA6-RFP (LE/MVB) proteome (Figure 4.3b). These two populations of 
endosomes display a significant overlap of 182 proteins. The H0of independent assignment 
of proteins between the two proteomes can be rejected with a χ2analysis (P<0.005). 
Figure 4.3.Venn diagrams comparing the proteins assigned to different 
endomembrane proteomes. The number in each area of the Venn diagram 
indicates number of proteins assigned to the proteome or proteomes indicated. 
a. Comparison of the YFP- GOT1 (Golgi) and the YFP-VAMP711 (Tonoplast). 
b. Comparison of the RFP-RABF2b/ARA7 (LE/MVB) and RABF1/ARA6-RFP 
(LE/MVB). 
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Therefore I am confident that my proteomic data reflects published biological similarities and 
differences between proteomes. 
4.2.3 The YFP-GOT1 proteome compares favourably with other published Golgi 
proteomes 
To establish the biological relevance of my dataset, relative to literature, I compared the 
YFP-GOT1 enrichment with the TGN and well characterised Golgi proteomic data (from 
different methodologiesoutlined in section 3.2.9) and displayed the results with a Venn 
diagram (Figure 4.4). The comparison revealed a large number of proteins known to be 
associated with Golgi: 63 of the 152 proteins in the YFP-GOT1 proteome were previously 
identified in Golgi proteomic analyses (Figure 4.4, Table S3). These include Golgi-localised 
enzyme complexes such as galacturonosyltransferases (AT2G20810, AT2G38650, 
AT3G02350, AT3G25140, AT3G61130), xylose synthase (AT2G47650) and xylose 
transferases (KKT5, AT1G74380; XYLT, AT5G55500) and two UDP-D-glucuronate 4-
Figure 4.4. Venn diagrams comparing the proteins assigned to YFP-GOT1 (Golgi) with 
published endomembrane proteomes. The number in each area of the Venn diagram 
indicate number of proteins assigned to the proteome or proteomes indicated. Venn diagram 
comparisons of YFP-GOT1 (Golgi) proteomes. Proteomes are A - Nikolovski et al. 2012, B - 
Parsons et al. 2012, C - Sadowski et al. 2008/Dunkley et al. 2006. Grey area highlights my 
data. 
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epimerase 6 (GAE1, AT3G23820; GAE6, AT4G30440). These enzymes were also identified 
by Parsons et al. (2012) and Nikolovski et al. (2012) but not observed in the CFP-SYP61 
affinity purification (Drakakaki et al. 2012). Of the remaining YFP-GOT1 proteins, 24 are 
predicted to have Golgi, ER-Golgi interface or PM/extracellular localisations and 33 
predicted to be cytosolic (SUBA3). The high overlap between my YFP-GOT1 proteome and 
the published data supports the hypothesis that this method enriches Golgi proteins and 
proteins trafficking through the Golgi.  
4.2.4 RFP-RABF2b/ARA7 is more TGN like than expected 
Whilst there is no published LE/MVB proteome, there are two published TGN proteomes that 
can be used for comparison with my LE/MVB proteomes. Therefore, to assess the biological 
relevance of my LE/MVB marker proteomes (RFP-RABF2b/ARA7, YFP-RABG3f, 
RABF1/ARA6-RFP), I compared the RFP-RABF2b/ARA7 proteome to the TGN, utilising the 
published proteomic data from VHA-A1-GFP IPs (Groen et al. 2014) (Figure 4.5a).  
 
30% of RFP-RABF2b/ARA7-labelled bodies co-localises with VHA-A1-GFP (personal 
communication,  Beck and Robatzek) and around 20% of VHA-A1-GFP labelled bodies co-
localises with RFP-RABF2b/ARA7 (Dettmer et al. 2006). Thus, I expected that there would 
be an overlap of between 20-30% of proteins from the RFP-RABF2b/ARA7 proteome and 
that of the VHA-A1-GFP proteome. Strikingly, we can accept the conservative H0 of 30% 
overlap (χ2 p<0.005). This unexpected similarity between the RFP-RABFb/ARA7 and the 
VHA-A1 proteomes suggests that RABF2b/ARA7 interacts closely with VHA-A1. Whilst the 
overlap between RFP-RABF2b/ARA7 is significant at 30% overlap, it should still be noted 
that only 20 proteins of 279 in the RFP-RABF2b/ARA7 proteome are shared with the VHA-
A1 proteome. Therefore, these two compartments are still largely independent, they 
associate more than the CLSM data would suggest. As a contrast, I compared the 
RABF1/ARA6 proteome to the VHA-A1 proteome and both a H0 of independent assignment 
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and 30% overlap can be rejected (χ2 p<0.005). Further supporting the observations that 
RABF1/ARA6 is more different from VHA-A1 labelled TGN than RABF2b/ARA7. 
 
Within the 20 protein overlap were several known TGN markers and residents: YIP4b 
(AT4G30260) (Gendre et al. 2013), VHA-A1 (AT2G28520) (Dettmer et al. 2006), and SYP43 
(AT3G05710) (Uemura et al. 2004)as well as the known RABF2b/ARA7 endosome resident 
SNARE VAMP727 (Ueda et al. 2004). These results further demonstrate the modest 
Figure 4.5.Venn diagram comparison of RFP-RABF2b/ARA7, YFP-
RABD2a/ARA5 and VHA-A1-GFP IPs.a. Venn diagramscomparing proteins 
assigned to RFP-RABF2b/ARA7 and VHA-A1-GFP. The number in each area 
of the Venn diagram indicates number of proteins assigned to the proteome or 
proteomes indicated. b. Venn diagram comparing the proteins assigned to the 
YFP-RABD2a/ARA5 (Golgi/TGN/EE) and the RFP-RABF2b/ARA7 (LE/MVB) 
with published TGN/EE proteomes. The number in each area of the Venn 
diagram indicate number of proteins assigned to the proteome or proteomes 
indicated. Proteomes are: D - Drakakaki et al. 2012., E – Groen et al. 2014. 
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biological overlap between the TGN and LE/MVB and further support the relatedness of 
these compartments and their proteomic interactions. It also provides evidence that RFP-
RABF2b/ARA7 labelled LE/MVBs form directly from a TGN subdomain labelled with VHA-
A1SYP61 was not identified in my LE/MVB marker proteomes, perhaps suggesting it labels 
a different subdomain of the TGN. However, lack detection does not mean SYP61 is absent. 
Instead it is more likely that in these experiments, it was below the limit of detection. 
4.2.5 YFP-RABD2a and RFP-RABF2b/ARA7 define subpopulations of the TGN 
To further examine TGN proteomes,I compared YFP-RABD2a/ARA5 enriched proteins with 
RFP-RABF2b/ARA7, and with the published CFP-SYP61 and VHA-a1-GFP proteomes 
(Figure 4.5b). YFP-RABD2a/ARA5 is localised throughout the TGN in punctate structures 
that are sensitive to BFA and co-localise with FM4-64 and VHA-a1(Geldner et al. 2009; 
Pinheiro et al. 2009. This RAB GTPase also has a role in regulating ER to Golgi traffic 
(Geldner et al. 2009, Pinheiro et al. 2009). Of the 120 proteins assigned to the YFP-
RABD2a/ARA5 proteome, there was substantial overlap with RFP-RABF2b/ARA7 (85 
proteins) and, to a lesser extent, with CFP-SYP61 (23 proteins) and VHA-a1-GFP (17 
proteins) enrichments (Figure4.5b, Table S3). I did not identify VHA-a1 in the YFP-
RABD2a/ARA5 enrichment. Six proteins are common to CFP-SYP61, VHA-a1-GFP and 
YFP-RABD2a/ARA5 enrichments but were not shared with RFP-RABF2b/ARA7, these 
include TRS85 (AT5G16280), YIP5b (AT3G05280) and a SCAMP family protein (Secretory 
Carrier Membrane protein, AT1G32050) suggesting spatial distinction within the TGN 
between YFP-RABD2a/ARA5 and RFP-RABF2b/ARA7. 
4.2.6 RABF1/ARA6-RFP functional specificity is conferred by 9unique proteins 
One striking observation, as discussed in Section 4.2.2, is that the proteomes of RFP-
RABF2b/ARA7 and RABF1/ARA6-RFP are very similar with an overlap of 49 proteins 
(Figure 4.3b). This overlap is significantly different from what would be expected if these 
proteins were independently assigned (Section 4.2.2). It is consistent with RABF2b/ARA7 
and RABF1/ARA6 labelling compartments within the same endocytic route (Ueda et al.2001, 
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Lee et al. 2004)There is also a much smaller proportion of unique RABF1/ARA6-RFP 
proteins than would be expected if proteins were independently assigned to the two 
proteomes. Only14 proteins are not detected in the RFP-RABF2b/ARA7 proteome and of 
these, just9 proteins are unique to RABF1/ARA6-RFP across my entire dataset.  
Surprisingly, there were no RABF1/ARA6 unique SNAREs or tethering factors identified.  
 
One substantial difference between the RFP-RABF2b/ARA7 and RABF1/ARA6-RFP 
endosomes was the presence of numerous TGN localised proteinsin the RFP-
RABF2b/ARA7 but not RABF1/ARA6-RFP proteomes (Table S3). These TGN localised 
proteins are SYP43 (AT3G05710) and (Chow et al. 2008, Saito and Ueda 2009, Feraru et al. 
2012). This observation provides additional supporting evidence to the notion that RFP-
RABF2b/ARA7 labels a sub population/sub compartment of the TGN.  
4.2.7 Canonical RAB GTPase regulators (GDFs) appear in the conventional RAB 
GTPase proteomes, but not in the atypical RAB RABF1/ARA6-RFP proteome 
To test whether my proteomic data could be used to predict the localisation of a protein, I 
examined three members of the PRA1 family of proteins. The PRA1 family is a protein family 
of potential regulators of RAB GTPases of which several were identified in my proteomic 
 PRA1.B1 PRA1.B2 PRA1.F1 
RFP-RABF2b/ARA7 Identified n.i. n.i. 
RABF1/ARA6-RFP n.i. n.i. n.i. 
YFP-GOT1 Identified Identified n.i. 
YFP-RABD2a/ARA5 Identified n.i. n.i. 
Table 4.1. Predicted localisation of PRA1 proteins based on my proteomic 
data.Proteins identified in the enrichments of RFP-RABF2b/ARA7, RABF1/ARA6-
RFP, YFP-GOT1 and YFP-RABD2a/ARA5 were predicted to co-localise. When 
proteins were not identified in a particular condition, n.i. is used.  
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data. I focused on localising PRA1.B1(AT3G56110), PRA1.B2 (AT2G40380) and PRA1.F1 
(AT1G17700). PRA1.F1 is included as a negative control that was not in the proteomic data 
(Table 4.1). Some PRA1 family members have been localised (including PRA1.F1) with 
transient expression of fluorescent protein fusions in tobacco leaf epidermal cells (Alvim 
Kamei et al. 2008), but the identity of PRA1.B1 and PRA1.B2 labelled compartments in 
A.thaliana are unknown. These chosen proteins have varied and overlapping predicted 
localizations. I therefore co-expressed PRA1.B1, PRA1.B2 and PRA1.F1 using particle 
bombardment with either a YFP or RFP tag in plants stably expressing a YFP-GOT1, YFP-
RABD2a/ARA5, RFP-RABF2b/ARA7, RABF1/ARA6-RFP in A. thalianaleaf epidermal cellsto 
test whether their predicted localisations. 
 
When YFP-PRA1.B1 was transiently co-expressed with stable RFP-RABF2b/ARA7 by 
particle bombardment (Figure 4.6), it co-labels a sub population of RFP-RABF2b/ARA7 
bodies. There are however, independent RFP-RABF2b/ARA7 and YFP-PRA1.B1 structures. 
Furthermore, I often observed a tight association between RFP-RABF2b/ARA7 and YFP-
PRA1.B2 and YFP-PRA1.F1 but rarely co-labelling of the same compartments. This is in 
agreement with the predictions I made from the proteomic data.  
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RABF1/ARA6-RFP was not predicted to co-localise with any of the PRA1 proteins and live 
cell imaging confirmed these predictions (Figure 4.7). Neither YFP-PRA1.B1, YFP-PRA1.B2 
nor YFP-PRA1.F1 co-labelled RABF1/ARA6-RFP positive structures. However, there was 
often a tight association between compartments, but rarely co-labelling.  
 
  
Figure 4.6.Co-localisation of YFP-PRA1 family members with RFP-
RABF2b/ARA7 (LE/MVB). Standard confocal micrographs of leaf epidermis of 
the indicated A.thaliana transgenic plants stably expressing UBQ10::RFP-
RABF2b/ARA7, transiently transformed using particle bombardment, expressing 
fluorescent tagged PRA1 family members. Insets show an enlarged section of 
each image. 
0.52 
0.28 
0.06 
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I predicted that YFP-GOT1 would co-localise with RFP-PRA1.B1 and RFP-PRA1.B2. This 
was confirmed with live cell imaging (Figure 4.8).  YFP-GOT1 labelled halo like cytoplasmic 
membrane structures, typical of a Golgi marker and both RFP-PRA1.B1 and RFP-PRA1.B2 
labelled small regions within these rings, suggesting that they partially localise to sub regions 
within the Golgi.  PRA1.F1 conversely, did not localise to YFP-GOT1 structures. 
Figure 4.7.Co-localisation of YFP-PRA1 family members with 
RABF1/ARA6-RFP (LE/MVB). Standard confocal micrographs of leaf epidermis 
of the indicated A.thaliana transgenic plants stably expressing 
UBQ10::RABF1/ARA6-RFP, transiently transformed using particle 
bombardment, expressing fluorescent tagged PRA1 family members. Insets 
show an enlarged section of each image. 
 
-0.02 
0.28 
-0.01 
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Intriguingly, I observed that RFP-PRA1.B1, RFP-PRA1.B2 and RFP-PRA1.F1 co-localise to 
some extent with YFP-RABD2a/ARA5 (Figure 4.9). This is a deviation from the predicted co-
localisation of only RFP-PRA1.B1 with YFP-RABD2a/ARA5. Overall, however, the co-
localisation of PRA1 family proteins with the target organelle markers used for IP are in 
agreement with the predictions of protein localisation derived from the proteomic data. 
 
Figure 4.8.Co-localisation of RFP-PRA1 family members with YFP-GOT1. 
Standard confocal micrographs of leaf epidermis of the indicated A.thaliana 
transgenic plants stably expressing UBQ10::YFP-GOT1, transiently transformed 
using particle bombardment, expressing fluorescent tagged PRA1 family 
members. Insets show an enlarged section of each image. 
0.68 
0.63 
0.13 
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4.2.8 Defining a combined LE/MVB proteome 
As my proteomic data compared well with literature and could be used to predict protein 
localisation I am confident that it is largely accurate and representative. Therefore, to 
achieve my aim of producing a putative LE/MVB proteome, I combined my YFP-RABG3f, 
RFP-RABF2b/ARA7 and RABF1/ARA6 proteomes and compared them to my control 
proteomes (YFP-RABD2a/ARA5, YFP-GOT1 and CLC2-GFP (Figure 4.10). I did not include 
Figure 4.9.Co-localisation of RFP-PRA1 family members with YFP-
RABD2a/ARA5. Standard confocal micrographs of leaf epidermis of the 
indicated A.thaliana transgenic plants stably expressing UBQ10::YFP-
RABD2a/ARA5, transiently transformed using particle bombardment, 
expressing fluorescent tagged PRA1 family members. Insets show an enlarged 
section of each image. 
0.58 
0.29 
0.37 
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YFP-VAMP711 as a control proteome since proteins that were present in the LE/MVB could 
conceivably be identified in the YFP-VAMP711 proteome, considering the tight association 
between these compartments. This is irrespective of known biological differences between 
the LE/MVBs (as demonstrated by my proteomic data). I considered proteins identified in the 
overlap between all the LE/MVB markers and not the control markers to be represent a 
‘core’ endosomal proteome. The proteins identified in one LE/MVB marker proteome and not 
the control proteomes were considered a ‘peripheral’ endosomal proteome. Combined they 
should form a suitable proteome for LE/MVBs for further work to assess the role of any 
LE/MVB population is signalling. 
 
4.3 Discussion 
In this chapter I demonstrated that my proteomic dataset is consistent with and contributes 
to knowledge of several endomembrane compartments. I also elucidated the function of 
Figure 4.10. Estimating the LE/MVB proteome with Venn diagram 
comparison of RFP-RABF2b/ARA7, YFP-RABG3f, RABF1/ARA6-RFP and 
non-endosomal proteomes.The number in each area of the Venn diagram 
indicates number of proteins assigned to the proteome or proteomes indicated. 
The non-endosomal segment is the combination of the control proteomes (YFP-
RABD2a/ARA5, YFP-GOT1 and CLC2-GFP. 
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several endomembrane regulators, whilst confirming predicted localisations made from the 
proteomic with an analogous technique. Finally, I also demonstrate that my proteomic data 
can be used to produce a putative LE/MVB proteome.  
4.3.1 The proteomic method discriminates between compartments and expands our 
knowledge of the Golgi 
My proteomic dataset reflects biological differences between defined endomembrane 
compartments. This IP based method can proteomically discriminate between the Golgi and 
the tonoplast as the proteins identified in the IPs of the Golgi and tonoplast markers were 
different (Section 4.2.2). Furthermore, my YFP-GOT1 proteomic data accurately identifies 
Golgi localised proteins. These data validate my method and allow me to make further 
biological inferences using my data. 
4.3.2 Localisation of PRA1s 
The proteins of the PRA1 family exhibit a varied distribution within the cell. PRA1.B2 is a 
Golgi localised GDF. PRA1.B1 has a much broader localisation along the secretory route of 
the Golgi and TGN as well as localisation to LE/MVBs with RFP-RABF2b/ARA7. PRA1.F1’s 
cellular localisation is not defined. RFP-PRA1.F1 co-localises with YFP-RABD2a/ARA5, 
which does not conform to my predictions from the MS data. This observation highlights the 
difficulty in inferring absence from MS data. Alternatively it may be that this is the correct 
localisation for RFP-PRA1.F1 in A. thaliana leaf epidermal cells, but in the majority of plant 
cell types, they do not co-localise and therefore, this small pool of PRA1.F1 cannot be 
detected in my YFP-RABD2a/ARA5 enrichments, which represent an average of all plant 
cell types. 
 
In contradiction to my results (that RABF2b/ARA7 and PRA1.F1 do not co-localise) a 
previous study reports co-localisation between RFP-RABF2b/ARA7 and PRA1.F1-GFP 
(Alvim Kamei et al. 2008). This contradiction could reflect differences in the systems used for 
expression. Whilst I utilised the native system of A. thaliana with stable expression of the 
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RAB GTPases, Alvim Kamei and colleagues use N. tabaccum and transient expression of 
both PRA1.F1 and RFP-RABF2b/ARA7. For example, atFLS2 co-localises with atSYP61 but 
not atVHA-A1 upon flg22 treatment in N. benthamiana(Choi et al. 2013), but the reverse is 
true in A. thaliana (Beck and Robatzek, personal communication). In addition, it has been 
demonstrated that RAB GTPases as markers are very sensitive to protein levels (Spallek et 
al. 2013). This suggests that localisation of RAB GTPases in particular in a heterologous 
system should be treated with caution. 
4.3.3 RFP-RABF2B/ARA7 labels a population of the TGN 
The TGN is known to not only have distinct sub-compartments, but also be divided into the 
two populations of SYP43/SYP61/VHA-A1 and RABA1b/RABA2a/VAMP721 (reviewed 
Gendre et al. 2014). The presence of different TGN localised proteins in the RFP-
RABF2b/ARA7 proteome and that of the YFP-RABD2a/ARA5 proteome demonstrates that 
these two RAB GTPases label different populations of the TGN. Due to the number of TGN 
marker proteins, but not SYP61, in the RFP-RABF2b/ARA7 proteome, I suggest that RFP-
RABF2b/ARA7 mainly labels one population of VHA-A1 positive TGN that is also SYP61 
independent. This would be the most parsimonious explanation of my approach identifying 
TGN markers in the RFP-RABF2b/ARA7 proteome. It is possible that these TGN mature into 
LE/MVBs and this is triggered by the action of RABF2b/ARA7 Moreover, this data suggests 
that some VHA-A1 TGN are at least partially independent of SYP61. It may be that VHA-A1 
is enriched in a sub-domain of the same TGN body with SYP61, however this cannot be 
resolved with my data. A model of the VHA-A1/SYP61/SYP43 function and sub-
compartmentalisation based on these data is presented in Figure 4.11.  
 
The similarity between the RFP-RABF2b/ARA7 proteome and the published TGN 
proteomes, suggests that whilst RABF2b/ARA7 is frequently cited as an exclusive LE/MVB 
marker (Dettmer et al. 2006, Robert et al. 2008, Gendre et al. 2014), it also labels the TGN 
as initially suggested (Ueda et al. 2001, Ueda et al. 2004).   
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4.3.4 RABF1/ARA6 identity is conferred by a few proteins 
Using my proteomic data, I could confirm that the RFP-RABF2b/ARA7 and the 
RABF1/ARA6-RFP proteomes show significant similarity. It is particularly interesting that the 
RABF1/ARA6-RFP proteome has so few unique proteins compared to the RFP-
RABF2b/ARA7 (Section 4.2.2). RAB GTPases need to recruit effector proteins to confer the 
unique functionality to a compartment. According to my dataset, there are few proteins that 
could confer such unique function to RABF1/ARA6 labelled LE/MVBs. The lack of unique 
SNAREs or tethering factors in the RABF1/ARA6 proteome is striking and raises the 
question of how the unique properties of RABF1/ARA6 LE/MVBs are conferred. It is 
therefore likely that a lack of RABF2b/ARA7 identifying proteins and quantitative differences 
in protein levels confer the unique RABF1/ARA6 identity to endosomes. 
 
Figure 4.11.Model of functional divisionwithin the TGN.The SYP61/ECH 
labelled TGN subdomains are preferentially involved in the secretion of proteins 
to the PM, whilst VHA-A1 labelled TGN subdomains are predominantly 
associated with MVBs. These are presented as subdomains, but could be 
interacting populations. The LE/MVB specifier RABF2b/ARA7 localises to the 
VHA-A1 labelled TGN and induces LE/MVB identity in these compartments. 
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This data also raises the question of how RABF1/ARA6 LE/MVBs form as no TGN markers 
were identified in this proteome. RABF1/ARA6 LE/MVBs must mature from RABF2b/ARA7 
endosomes or form directly from another structure such as the PM (Ebine et al. 2011). That 
the proteins identified with RABF1/ARA6-RFP are nearly a subset of RFP-RABF2b/ARA7 
accords with observations that a RABF2b/ARA7 endosome population matures into the 
RABF1/ARA6 endosomes on the endocytic route(Ueda et al. 2004, Ebine et al. 2011). An 
alternative explanation is that this method of discovery LC-MS/MS analysis does not provide 
sufficient quantitative data to resolve any differences in protein abundance between the 
RFP-RABF2b/ARA7 and RABF1/ARA6-RFP proteomes. 
 
There are however a few RAB GTPase effector candidates. Perhaps the most likely 
RABF1/ARA6 specific effector protein is Guanylate binding protein (AT5G46070). 
Homologous proteins are implicated in endomembrane trafficking and pathogen defence in 
mammalian systems but the exact role is unclear (Britzen-Laurent et al. 2010, Vestal and 
Jeyaratnam 2011). Most of the other 9 other RABF1/ARA6-RFP unique proteins are poorly 
characterised, so whilst they may be RABF1/ARA6 effectors their function cannot yet be 
inferred.  
 
4.3.5 RABF1/ARA6 requires non-canonical GDF machinery to associate with 
membranes. 
Numerous canonical GDFs were found in the combined proteomic analysis, with at least one 
member of the PRA1 or YIP1 family identified with each RAB GTPase studied, except for 
RABF1/ARA6. This conforms to the hypothesis that RABF1/ARA6 uses different GDF 
machinery to all other RAB GTPases, as it lacks a C terminal palmitoylation site. No tested 
GDFs co-localised, with CLSM, with RABF1/ARA6 labelled compartments. Nevertheless, 
RABF1/ARA6 must still need GDF machinery to bring it onto the correct membranes, as it 
cycles between a membrane and cytosol localisation (Ueda et al. 2004). Therefore, I 
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postulate that RABF1/ARA6 requires non-canonical GDF machinery; as yet we cannot 
identify any of these non-canonical GDFs.  
4.3.6 A preliminary LE/MVB proteome 
Utilising my proteomic dataset, I estimated a preliminary LE/MVB specific proteome. This 
proteome can be defined as the proteins identified in the RFP-RABF2b/ARA7, YFP-RABG3f, 
RABF1/ARA6-RFP proteomes but not the YFP-RABD2a, YFP-GOT1 or CLC2-GFP 
proteomes (Section 4.2.9). This estimation of the proteome is deliberately conservative, to 
remove proteins commonly found in endomembrane compartments. Despite this, my 
estimation cannot be a conclusive LE/MVB proteome. As demonstrated in Section 4.2.3 and 
(reviewed Parsons et al. 2013), multiple techniques are needed to definitively confirm an 
organelle proteome. The proteome put forward here is only a starting point for the further 
examination of LE/MVBs.  
 
With regards to my overall aims of assessing the role of LE/MVBs in signalling, I identified 
MKK2 and MKK5 in my LE/MVB proteomes. MKK5 was identified with the RABF1/ARA6-
RFP proteome and MKK2 was identified with the YFP-RABG3f proteome. MAPK cascade 
components localising to the endomembrane system is not unprecedented. MPK6 was 
identified in proteomic studies of the TGN (Muller and Beck et al. 2011), whilst MPK4 was 
identified on microtubules (Beck and Muller et al. 2011) and these localisations are relevant 
to their role in cell division. Furthermore, a MAPKKK (EDR1) is recruited to the TGN by Keep 
on going (KEG) (Gu et al. 2011).The identification of MKKs is particularly relevant to my 
overall aims of testing the role of LE/MVBs in defence signalling as MKK2 and 5 are 
components of the MPK cascade downstream of FLS2. The relevance of MKKs in LE/MVB 
proteomes will be explored in Chapter 5. 
4.3.7 Conclusions and further work 
The proteomic data obtained through my IP method is biologically relevant. In this chapter it 
was essential to establish a method suitable for LE/MVB enrichment with the analogous 
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technique of CLSM. This method is faster than the previous methods discussed and requires 
minimal knowledge of the target compartment’s biophysical properties. Therefore this 
method is generally applicable and will be incredibly useful to the community. Strikingly, 
MPK cascade components were identified in the LE/MVB proteomes, suggesting that 
defence signalling may occur from this compartment. Now the endosomal proteome can be 
assessed for functionality and changes after bacterial attack. This will be explored in Chapter 
5. 
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5 Characterising flg22-induced proteome changes in 
Endosomes 
5.1 Introduction and Objectives 
To further interrogate the role of LE/MVBs in the plant cell’s response to bacterial attack and 
their involvement in signalling, I needed to assess proteome changes in LE/MVBs following 
flg22 treatment. If LE/MVBs are important in immune signalling or indeed any part of the 
response to pathogens, it should be reflected by a proteomic change in LE/MVBs following 
flg22 treatment. 
5.1.1 Endosomes are functionally altered during biotic interactions 
Endomembranes dictate the outcome of biotic infections. The TGN, which can act as an 
early endosome, has a well characterised role in secretion (as discussed in Chapter 4). 
During biotic interactions defence proteins such as PR1, C14 (Wang et al. 2005, Bozkurt et 
al. 2011) are secreted via the TGN and secretion is up regulated following defence activation 
with SA (Wang et al. 2005, Wang and Dong 2011). Moreover PMR4/GSL5, the principal 
enzyme involved in callose deposition upon biotic stress and wounding (Jacobs et al. 2003, 
Nishimura et al. 2003, Luna et al. 2011), is recycled constitutively through the TGN 
(Drakakaki et al. 2012, Ellinger et al. 2013). Whilst the TGN has an undoubtedly significant 
and highly relevant role in defence, I will focus on the less well understood role of LE/MVBs 
in biotic interactions. 
 
LE/MVBs exhibit altered function during plant-pathogen interactions. Substantial work has 
focused on the role of LE/MVBs in resistance to filamentous fungal and oomycete pathogens 
reviewed by Voigt (2014). Whilst bacteria are not filamentous pathogens, but ideally grow in 
the apoplast, defence responses to both types of pathogen share similarities that will be 
explored here. One example is callose deposition, which is thought to provide a mechanical 
barrier to penetration of the cell wall by pathogens, yet also occurs during bacterial infection 
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(Voigt 2014). Whilst both defence against bacteria and filamentous pathogens share 
similarities, there are also marked differences. For example defence against bacteria 
requires SYP132 but not PEN1, whilst defence against filamentous pathogens requires 
PEN1 but not SYP132 (Collins et al. 2003, Kalde et al. 2007, Kwon et al. 2008) 
 
LE/MVBs are altered in both movement and function following pathogen attack. Various 
endomembranes, including LE/MVBs, cluster around sites of attempted or actual pathogen 
penetration of host cells (An et al. 2006, An et al. 2006, Böhlenius et al. 2010, Lu et al. 
2012). This altered localisation demonstrates a significant rearrangement in the usual 
movements of LE/MVBs.  LE/MVBs are also involved in a novel route of secretion during the 
interaction of N. benthamiana and the plant pathogen P. infestans (Bozkurt et al. 2014). 
Here FLS2, which is trafficked through the late endocytic route after flg22 treatment, is 
directed from LE/MVBs to the haustoria. A haustaurium is the main site of interaction 
between the plant cells and the pathogen. These examples clearly demonstrate altered 
movement of LE/MVBs during plant-pathogen interactions.  
 
LE/MVBs also have a role in limiting progression of pathogen infection. LE/MVBs are 
involved in callose deposition (Meyer et al. 2009).RABF1/ARA6 labelled LE/MVBs were 
proposed as the origin of exosomes for the secretion of callose to form papillae in a GNOM 
dependent fashion (Nielsen et al. 2012). Another proposed function for LE/MVBs is through 
delivery of defence compounds to the apoplast via exosomes. For example, during infection 
of Hordeum vulgare L.(barley) by the powdery mildew fungus Bgh, LE/MVBs provide the 
secretion route for phenolics and H2O2 (An et al. 2006). Furthermore, the LE/MVB localised 
ARFA1b/c is required for Required for MLO-Specified 2 (ROR2) mediated penetration 
resistance through callose deposition in the H. vulgare and Bgh interaction (Böhlenius et al. 
2010). Although this implicates LE/MVBs in callose deposition, their exact role is unclear 
(Böhlenius et al. 2010).  
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LE/MVBs are clearly important in the delivery of defence compounds and antimicrobials to 
the extracellular space to inhibit pathogen growth. One class of defence compounds that 
may be involved in defence against pathogens are the class of flavonoids known as 
flavonols. Flavonols are phenolic compounds and have roles in many processes including 
UV protection, pathogen defence and auxin transport (Treutter 2006). Several flavonols have 
been shown to have antimicrobial properties and are used as biopesticides (Cespedes et al. 
2014, de Lima et al. 2014). Flavonols are also found in strategic locations within plants ready 
for deployment (reviewed in Treutter 2006). It may be that these flavonols are present in 
LE/MVBs ready for exosome mediated secretion during pathogen infection, although 
evidence about their localisation is lacking. 
 
The altered function of LE/MVBs in defence must be dictated to some extent by proteome 
changes. The proteins that regulate compartment identity, like the RAB effectors that control 
the interactions of a compartment, are probably altered in abundance during defence.It is 
likely that tethering factors and SNARE proteins change in abundance, allowing the LE/MVB 
to interact with novel compartments, such as the PM or EHM, for secretion. 
VAMP721/VAMP722 protein levels are stabilised following flg22 treatment demonstrating 
that the SNARE complement of some compartments must be altered although the exact 
nature of the VAMP721/VAMP722 compartments is unclear (Yun et al. 2013, Yun et al. 
2013). In addition defence proteins may be re-directed to LE/MVBs for degradation or for 
further signalling. Therefore these changes could be detected with proteomic analysis of 
LE/MVBs after flg22 treatment. Assessing these RFP-RABF2b/ARA7 proteome changes 
with IP after flg22 treatment could also help elucidate the role of LE/MVBs in defence against 
bacteria and against filamentous pathogens. 
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5.1.2 Quantitative proteomic analysis is essential to understand responses to flg22 
treatment 
In order to understand the specific roles of LE/MVBs during pathogen infection, we must first 
examine how their proteomes change during the course of a biotic interaction. Quantitative 
proteomics is an incredibly powerful tool that allows the abundance changes of proteins 
following a stimulus to be measured. This approach has several advantages over changes 
quantified by transcriptome and translatome data. For example, quantitative proteomics 
allows measurement of protein levels directly, unlike transcriptome or translatome data. 
Furthermore, proteomic techniques can also be used to measure changes in protein 
modifications and changes that occur before transcriptional change, something unattainable 
with RNA based techniques.  
 
Quantitative proteomic analysis has proven very successful in determining changes in the 
abundance of proteins during biotic interactions. The rapid interactions of PRRs with other 
proteins, such as FLS2 and EFR following ligand perception, have been extensively 
characterised using IP and LC-MS/MS (Heese et al. 2007, Lu et al. 2010, Roux et al. 2011, 
Kadota et al. 2014). This approach led to the discovery of the interaction of FLS2/EFR with 
the co-receptor BAK1 (Heese et al. 2007, Roux et al. 2011) and downstream targets 
RBOHD and BIK (Lu et al. 2010, Kadota et al. 2014), which helped develop our 
understanding of PAMP perception and PRR signalling. 
 
Subcellular fractionation can also provide a spatial aspect to the proteomic data so 
quantitative changes can be localised within the cell. Extensive quantitative proteomic 
analysis was performed on the PM after activation of defence via the R protein Resistance to 
P. syringae 2 (RPS2) (Elmore et al. 2012). Activation of RPS2 is triggered upon the 
degradation of the PM associated protein RPM1 interacting protein 4 (RIN4) by avirulence 
Resistance to Pseudomonas syringaepv tomato 2 (avrRpt2) (Mackey et al. 2003). Therefore, 
RPS2 can be activated inducibly by application of DEX to plants transformed with avrRpt2 
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under a DEX inducible promoter. This study used a label free analysis (which will be 
expanded upon later) to quantify relative changes in proteins between treated and untreated 
conditions. Interestingly, the PRRs (PEPR1, Wall associated kinase - WAK1) were more 
abundant at the PM following defence activation (Elmore et al. 2012). Other downstream 
components of the PRRs, e.g. RBOHD and BIK1, were also increased in abundance at the 
PM following RPS2 activation (Elmore et al. 2012). The PM has also been analysed for 
quantitative changes following flg22 treatment (Benschop et al. 2007, Nühse et al. 2007) 
revealing phosphorylation on several endomembrane regulators. Another study assessed 
detergent resistant membranes from PM preparations to identify quantitative changes at the 
PM following flg22 treatment (Keinath et al. 2010). A similar approach of PM enrichment with 
two phase partitioning has also been used successfully in studying non-PRR RLKs such as 
BRI1 to identify proteins in its signalling pathway such as the Brassinosteroid-Signalling 
kinases (BSKs) (Tang et al. 2008, Tang et al. 2010).  
 
Overall, these quantitative techniques allowed the characterisation of proteins that change in 
abundance at the PM following flg22 treatment. Yet, there are no published studies 
assessing the quantitative changes occurring at LE/MVBs following flg22 treatment. Using 
my IP approach at various times following flg22 elicitation could allow characterisation of 
proteome changes at LE/MVBs and further our understanding of the role of LE/MVBs in 
defence. Choosing the correct techniques for quantitation are essential. 
5.1.3 Detection and quantitation of proteins require different experimental 
conditions 
Measuring abundance changes in proteins between two conditions requires a different 
experimental approach to determining presence or absence of proteins. Proteins must be 
sufficiently abundant to be detected in all the conditions examined to be reliably quantified 
(Bantscheff et al. 2007). This is due to the high level of stochasticity inherent in detection of 
low abundance peptides (Bantscheff et al. 2007). Moreover more data is required to 
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accurately gauge levels of a protein than is required to simply determine presence. 
Therefore proteins need to be at a higher abundance in a sample for reliable quantification 
(limit of quantification) than they do for detection (limit of detection) (Steen and Mann 2004). 
Abundance here does not just necessarily mean absolute abundance but also relative 
abundance within a sample as most mass spectrometers work by sampling the most 
abundant MS1 spectra for MS2 analysis.  
 
There are multiple techniques for quantification of proteins that are detected in a sample 
analysed with MS/MS. Methods for quantitation can be generally divided into those that use 
stable isotope labelling and label free techniques. I will focus on techniques for relative 
quantification within an experiment, rather than absolute quantification, as I only need to 
compare IPs over time. 
5.1.4 Spectrum counting provides a rough measure of protein abundance 
The most straightforward to perform method of quantitation from mass spectrometric data is 
by spectrum counting. Spectrum counting is a label free approach, in which MS2 spectra are 
counted and used to infer abundance of the protein from whose peptides they are matched. 
Quantitation by spectrum counting was used to great effect in Heese et al. 2007 and Roux et 
al. 2011. Thereby a rough measure of abundance was determined. This approach is 
appealing for the simplicity of data acquisition and does not require expensive chemical 
labels (as required for a labelling analysis). It is also controversial as spectrum counting 
does not measure any direct physical property of a peptide and assumes a linear response 
of each peptide from protein (Bantscheff et al. 2007). As the number of spectra counted for 
each peptide is so dependent on the properties of the individual peptides, it requires multiple 
spectra from multiple peptides to be analysed to provide accurate quantitation (Bantscheff et 
al. 2007). The major confounding factors to accurate quantitation with spectrum counting are 
the protein coverage and number of spectra needed and the necessity of separate MS 
analysis as peptides from multiple conditions are indistinguishable (Russell and Lilley 2012). 
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Old et al. demonstrate that the number of spectra required to determine a fold change 
increases exponentially with decreasing magnitude of the change (Old et al. 2005). Four 
spectra are required to detect a threefold change whereas 15 are required to detect a 
twofold change (Old et al. 2005).  
 
Despite these issues, spectrum counting is frequently used and can reflect protein 
abundance changes (Old et al. 2005). Accuracy of measurement of protein abundance can 
be further improved by using the Protein Abundance Index (PAI) (Rappsilber et al. 2002). 
PAI is calculated by dividing the number of observed peptides by the number of possible 
tryptic peptides from a protein (Rappsilber et al. 2002). Thus, PAI allows the number of 
peptides detected to be scaled to the number of possible peptides generated by a given 
protein, thereby facilitating comparisons from protein to protein. PAI is useful for comparing 
abundance across proteins, but in my case of comparing the same protein across multiple 
conditions, PAI is not necessary.  
 
An analogous technique for label free quantitation of proteins is by generating Extracted Ion 
Chromatograms (XICs). Here, the ion chromatograms from the precursor peptides 
fragmented in an LC-MS/MS run are extracted to give a signal intensity over time plot for 
each peptide (Bondarenko et al. 2002). This can then be used to infer protein abundance 
from abundance of the constituent peptides as peak area increases linearly with protein 
abundance (Bondarenko et al. 2002). Comparing the intensity of XICs, however, requires 
strong reproducibility from each LC-MS run to allow peaks areas to be overlaid for 
comparison and quantitation (Bondarenko et al. 2002).  
 
One last method of label free quantitation with a mass spectrometer uses a candidate led 
approach. This technique is known as Multiple Reaction Monitoring (MRM) (Kirkpatrick et al. 
2005). The reactions that are monitored here are transitions of a peptide as it is fragmented 
in a triple quadrupole to allow quantitation against a synthetic peptide or for relative 
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quantification based on intensity (Kirkpatrick et al. 2005). Triple quadrupoles are utilised to 
maximise specificity. Here only peptides with the correct m/z ratio are selected by the first 
quadrupole for fragmentation by the second quadrupole and detection in the third 
quadrupole. This allows for the required purification for accurate quantification of peptides as 
retention time, peptide mass, and fragment mass combine to effectively eliminate ambiguity 
(Wolf-Yadlin et al. 2007).  
5.1.5 Mass tagging improves quantitation 
The alternative approach to label free quantitation with MS is to use labelling, usually with 
stable isotopes. Ultimately peptides from the experimental conditions to be analysed are 
labelled with isotopically different (and so different mass) tags. Therefore the differently 
labelled peptides can be analysed together but differentiated upon analysis.  
 
The isotopes can be integrated in the growing organism by feeding with the different 
isotopes, either 2H, 
15N, 13C or 18O (Bantscheff et al. 2007). One particularly popular method 
is to use Stable Isotope Labelling with Amino Acids in Cell Culture (SILAC) (Ong et al. 2002) 
and has been used successfully in plants (Gruhler et al. 2005). One population of cell culture 
is fed 13C6 arginine so that arginine containing peptides from this population will be mass 
shifted compared to the other population of cell culture. The SILAC technique therefore 
labels the proteins as they are being synthesised. Metabolic labelling, however, is only really 
feasible in cell culture, as multiple generations need to be grown exclusively on the isotopic 
media, and so in many cases is prohibitively expensive (Bantscheff et al. 2007).  
 
Alternatively, the labels can be added to the peptides after biosynthesis. These approaches 
rely on the biochemical modification of peptides, usually on reactive amine groups 
(Bantscheff et al. 2007). A peptide is sequenced using MS/MS and the abundance of a 
peptide is inferred by the intensity of a reporter ion that dissociates from the rest of the 
tagged peptide during CID and generation of MS2 spectra (Bantscheff et al. 2007). The 
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favoured target sites for labelling are cysteines and lysines as these have particularly 
reactive side chains (Bantscheff et al. 2007). Initial work developed the isotope-coded affinity 
tag (ICAT) technique, using variably deuterated biotin tags to label cysteines (Gygi et al. 
1999). Obviously peptides without cysteines are therefore unlabelled, limiting this approach. 
Isobaric tag for relative and absolute quantitation (iTRAQ) was developed as an alternative 
mass tagging approach (Ross et al. 2004). iTRAQ labels both lysine residues and the N 
terminus of peptides, drastically increasing applicability as most peptides will be labelled 
(Ross et al. 2004). This technique has been used very successfully for plant endomembrane 
proteomics as part of LOPIT (Dunkley et al. 2004, Dunkley et al. 2006, Nühse et al. 2007, 
Sadowski et al. 2008, Nikolovski et al. 2012, Groen et al. 2013). 
 
Taken together mass tagging approaches allow for quantitation of peptides in all samples 
(as samples are combined for analysis) and fractionating combined peptides from each 
condition reduces variability (Berg et al. 2006). Therefore they should lead to a more 
reproducible measure of protein quantitation in a sample than with label free analysis. 
5.1.6 Alternatives to mass spectrometry for protein quantitation 
Mass spectrometric approaches are not always the most appropriate for assessing protein 
abundance or PTM abundance in samples. If the proteins of interest can be identified or 
predicted, and commercial antibodies are available, then immunoblot allows for a more 
direct and simpler measurement of abundance. Immunoblot and MRM require prior 
knowledge of the proteome and will inevitably bias the proteins investigated towards those 
already known to function in the process studied. MRM and antibody based approaches do, 
however, have the advantage of being relatively complexity independent. As there is no 
perfect technique for protein quantification multiple approaches should be used to triangulate 
the answer of which proteins are altered in abundance or modified following a stimulus. 
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5.1.7 Objectives 
To characterise the changes in the proteomes of LE/MVBs during pathogen attack, using the 
PAMP flg22 and IP of RFP-RABF2b/ARA7 (as a proxy for LE/MVBs). I will initially use the 
unbiased approach of shotgun proteomics and quantification with spectrum counting and 
iTRAQ. A candidate based approach of western blot will also be used to investigate 
proteome changes in specific target proteins. 
5.2 Results 
Acknowledgements: iTRAQ labelling and all LC-MS/MS analysis was performed by Dr Jan 
Sklenar, analysis of data generated through LC-MS/MS analysis was partially analysed by 
Dr Jan Sklenar and partially by William Heard. All other techniques were performed by 
William Heard. 
5.2.1 Spectrum counting is not sufficiently quantitative to decipher flg22 induced 
proteome changes in RFP-RABF2b/ARA7 labelled endosomes 
In order to identify changes in the LE/MVB proteome following pathogen attack I utilised the 
IP approach (Section 3.2.5) on liquid grown seedlings expressing the RFP-RABF2b/ARA7 
marker at 0, 15 and 60 min after flg22 treatment with an additional control of Col-0. These 
time points were chosen as 15 min is at the peak of cytosolic MPK activation and 60 is after 
most MPKs have been activated. Gel lanes were sliced, excised (as shown in Figure 5.1) 
and the proteins tryptically digested and analysed with LC-MS/MS.  
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Using this approach 1216 proteins were identified over three replicates. Proteins equally 
abundant (determined by spectrum counting) in the control (Col-0) conditions were 
eliminated from further analysis. Proteins were grouped based on their changes at times (15 
or 60 min) after flg22 treatment relative to untreated RFP-RABF2b/ARA7 IPs. If a protein 
was not present at one time point it was regarded simply as increased or decreased, 
otherwise a log2 ratio is calculated for protein abundance at 15 or 60 min flg22 relative to the 
untreated control. The numbers of proteins changing (by over twofold or with an incalculable 
increase due to missing values) in each repetition is displayed in Figure 5.2. There were 50 
and 36 proteins that displayed a greater than twofold change at 15 min and 60 min, 
respectively, relative to untreated. 
 
 
Figure 5.1.SDS-PAGE separation and excision of bands for tryptic 
digestion of IPs RFP-RABF2b/ARA7 after flg22 treatment.1 g of protein (in 
solution) was extracted from sterile grown A.thaliana seedlings stably 
expressing both RFP-RABF2b/ARA7 and FLS2-GFP at 0, 15 and 60 minutes of 
flg22 treatment. 100% of each IP was used for SDS-PAGE. Proteins were 
visualised with Colloidal Coomassie (Instant Blue – Invitrogen). Gel lanes were 
excised as indicated into seven slices. Representative gel of three replicates. 
55 kDa 
26 kDa 
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To test for the consistency in protein changes (up or down relative to time 0) I visualised the 
proteins with twofold or greater changes at one time point in all three replicates using a heat 
map (Figure 5.3). Proteins were grouped depending on their changes at the two time points 
and surprisingly, only 20 of the 80 proteins displayed a consistent directional change (the 
same directional change in all three experiments relative to untreated). Of the proteins with 
consistent changes, all have a missing value in one of the time points, and <5 spectra when 
they are detected (Table S5). This reduces confidence in the conclusion that these proteins 
really do change in abundance after flg22 treatment, as they are on the limit of detection, 
and so subject to the inherent stochasticity involved in quantitation by spectrum counting 
(Section 5.1.4). Also 3 of the 20 proteins have inconsistent changes between different 
replicates at the other time point, again reducing my confidence in this method for 
Figure 5.2.Venn diagram comparison of proteins that change in the RFP-
RABF2b/ARA7 proteomes following flg22 treatment.a. Venn diagram comparing the 
proteins assigned to the RFP-RABF2b/ARA7 (LE/MVB) proteome with a greater than 
two fold change relative to untreated samples following 15 minutes of flg22 
treatment.The numbers in each area of the Venn diagram indicate number of proteins 
assigned to the proteome or proteomes indicated. b. Venn diagram comparing the 
proteins assigned to the RFP-RABF2b/ARA7 (LE/MVB) proteome with a greater than 
two fold change relative to untreated samples following 60 minutes of flg22 
treatment.The numbers in each area of the Venn diagram indicate number of proteins 
assigned to the proteome or proteomes indicated. 
a. b. 
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determining protein quantification. This dataset is useful but, for the above reasons, needs to 
be tested with an analogous technique to confirm for change in protein abundance. 
  15 15 15 60 60 60 
 
iTRAQ 
AT1G05240 up up up null up null   
AT1G20330 up up up null null null   
AT2G05830 up up up null up null   
AT2G44120 1 up up 0 up up   
AT4G16390 up 1 1 null 1.321928 1.321928   
AT5G51430 up 1 up up 1.222392 null   
AT1G09620 null up null up up up   
AT1G70940 null up up up up up   
AT1G74470 null 0 2 up 1.321928 1.584963   
AT1G76850 null up down up up 1.584963   
AT1G78570 up null 1.584963 up up 1 Up at 60 mins 
AT2G20360 null null up up up up   
AT2G26890 null up -0.58496 up up 1.415037   
AT3G58500 null null up up up up   
AT4G25080 null 1 0 up 1 1.321928   
AT5G13530 null up up up up up   
AT5G59730 null null null up up up   
AT2G39990 down 1 up 1 0.807355 up   
AT3G52140 -0.22239 -0.41504 0.485427 -1.80735 -1.41504 down   
AT4G12060 down down -1 down down -1   
AT1G06950 0 up 0.678072 down up 2   
AT1G09430 -2 -0.41504 up down -1 up   
AT1G09630 up -1 down null -1 0   
AT1G10200 down up up down up up   
AT1G18270 down up 2 1.584963 up 0   
AT1G20200 -1 up -0.73697 down up down   
AT1G22530 -1 2.321928 1.099536 -2 0.415037 1.440573   
AT1G43800 up 0 up up down up   
AT1G44170 0.321928 up up -1 up up   
AT1G49340 null down 0.321928 up down down   
AT1G55860 down 2 1 0.36257 1 0.263034   
AT1G57660 -1 0 up 1 -1.58496 up   
AT1G64090 up up down null null down   
AT1G67930 down up up 1 up null   
AT1G70320 down up down 0 null 0.584963   
AT1G72560 down up null down up up   
AT2G17930 null down null up down up   
AT2G26250 -1.80735 1.321928 -1 down 1.321928 0   
AT2G28900 down null null down up up   
AT2G32920 -0.73697 1.584963 up down 1.584963 up   
AT2G34460 -0.58496 -1.32193 up down -1.32193 up   
AT2G34560 down null up down up up   
AT2G36360 down 1.321928 1.584963 down 1.321928 2   
AT2G37620 up 1 up null 1 null   
AT2G41840 down down up down -0.41504 null   
AT2G44610 0 -1.22239 up down -1.22239 up   
AT2G45770 1 -0.41504 up 1 down up   
AT2G46280 down 1.584963 up down 0.584963 up   
AT2G47240 up up down null up 0.584963   
AT3G04870 down 1 0.415037 down down 1   
AT3G05040 null down 0.584963 up down -1   
AT3G05280 down 0.584963 up down down up   
AT3G07690 down null up down up up   
AT3G09740 down down up down 0 null   
AT3G18000 -1.45943 0 1.584963 down down 1   
AT3G27530 down up 0.584963 down up down   
AT3G49910 up up down up null 0.584963   
AT3G57290 -1.48543 1 0.678072 -2.80735 1.415037 1.137504   
AT3G62830 0.584963 up 1 down up down   
AT4G01800 -1.41504 1 -1 down 1.415037 1.807355   
AT4G02030 up up 0 up up down   
 126 | P a g e  
 
AT4G10060 down up down down up -0.58496   
AT4G18480 0 -0.41504 up down -1 up   
AT4G31850 null 0.415037 up up -1.16993 up   
AT4G36440 up down up null 0.415037 up   
AT4G38540 down 0.736966 up down 1.415037 up   
AT4G39200 null down up up -1 up   
AT5G01010 0 down up down down up   
AT5G02960 null down null up down up   
AT5G03540 
up 1 down up 0 down 
Down at 15 
mins 
AT5G06140 0 up 0.321928 down up 1.169925   
AT5G09900 0.652077 2 1.321928 -1.80735 2 2.321928   
AT5G13710 -1 1 up 0.807355 1 up   
AT5G15450 -0.58496 up 0 down up down   
AT5G22800 down up up down up up   
AT5G41950 0 0 0 1 1 down   
AT5G42650 -1.32193 0.584963 down -1.73697 1.5025 1   
AT5G49830 down 0 null down -1.32193 up   
AT5G61780 -1.80735 2.169925 -0.67807 down 2.459432 1.247928   
ATCG00770 up -1 up up -0.67807 null   
 
 
5.2.2 iTRAQ labelling and Q-TOF MS improves confidence in quantitative proteome 
changes 
To improve my confidence in quantification of proteins in RFP-RABF2b/ARA7 enrichments 
that change after flg22 treatment, I utilised the analogous quantification technique of mass 
labelling to assess protein amounts. I performed IP of RFP-RABF2b/ARA7 in a RFP-
RABF2b/ARA7, FLS2-GFP background at 0, 15, 30 and 60 min of flg22 treatment with only 
one repetition (due to time limitations and technical problems with subsequent iTRAQ 
repetitions). The proteins were digested and analysed with the iTRAQ Q-TOF protocol.Whilst 
Figure 5.3.Heat map of protein abundance changes in RFP-RABF2b/ARA7 IPs 
following flg22 treatment. Log2 ratios of spectrum counts of proteins are shown at the 
indicated time of flg22 treatment relative to the respective control (RFP-RABF2b/ARA7 and 
no flg22 treatment). Only proteins with log2 ratios greater than ±1 consistently in one time 
point are shown. If there is a missing value in one time point, no ratio could be calculated 
and “Up” is used if a protein was only detected at that time after flg22 treatment. “Down” is 
used if a protein is not identified at the indicated time after flg22 treatment, but was in the IP 
before flg22 treatment. Data from three replicates is shown. Quantitative data from one 
iTRAQ replicate is shown in the final column. Only proteins with log2 ratios greater than ±0.5 
in one time point are shown with the corresponding direction of change. Colours indicate 
direction and magnitude of the change relative to unelicited RFP-RABF2b/ARA7 IPs, red 
indicates an increase in abundance relative to 0 min and green indicates a decrease in 
abundance relative to 0 min. 
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there is a substantial reduction in the number of proteins identified in one repetition of the 
iTRAQ mass labelling and analysis with LC-Q-TOF (compared to the spectrum counting LC-
Orbitrap data),I could improve the number of proteins identified as suitable for reliable 
quantification (Figure 5.4). The definition of proteins that can be reliably quantified with 
spectrum counting is deliberately generous (identified with >5 spectra in one time point in a 
replicate). Even using these criteria, mass labelling with iTRAQ still yields a superior number 
of quantifiable proteins. 
 
5.2.3 Combined iTRAQ and spectrum counting quantitative data implicates RHM1 in 
abundance changes in LE/MVBs after flg22 treatment 
To determine whether any of the proteins with suspected abundance changes in RFP-
RABF2b/ARA7 affinity purifications following flg22 treatment were reproducible with 
analogous techniques of quantification, I compared my spectrum counting and iTRAQ 
Figure 5.4. Proteins identified and proteins that might be quantified in both Orbitrap 
and Synapt repeats. Columns represent total proteins that were identified in each of the 
MS runs indicated (combining all proteins identified in RFP-RABF2b/ARA7 IPs at each time 
point after flg22 but not present in Col-0 controls). Proteins are deemed as reliably 
quantifiable if they are identified in all conditions, except Col-0 control, in one IP repeat.
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quantification datasets (Figure 5.5). As only two proteins were changed by more than twofold 
compared to unelicited in the iTRAQ dataset, I allowed proteins with >1.5 fold change to be 
included. However, there was only one protein with a consistent abundance change in all 
three spectrum counting quantification repetitions and the iTRAQ quantification experiment 
at the same time points. This protein, Rhamnose synthase 1 (RHM1 - AT1G78570), is 
consistently more abundant in the RFP-RABF2b/ARA7 enrichments after 60 min flg22 
treatment (Figure 5.3 and Figure 5.5). It is therefore a very strong candidate for further study. 
 
To gain first insights into the potential role of RHM1 in the plant response to pathogens, I 
obtained rol1-1 mutants. These mutants carry a point mutation causing a premature stop 
codon in the coding sequence of RHM1 (Diet et al. 2006, Ringli et al. 2008). I tested rol1-
Figure 5.5.Venn diagram comparison of proteins that change in the RFP-
RABF2b/ARA7 proteomes following flg22 treatment including iTRAQ data.a. Venn 
diagram comparing the proteins assigned to the RFP-RABF2b/ARA7 (LE/MVB) 
proteome with a greater than two fold change relative to untreated samples following 15 
minutes of flg22 treatment.The numbers in each area of the Venn diagram indicate the 
number of proteins assigned to the proteome or proteomes indicated. b. Venn diagram 
comparing the proteins assigned to the RFP-RABF2b/ARA7 (LE/MVB) proteome with a 
greater than two fold change relative to untreated samples following 60 minutes of flg22 
treatment.The numbers in each area of the Venn diagram indicate number of proteins 
assigned to the proteome or proteomes indicated. If there were no proteins in the 
overlap, the region has been left blank. 
a. b. 
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1mutants for altered susceptibility to spray inoculated Pto DC3000. The rol1-1 mutant 
displayed enhanced susceptibility to Pto DC3000 (Figure 5.6), suggesting a role for RHM1 in 
resistance to bacteria. 
5.2.4 Candidate led quantification is necessary to further characterise changes in 
LE/MVBs following flg22 treatment 
To further characterise proteomic changes in LE/MVBs I utilised a candidate led approach 
focussing on known components of the FLS2 signalling pathway – FLS2 and MPK3, 4 and 6. 
FLS2 was chosen as it is endocytosed following flg22 treatment (Robatzek et al. 2006). The 
MPKs were chosen as both MKK2 and MKK5 were identified in the combined LE/MVB 
proteome (Section 4.2.9). These MKKs are signalling components downstream of FLS2 
signalling (Mészáros et al. 2006, Brader et al. 2007, Gao et al. 2008) and reviewed 
Figure 5.6.rol1-1 mutants are more susceptible to spray inoculated P.syringae 
DC3000 than Col-0. 4 weeks oldmutants were spray inoculated with the virulent 
pathogen P.syringae DC3000. Columns represent estimated bacterial growth 3 days 
post infection. Error bars represent the standard deviation. * denotes a significant 
difference (Student’s t test) from Col-0, p<0.05. Graph shows data from 3 biological 
replicates. 
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(CristinaRodriguez et al. 2010). Identification of these MKKs at LE/MVBs indicates that the 
downstream MPKs may also be present at LE/MVBs.  
5.2.5 Active MPKs are detected in RFP-RABF2b/ARA7 enrichments after flg22 
treatment 
To test for the presence of signalling components (FLS2 or MPK3,4 or 6) in LE/MVB marker 
IPs, I performed IP of RFP-RABF2b/ARA7 on sterile grown seedlings stably expressing 
RFP-RABF2b/ARA7 and FLS2-GFP, following flg22 treatment at 0, 15, 30, 60 and 90 min 
flg22 treatment. RFP-RABF2b/ARA7 was enriched in the IP and this was independent of 
flg22 treatment (Figure 5.7). Strikingly, FLS2-GFP was detected in unelicited samples. This 
is surprising as FLS2-GFP and RFP-RABF2b/ARA7 exhibit maximum co-localisation 
between 20 and 40 min of flg22 treatment (Beck et al. 2012). Suggesting FLS2 is trafficked 
Figure 5.7. Immunoblotting of RFP-RABF2b/ARA7 IPs after flg22 treatment to 
assess the abundance of FLS2 and active MPKs. RFP-RABF2b/ARA7 was subjected 
to IP after flg22 treatment, separated on SDS-PAGE and subjected to immunoblot with 
αGFP, αRFP and αpMPK as indicated. Representative blot of three replicates. 
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from this compartment at this time or internalised into intraluminal vesicles. Furthermore the 
downstream kinases of MKK2 and MKK5, MPK3, 4 and 6, are present and phosphorylated 
in RFP-RABF2b/ARA7 affinity purifications following flg22 treatment (Figure 5.7). This 
suggests that RFP-RABF2b/ARA7 labelled LE/MVBs function as sites of signal transduction. 
 
5.2.6 Active MPKs are detected in RABF1/ARA6-RFP enrichments after flg22 
treatment 
To test whether active MPKs and FLS2 are present in another LE/MVB marker proteome, I 
performed IP of RABF1/ARA6-RFP on sterile grown seedlings stably expressing 
RABF1/ARA6-RFP and FLS2-GFP, following flg22 treatment. I could not detect FLS2-GFP 
in IP of RABF1/ARA6-RFP.By contrast, active MPK 3, 4 and 6 were identified in IPs of 
RABF1/ARA6-RFP enrichments with immunoblot (Figure 5.8), demonstrating that active 
Figure 5.8. Immunoblotting of RABF1/ARA6-RFP IPs after flg22 treatment to 
assess the abundance of FLS2 and active MPKs. RABF1/ARA6-RFP was subjected 
to IP after flg22 treatment, separated on SDS-PAGE and subjected to immunoblot with 
αRFP and αpMPK as indicated. Representative blot of three replicates. 
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MPKs are probably present at all RAB5 GTPase labelled LE/MVBs in A. thaliana. 
Furthermore, as MKK5 was identified in the YFP-RABG3f proteome it is likely that this is 
also the case for RAB7 GTPase labelled LE/MVBs as well. 
5.3 Discussion 
In this chapter I demonstrated that RHM1 is a positive regulator of immunity and probably 
functions at LE/MVBs. A biased, candidate led approach revealed that, not only are 
signalling components present at endosomes, but they are also active. This data is 
intriguing, but needs further analysis to determine whether the LE/MVB localised MPKs 
contribute to flg22 induced signalling.  
5.3.1 Spectrum counting is unsuitable for thorough quantitative analysis of RFP-
RABF2b/ARA7 affinity purifications 
Quantification using spectrum counting identified 20 proteins consistently changed in 
abundance in the RFP-RABF2b/ARA7 proteome after flg22 treatment with limited 
confidence. However, I was unable to consistently detect (at any time point) proteins such as 
FLS2 (Section 5.2.4). The experimental design is one of the primary limitations of 
quantification by spectrum counting. Russell and Lilley (2012) demonstrate that the stage at 
which data is combined is the principal component of technical variation. Experiments are 
most technically variable when peptides are combined after lyophilisation to be analysed in 
one LC-MS/MS run (Russell and Lilley 2012). As in my experiments data was only combined 
after LC-MS/MS, it is unsurprising that there is high variation within and between 
experiments. Options to compensate for this technical variation would be to scale 
quantitative values to an internal standard (such as RFP-RABF2b/ARA7 or an exogenous 
non-A. thaliana protein). Using an internal standard is limited, however, as the standard must 
be present in all gel slices, as each gel slice is individually processed. Therefore, there were 
no appropriate internal standard proteins to be used in my experiments even though input 
quantity of RFP-RABF2b/ARA7 was normalised during SDS-PAGE (Figure 5.1). Thus, 
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instead of repeating these experiments I decided to analyse these proteins using an 
orthologous technique. 
 
The addition of the iTRAQ experimental analysis adds confidence to the conclusions of 
quantitative changes after flg22 treatment. The methodology used for the iTRAQ 
experiments meant that all peptides from one time point were digested simultaneously. 
Therefore, RFP-RABF2b/ARA7 could be used as an internal standard between IP conditions 
and experiments to compensate for variability introduced at digestion stages. Furthermore 
peptides from each experimental condition are combined after iTRAQ labelling, so at least 
are analysed in the same LC-Q-TOF run. Utilising these two quantitative datasets, only one 
protein could be reproducibly identified as changing in abundance following flg22 treatment 
in all experiments.  
 
Therefore, further work will include using a more sensitive mass spectrometer to analyse IPs 
of RFP-RABF2b/ARA7 after flg22 treatment. Peptides need to be digestion in solution to 
allow an internal RFP-RABF2b/ARA7 standard to be used to normalise abundances 
between conditions. Subsequent separation at the peptide level should help minimise 
variation based on individual sample handling compared to separation at the protein level 
with SDS-PAGE and lane slicing. Without labelling, the peptides cannot be analysed in a 
single LC-MS/MS run. However the department has recently purchased an Orbitrap Fusion 
and this more sensitive mass spectrometer should increase the number of spectra assigned 
to each protein and so bring more proteins above the limit of quantification. Thus the 
combination of an internal standard and the more sensitive mass spectrometer should yield 
better quantitative data. 
5.3.2 RHM1 is a positive regulator of immunity 
The combined spectrum counting and iTRAQ quantitation indicates RHM1 increases by over 
1.5 fold in abundance in RFP-RABF2b/ARA7 LE/MVBs following 60 min of flg22 treatment. 
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Furthermore the non-functional rol1-1 allele is more susceptible to the virulent pathogen 
PtoDC3000. I focussed my study on rol1-1 as this allele is non-functional and has fewer 
pleiotropic effects than the reported gain of function rol1-2 allele (Diet et al. 2006). 
Confirmation of the abundance changes of RHM1 in LE/MVBs after flg22 treatment, using an 
analogous technique is also necessary. As is thorough characterisation of other PAMP 
induced responses is essential to ensure that the enhanced susceptibility is not due to off 
target effects, affecting receptor abundance or SA levels for example  
 
The role of RHM1 in A. thalianahas not been well characterised. RHM1 functions by 
converting UDP-D-Glc to UDP-L-Rha in planta(Reiter and Vanzin 2001), however the full 
implications of this function are unknown. Two rol1 mutants were identified, one carries a 
premature stop codon in the coding sequence (rol1-1) and one carries a point mutation 
(R283K) in the coding sequence (rol1-2) (Diet et al. 2006). Both of these mutations lead to a 
decrease in the dehydratase activity of the expressed product. The rol1-2 allele has a more 
severe developmental phenotype, however, than the rol1-1 allele and this was suggested to 
be from pleiotropic effects of this point mutation (Diet et al. 2006). 
 
Based on my quantitative data RHM1 is recruited to LE/MVBs following flg22 treatment. The 
reason for this recruitment is unclear, but there are three conflicting hypotheses. RHM1 
could modify pectin for secretion through exosomes and alter the pectin matrix to help 
strengthen the cell wall and so prevent pathogen penetration. There is a reduction in 
rhamnogalacturonan I and II (RGI and RGII) levels in the rol1 mutants (Diet et al. 2006). RGI 
and RGII with homogalacturonan (HGA) form the pectin matrix of the cell wall, and RGI is 
thought to regulate cell wall porosity (Ridley et al. 2001). There is, however, limited evidence 
of pectin following pathogen challenge, making this hypothesis unlikely. 
 
Alternatively the altered flavonol composition could affect constitutive defence responses. 
rol1 mutants display altered leaf phenotypes due to altered flavonol biosynthesis (Kuhn et 
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al.2011). Furthermore the rol1 leaf phenotype is partially due to altered auxin accumulation 
in leaves and partially through an unknown mechanism (Ringli et al. 2008, Kuhn et al. 2011). 
Flavonol accumulation affects the functioning of the actin cyctoskeleton (Ringli et al. 2008, 
Kuhn et al. 2011) and a properly functioning actin cytoskeleton is important for secretion and 
stomatal immunity.As my data suggests an increase in RHM1 at LE/MVBs following flg22 
treatment this hypothesis is unlikely. The enhanced flavonol phenotypein rol1 mutants is 
constitutive and so does not explain the altered localisation of RHM1 following flg22 
treatment. 
 
The third hypothesis for the observed enhanced susceptibility of the rol1 mutants is that 
RHM1 may be recruited to LE/MVBs following flg22 treatment to produce additional flavonols 
for secretion and defence. The rol1 mutants display altered flavonol accumulation and 
altered leaf and stomatal morphology (Diet et al. 2006, Ringli et al. 2008, Kuhn et al. 2011). 
rol1 mutants contain strongly reduced amounts of flavonols glycosylated with multiple 
rhamnose units, while flavonols with single rhamnose units are often more abundant in rol1 
mutants(Ringli et al. 2008).  In roots there is a decrease in overall flavonol content of 25% in 
both rol1 mutants and an increase by 30% (rol1-1) and 10% (rol1-2) in shoots (Ringli et al. 
2008). It may be that these flavonols are produced in LE/MVBs ready for exosome mediated 
secretion during pathogen infection. Several flavonols have been shown to have 
antimicrobial properties and have been used as biopesticides (Cespedes et al. 2014, de 
Lima et al. 2014) but no role have been demonstrated in PTI. Flavonols modified with 
multiple rhamnose subunits could contribute to defence against microbial pathogens and are 
secreted after synthesis at LE/MVBs. This is the most likely explanation, but whether 
secretion of flavonols is affected in rol1-1 mutants both before and after flg22 treatment 
needs to be tested. 
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5.3.3 Recycling FLS2 is enriched with RFP-RABF2b/ARA7 not RABF1/ARA6-RFP 
One striking observation from my data is that FLS2-GFP can be found in IPs of RFP-
RABF2b/ARA7 before flg22 treatment and it decreases in abundance from 30 min. FLS2 
constitutively recycles through partially RFP-RABF2b/ARA7 positive compartments identified 
after BFA treatment (Beck et al. 2012) and these are enriched in my IPs. Furthermore, the 
decrease in abundance of FLS2-GFP in the RFP-RABF2b/ARA7 proteome after 30 minutes 
of flg22 could reflect FLS2 being trafficked from the compartment further on in the late 
endocytic route. This contrasts with CLSM data from Beck et al. (2012) showing that FLS2-
GFP maintains a high level of co-localisation with RFP-RABF2b/ARA7 after 30 minutes of 
flg22 treatment. This observed difference could be due to the different tissues being 
examined (whole seedlings compared to leaf epidermis) or due to the different age and 
growth the seedlings examined. Alternatively this IP method could preferentially enrich for 
proteins on the exterior of the LE/MVB and during this timeframe FLS2 is moved into the 
intraluminal vesicles of LE/MVBs (Spallek et al. 2013) resulting in less FLS2-GFP detected 
even though it is present in the compartment. As FLS2-GFP does not co-localise to the 
same extent with RABF1/ARA6-RFP as with RFP-RABF2b/ARA7 (Beck et al. 2012), it is 
unsurprising it is not detected in the RABF1/ARA6-RFP IPs.  
5.3.4 Active MPKs are localised to endosomes following flg22 treatment but their 
role in signalling is still unclear 
Active MPKs can be enriched with the two RAB5 GTPases (RABF2b/ARA7 and 
RABF1/ARA6) as well as with RABG3f. The most parsimonious explanation is that MPKs 
are constitutively localised to LE/MVBs. MKK2 and 5 were identified in my proteomic 
analysis of LE/MVBs without flg22 treatment. Furthermore MPKs have been localised to the 
TGN and the endomembrane system or cytoskeleton in several studies (Müller et al. 2010, 
Beck et al. 2011, Gu and Innes 2011). Therefore, even without direct localisation data, my 
postulation that MPKs are present at LE/MVBs constitutively is sound, but not conclusive. 
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This data demonstrates that signalling components are active, in a biochemical sense, at 
LE/MVBs following flg22 treatment. To support the biological significance of MPK activation 
at endosomes, substrates should also be present at this location. This data is essential for 
conclusions to be made, as an alternative interpretation of the presence of phosphorylated 
MPKs in LE/MVBs following flg22 treatment is that they are en route for degradation (with 
FLS2) and no longer play a role in signalling.  
5.3.5 Conclusions and further work 
RHM1 is increased in abundance at LE/MVBs and is a positive regulator of PTI. The role of 
RHM1 in the resistance of A. thaliana to Pto DC3000 will be further explored, but not in this 
thesis. The principal conclusion from this chapter, however, is that active MPKs are present 
at LE/MVBs following flg22 treatment. My attempts to determine the biological significance of 
LE/MVB localised active MPK3,4 and 6 will be explored in Chapter 6. 
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6 Identifying potential targets for endosome localised 
MPKs after flg22 treatment 
6.1 Introduction and Objectives 
As demonstrated in Chapter 5 active MPKs have been identified in LE/MVB proteomes. The 
next question to be addressed is whether these endosome localised MPKs contribute to 
FLS2 signalling. If endosomal MPKs contribute to signalling, there must be proteins present 
at the same location that are kinase targets of these MPKs and should have been identified 
in my LE/MVB proteomics. I, therefore, assessed my combined LE/MVB proteome for 
MPK3, 4 and 6 kinase target proteins that contribute to defence responses. 
6.1.1 Candidate MPK3, 4 and 6 targets have been identified in A.thaliana 
Several studies have identified numerous potential MPK3, 4 and 6 kinase targets utilising 
diverse approaches. Methods to identify MPK targets have followed three broad strategies: 
1). identification of MPK interaction partners, 2). identification of specific motifs 
phosphorylated by MPK3 and 6, and 3). identification of peptides/proteins phosphorylated by 
specific MPKs. The first strategy is exemplified by Mukhtar et al., who utilised an extensive 
library of A.thalianacoding sequences as well as pathogen effectors in yeast two hybrid 
interaction studies to identify candidate MPK interactors (Mukhtar et al. 2011). This approach 
should identify any proteins associating with MPKs, including kinase targets and regulatory 
proteins. A similar approach was also used to identify rice MPK targets (Singh et al. 2012).  
 
Using the second approach, a conserved sequence (L/P-P/X-S-P-R/K)was identified as the 
targeting sequence of MPK3 and 6. One of the putative MPK3/6 targets was confirmed 
(At1g80180.1) with this approach (Sörensson et al. 2012). The third approach was used in 
two different ways to identify targets of MPK3, 4 and 6 in A. thaliana. Popescu et al 
incubated an array of 3840 A. thaliana proteins with 10 different recombinant MPKs, 
activated by two different MKKs, and radio labelled 33P-γ-ATP to identify 570 putative MPK 
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substrates (Popescu et al. 2009). This study identified several transcription factors including 
the SA responsive WRKY DNA-binding protein 62 (WRKY62) as a target of MPK6 (Popescu 
et al. 2009). While Hoehnwarter and colleagues inducibly expressed a constitutively active 
N. tabacum variant of ntMEK2, known as ntMEK2DD (Hoehenwarter et al. 2013). This 
ntMEK2 variant has two amino acid substitutions in the activation loop (S and T to D) and 
constitutively phosphorylates MPK3 and MPK6 in vivo. Following expression of MEK2DD in 
A. thaliana phosphopeptides were enriched and identified with LC-MS/MS to identify 141 
candidate MPK3 and 6 substrates (Hoehenwarter et al. 2013). These candidates include a 
cytoskeleton regulatory protein Villin 3 (VLN3) (Hoehenwarter et al. 2013). Villin 3 is a 
member of a protein family that regulates actin filament dynamics by severing or bundling 
actin depending on the cytosolic conditions, which will be expanded in section 6.3.3. All of 
these techniques help elucidate the role of MPKs in signalling and these datasets are useful 
tools with which to identify potential targets of MPKs. 
 
Whilst these datasets are useful as indicators, they are not conclusive lists. As with the 
proteomic data presented in this thesis they are starting points for further analysis. 
Confidence on whether a protein is an MPK target can be improved by combining 
phosphoproteomic data with the data from the studies listed above.  
6.1.2 Extensive phospho-proteomic data has been obtained following flg22 
elicitation 
The approaches discussed above are limited in that they can only define which proteins can 
be phosphorylated by MPKs. Other information about localisation or level of phosphorylation 
following a stimulus are needed to decipher the location at which the interaction occurs and 
after which stimuli are they phosphorylated. Two landmark phospho-proteomic studies 
following flg22 treatment focused on the PM (Benschop et al. 2007, Nühse et al. 2007). 
Interestingly a number of endomembrane regulators were identified as phosphorylated after 
flg22 treatment including the SNAREs SYP121 and SYP122(Benschop et al. 2007) and the 
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dynamin like protein DRP2a (Nühse et al. 2007). A more recent study of phospho-proteomic 
changes following flg22 treatment assessed a crude extract of proteins from plant cell culture 
(Rayapuram et al. 2014). Rayapuram et al. also identify endomembrane regulators, including 
the actin cytoskeleton regulator VLN3, as more phosphorylated after flg22 treatment. 
Comparisons between phosphoproteomic datasets after flg22 treatment and MPK kinase 
targets will give a higher confidence dataset of MPK kinase targets that are phosphorylated 
after flg22 treatment. The combination of data from studies identifying putative MPK targets 
and from phospho-changes after flg22 treatment provides two powerful tools with which to 
identify endosomal MPK targets when compared to my proteomic data.  
 
6.1.3 Objectives 
My main objective is to identify credible MPK targets in my LE/MVB proteome dataset. I 
therefore compared my LE/MVB proteome to the candidate MPK kinase target lists 
(Popescu et al. 2009, Mukhtar et al. 2011, Sörensson et al. 2012, Hoehenwarter et al. 2013). 
This provided a candidate list of endosomal MPK targets to be tested for defects in defence 
signalling and to be compared other to phospho-proteomic studies after PAMP treatment.  
6.2 Results 
6.2.1 Identification of putative endosome localised MPK targets 
In order to identify targets of endosome localised MPKs, I utilised four studies to create a 
candidate list of MPK3, 4 or 6 targets (Popescu et al. 2009, Mukhtar et al. 2011, Sörensson 
et al. 2012, Hoehenwarter et al. 2013). This combined candidate list was then compared to 
the combined LE/MVB proteomes (Section 4.2.8) and the intersection is the pool of potential 
kinase targets for LE/MVB localised MPKs. This led to the identification of 16 candidate 
proteins (Table 6.1). I obtained 30 different lines with independent tDNA insertions in 15 
genes encoding the candidate proteins, from NASC (http://arabidopsis.info/The European 
Arabidopsis Stock Centre). In addition, VLN3 is one candidate that has been studied and is 
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partially redundant with VLN2.Therefore, I obtained published tDNA insertion lines with no 
detectable transcripts of vln2, vln3 and the double mutantcross of vln2and vln3(Khurana et 
al. 2010, Bao et al. 2012). Seven of these lines did not germinate leaving 26 lines in total 
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(including vln2, vln3 and vln2,3).These lines were analysed in a pipeline outlined in figure 6. 
 
 
 
6.2.2 Screening of tDNA insertion lines for defects in PAMP induced resistance 
I confirmed the homozygosity of these tDNA insertion lines with PCR and tested them for 
defects in PIR by pre-treatment with flg22 before infection with the virulent pathogen Pto 
DC3000expressing the luciferase operon (LUX) (Figure 6.2a). There are 10 separate lines 
with a defect in flg22 induced PIR when compared to Col-0. Five of these 10 lines of interest 
were tested again (Table 6.1). When these experiments were repeated with more seedlings 
from five of the lines of interest, none of them were significantly different from Col-0 (Figure 
6.2b). Therefore it is unlikely that these mutants have a defect in PIR, but the initial observed 
Figure 6.1 Screening pipeline for potential endosomal MPK targets.Endosomal proteins 
were screened for potential MPK phosphorylation leaving 16 candidates. These candidates 
were then tested with a PIR screen in seedlings, PCR checked to confirm homozygosity and 
tested for susceptibility to Pst DC3000 in adult plants. 
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deviations are due to high technical variation in these experiments and limited sampling. I 
therefore did not further test these lines for PIR and used an alternative screening method. 
 
I screened all 23 lines for altered susceptibility to spray inoculation of the virulent pathogen 
Pto DC3000. Mutant lines in two of the tested candidate endosomal MPK targets were 
altered in susceptibility to the bacterium compared to Col-0 in one replicate. I therefore 
selected Guanylate binding protein (GTP) and VLN2/VLN3 as candidates to work with 
further. 
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Figure 6.2.High throughput screening of PIR for candidate 
endosomal MPK targets. Estimated growth of the virulent pathogen P. 
syringae DC3000 expressing the luciferase operon on liquid grown A. 
thaliana after pre-treatment with flg22. Columns represent log2 ratios of 
measured luminescence in each genotype to that of Col-0 controls. Error 
bars represent the standard deviation. a. Initial screening of reported 
homozygous SALK lines. (n=8 per genotype) b. Secondary screen of 
SALK lines with confirmed homozygous lines. (n=24 per genotype) 
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6.2.3 gtp-1and gtp-2 mutants are more resistant to Pto DC3000 
To preliminarily characterise the gtpmutants, I grew these plants under short day conditions. 
Both mutants appear normal at early stages of growth. By four weeks gtp-1 is smaller than 
both Col-0 and gtp-2 (Figure 6.3a).I repeated the susceptibility assays for gtp-1 and gtp-2 
tDNA insertion lines and found that gtp-1 and gtp-2 alleles are consistently more resistant to 
spray inoculated Pto DC3000 than Col-0 (Figure 6.3b). gtp-1 displays a stronger resistance 
phenotype to gtp-2 suggesting it is a stronger allele than gtp-2. This relationship between 
gtp-1 and gtp-2 and their phenotypes is reflected by the growth of both gtp-1 and gtp-2, as 
gtp-1 is more stunted than gtp-2. One reason for an increased resistance to Pto DC3000 is a 
hyper sensitivity to flg22. Therefore, I tested for an altered flg22 induced ROS burst in gtp-1 
and gtp-2 mutants (Figure 6.3c). The ROS burst from these mutants was indistinguishable 
from Col-0. All of these data suggest GTP is involved in the cell’s response to pathogenic 
bacteria downstream of recognition. 
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6.2.4 vln mutants are more susceptible to Pto DC3000 
Visual characterisation of the vln2, vln3 and vln2/3 mutants at eight weeks old confirms the 
reported phenotypes of these mutants (Figure 6.4a). vln2 and vln3phenotypically resemble 
Col-0, whereas the vln2/3 mutants display the reported leaf curling phenotype (van der 
Honing et al. 2012). To further interrogate the role of VLN2 and VLN3 in defence, I analysed 
Figure 6.3. Characterisation of phenotype of gtpmutants. a. Images of 4 week 
old plants of the respective genotypes grown on soil in short day conditions. b. 
Estimation of growth of spray inoculated P. syringae DC3000. 4 week oldmutants 
were spray inoculated with the virulent pathogen P.syringae DC3000. Columns 
represent estimated bacterial growth 3 days post infection. Error bars represent the 
standard deviation. * denotes a significant difference (Student’s t test) from Col-0, 
p<0.05. Graph shows data from 3 biological replicates. c. Oxidative burst triggered 
by 100 nM flg22 in the indicated genotypes measured with a luminol-based assay 
as relative light units. Columns represent the average of total photon counts per 
leaf disc over 40 minutes of flg22 treatment (n=16 for each genotype). Error bars 
represent the standard deviation. * denotes a significant difference (Student’s t 
test) from Col-0, p<0.05. Graph shows a representative experiment of 3 replicates. 
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vln2, vln3 and vln2/3 mutants for altered susceptibility to Pto DC3000. All threemutants were 
consistently more susceptible to spray inoculated Pto DC3000 than Col-0 (Figure 6.4b). 
Interestingly the phenotypes are not additive, suggesting VLN2 and VLN3 act in the same 
genetic pathway for pathogen defence. 
Figure 6.4. Characterisation of phenotype of vln2, vln3 and vln2,3. a. 
Images of 8 week old plants of the respective genotypes grown on soil in 
short day conditions. b. Estimation of growth of spray inoculated P. 
syringae DC3000. 4 week oldmutants were spray inoculated with the 
virulent pathogen P.syringae DC3000. Columns represent estimated 
bacterial growth 3 days post infection. Error bars represent the standard 
deviation. * denotes a significant difference (Student’s t test) from Col-0, 
p<0.05. Graph shows data from 1 representative experiment  from3 
biological replicates. c. Oxidative burst triggered by 100 nM flg22 in the 
indicated genotypes measured with a luminol-based assay as relative light 
units. Columns represent the average of total photon counts per leaf disc 
over 40 minutes of flg22 treatment (n=16 for each genotype). Error bars 
represent the standard deviation. * denotes a significant difference 
(Student’s t test) from Col-0, p<0.05. Graph shows a representative 
experiment of 3 replicates. 
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To test whether the enhanced susceptibility phenotype was due to reduced perception of 
bacterial PAMPs I tested the vln2, vln3 and vln2/3 mutants for altered ROS burst following 
flg22 treatment (Figure 6.4b). The mutant lines were indistinguishable from Col-0 
demonstrating that the tDNA insertions do not have an unintended effect on the cell’s ability 
to perceive flg22 or respond with a ROS burst. 
6.2.5 VLN3 and GTP have experimentally annotated phosphosites 
To further assess VLN3 and GTP as kinase targets for endosome localised MPKs I 
examined their coding sequences for recognised domains and characterised phosphosites 
(Figure 6.5). VLN3 has three experimentally confirmed phosphosites on serine (S778, S814, 
S880) residues between the six N terminal gelosin domains and the villin headpiece (Figure 
6.5a). These phosphosites have been detected experimentally both before and after JA 
treatment(Brodersen et al. 2006). There is also one additional phosphosite on VLN3 (S812) 
that was detected following flg22 treatment (Rayapuram et al. 2014). Interestingly peptides 
phosphorylated on S812 and S814 were more abundant compared to un-phosphorylated 
peptide after flg22 treatment (Rayapuram et al. 2014). GTP has two experimentally 
annotated phosphosites (T814, S815) in between the C-terminal coiled coil domains and the 
GTP binding domains at the N-terminus (Figure 6.5b). These data supports the hypothesis 
that GTP and VLN3 are targets of MPKs after flg22 treatment. 
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6.2.6 VLN3-GFPis not more phosphorylated on serine residues after flg22 treatment 
To investigate whether VLN3 is differentially phosphorylated after flg22 treatment, I 
performed IP of VLN3-GFP in a time course after flg22 treatment and subjected to 
immunoblot (Figure 6.6). I was able to consistently detect VLN3-GFP after IP of GFP in 
unelicited and flg22 treated samples and there is no abundance change of the protein. I 
could detect a signal at the size of VLN3-GFP with the αpS antibody, raised against 
phosphorylated serine residues. However, there did not appear to be a consistent change in 
total phosphorylation on all serine residues in VLN3-GFP following flg22 treatment. 
Interestingly there was a double band present in both blots in IP of VLN3-GFP reminiscent of 
a phosphorylated protein. These data suggest VLN3-GFP is phosphorylated on serine 
Figure 6.5.Protein structure of MPK phosphorylation 
candidates.a.VLN3: Gellosin like domains (PF00597): 28-111; 153-
206;270-237; 412-484; 533-601. Villin headpiece (PF02209): 930-965. 
Annotated phosphosites on S778, S812, S814, S880 Reiland et al. (2009) 
and Rayapuram et al. (2014).Blue coloured phosphosites indicate flg22 
inducibility. b. GTP: Guanylate Binding Protein (PF02263): 51-310. 
Guanylate Binding Protein (PF02841): 314-618. Coiled Coil domains: 632-
653, 826-864, 868-889.Anotated phosophosites on T814, S815 
Hoehnwarter et al. (2013). 
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residues both before and after flg22 treatment and total serine phosphorylation on the 
protein did not change following flg22 treatment. 
6.3 Discussion 
I demonstrated that VLN2, VLN3 are involved and GTP is implicated in the plant’s response 
to bacterial attack, downstream of FLS2 and the ROS burst. My data and published literature 
also provides circumstantial evidence that VLN3 and GTP are targets of endosomal MPKs 
following flg22 treatment.  
6.3.1 Several putative targets of endosomal MPK are present in RFP-RABF2b/ARA7 
Using a combination of knowledge derived from the literature and my proteomic data, I was 
able to identify 16 candidate targets for endosomal MPKs. Screening for mutants in the 
genes coding for these candidates allowed me to eliminate 13 targets to leave three 
potential endosomal MPK targets (VLN2, VLN3 and GTP). These proteins have been 
identified as potential targets of MPK3/6 (Hoehenwarter et al. 2013). When the constitutively 
active variant of MEKK2 (MEKK2DD) is expressed in A. thaliana seedlings phosphopeptides 
from these proteins are more abundant. Whilst this approach is very powerful, it does not 
conclusively demonstrate that VLN3 and GTP are direct targets of MPK3/6 as there may be 
Figure 6.6. Total VLN3-GFP Serine phosphorylation following flg22 
treatment is not altered. VLN3-GFP was subjected to IP after 
flg22treatment, separated with SDS-PAGE and subjected to immunoblot 
with αGFP and αpS as indicated. Representative blot of two replicates. 
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off target effects, and expression of MKK2DD may cause indirect activation of other kinases. 
The most likely explanation, however, is that VLN3 and GTP are targets of MPK3 and 6.   
 
It would also be interesting to compare this proteomic dataset to other proteomic or 
transcriptomic datasets. Identifying endomembrane regulators that are phosphorylated after 
defence signal activation (flg22 – Benschop et al. 2007 or Nuhse et al. 2007, RIN4 activation 
– Elmore et al. 2012) would help characterise the mechanisms by which endomembranes 
are modified during immune responses. Furthermore transcriptome studies could also be 
used to indicate endomembrane trafficking over the longer term and these comparisons 
extended to BR mediated responses.   
6.3.2 GTP regulates plant defence 
GTP is implicated in defence. Both alleles of the gtp mutants were more resistant to Pto 
DC3000 than Col-0, and gtp-1 was more resistant than gtp-2. Due to the data discussed in 
Section 6.2.3 I assumed that gtp-1 represents a strong allele and gtp-2 represents a weak 
allele, probably due to transcript abundance. There is only phenotypic developmental data to 
support this assumed relationship between the alleles and RT-PCR is essential to validate 
this assumption.  
 
The function of GTP in plants is unclear but its orthologs have been characterised in other 
systems. GTP is a homolog of the mammalian Guanlyate binding protein (GBP) family of 
proteins. These proteins are endomembrane regulators of the dynamin GTPase family, 
however have been poorly biochemically characterised (Britzen-Laurent et al. 2010, Vestal 
and Jeyaratnam 2011). GBPs are transcriptionally up-regulated by defence signalling 
through interferon γ and p53 signalling (Kim et al. 2011, Yamamoto et al. 2012, Zhu et al. 
2013). Interestingly, human GBPs help protect against intracellular pathogens by recruiting 
NADPH oxidases, antimicrobial peptides and autophagic machinery to the pathogen infected 
intracellular compartments (Dupont and Hunter 2012, Yamamoto et al. 2012). A. thaliana 
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GTP proteins may fulfil a similar role during biotic interactions. This explanation of their 
function would, however, conflict with the observed enhanced resistance to bacteria in the 
gtpmutants as a null mutant would be expected to be more susceptible to bacterial infection. 
The essential next step, however, is to confirm expression levels of gtp in these mutants. 
 
There are two most likely explanations for the enhanced resistance phenotype observed in 
the gtpmutants. The first is that GTP is a negative regulator of immune signalling and has a 
role unlike that of mammalian GBP. GTP may be involved in defence and also be crucial for 
plant development and so alteration in protein levels results in smaller plants with a reduced 
inducible immune response. Alternatively GTP protein levels may be monitored by an R 
gene, and interference with the production of the protein results in constitutive defence 
activation causing a reduced growth phenotype. Arguing against the second hypothesis is 
that the gtp mutants are indistinguishable from Col-0 in terms of PAMP induced ROS burst. 
Constitutive activation of defence through R protein signalling can result in high SA levels in 
a plant. SA signalling promotes increased accumulation of FLS2 and RBOHD, so mutants 
with constitutive SA signalling might be expected to display an enhanced ROS burst upon 
flg22 treatment, as seen in acd6 mutants over-accumulating SA (Tateda et al. 2014). All of 
these data are, however, circumstantial and both possibilities need to be tested. Regardless 
of mode of action GTP is clearly an important player in plant immunity. 
6.3.3 VLN3 may regulate the cytoskeleton in response to flg22 
VLN3 is another candidate target of endosomal MPK3 and 6. As with GTP the evidence that 
it is directly phosphorylated by MPK3 and 6 is circumstantial. VLN3 phosphopeptides are 
more abundant when MEK2DD is over expressed (Hoehenwarter et al. 2013) and a VLN3 
peptide that is phosphorylated on S812 and S814 is more abundant, relative to un-
phosphorylated peptide, after flg22 treatment (Rayapuram et al. 2014). The data presented 
in Figure 6.6 (Section 6.2.6) suggests that serine phosphorylation averaged over all VLN3 
before and after flg22 treatment is equal. Therefore there must be compensatory de-
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phosphorylation of other serine residues (not S812 and S814) after flg22 treatment to 
maintain the same overall level of serine phosphorylation. The effects of positional 
phosphorylation on the activity of VLN3 therefore need to be determined. Alternatively, it 
may be that this experiment technically failed and other antibodies detecting different 
phosphosites need to be used for testing. 
 
The data presented in Section 6.2.4 demonstrate that mutant vln2, vln3 and the double 
vln2,3 mutants are more susceptible to spray inoculated Pto DC3000 and that perception of 
flg22 is not impaired. The function of VLN3 in plants has been fairly well characterised. 
VLN3-GFP localises to actin filaments in leaf and root epidermal cells (van der Honing et al. 
2012). However, VLN3’s localisation to RABF2b/ARA7 or RABF1/ARA6 positive structures 
has not been tested. However LE/MVBs move along actin filaments, reviewed Anitei et 
al.(2012), providing ample opportunity for interaction between VLN3 and endosome localised 
MPKs.  
 
I propose a model of differential VLN3 activity regulated by Ca2+ and phosphorylation status 
following flg22 treatment (Figure 6.7), I will now elaborate on the data behind this model: 
Human VLN regulates actin in a variety of ways including bundling, capping, severing and 
disassembling bundles or fibres (Kumar and Khurana 2004, Kumar et al. 2004, Kumar et al. 
2004). The activity of VLN is dependent on Ca2+ concentration and phosphostatus (Kumar 
and Khurana 2004, Kumar et al. 2004), although phosphorylation is the primary determinant 
of VLN severing activity (Kumar and Khurana 2004). There are five Villins in A. thaliana, 
VLN1-5, and they display functional differentiation (Klahre et al. 2000). VLN1 is insensitive to 
Ca2+ and does not appear to have any severing or capping ability but only protects actin 
from depolymerisation by Actin Depolymerising Factor 1 (ADF1) (Huang et al. 2005). 
Conversely VLN3 activity is sensitive to cellular Ca2+ levels and can bundle and sever actin 
filaments. VLN3 bundles actin into filaments at levels of Ca2+ below 1 µM into thicker actin 
cables, but over 1 µM it starts severing actin cables and filaments (Khurana et al. 2010). 
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This makes the activity of VLN3 more like that of human VLN. It may be that the rise in 
intracellular Ca2+ following PAMP perception functions together with endosomal MPK 
phosphorylation to alter VLN3 activity and trigger actin severing. Whilst VLN3 has been 
shown to sever actin structures at concentrations of intracellular Ca2+ of 1 µM (Khurana et al. 
2010), intracellular levels of Ca2+ following PAMP treatment does not usually reach such 
high concentrations (Ranf et al. 2011). Therefore the relative contributions of 
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phosphorylation and Ca2+ to VLN3 severing activity need to be determined. Currently data 
on the effects of phosphorylation on any A. thaliana VLN is lacking.  
 
The functional observations of the activity of VLN3 accords well with the phenotypic data that 
vln2,3 mutants are less bundled, have no actin cables and more small filaments. 
Furthermore upon flg22 treatment the actin cytoskeleton undergoes disassembly in the first 
Figure 6.7.Model of VLN3 action following fl22 treatment.a. Before flg22 treatment 
VLN3 localises to actin filaments and bundles them into actin cables. VLN3 is 
phosphorylated on S778 and S880. MPKs localised to LE/MVBs, which are trafficked 
along actin via myosins. b. Upon flg22 treatment an LE/MVB localised MPK cascade is 
activated and phosphorylates VLN3 on S812 and S814. Phosphorylation and 
Ca2+binding to VLN3 triggers its severing activity to break actin structures. c. After 3 
hours of flg22 treatment VLN3 is dephosphorylated on S812 and S814 and Ca2+ is 
removed and VLN3 now promotes actin bundling and formation of actin cables. d. In 
the absence of VLN2 and VLN3 actin is not bundled into cables. 
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three hours following flg22 treatment (Henty-Ridilla et al. 2013), phenocopying a vln2,3 
mutant. Then over the next 24 hours the cytoskeleton re-arranges and re-bundles with new 
polarity (Henty-Ridilla et al. 2013). These two pieces of evidence implicate VLN2 and VLN3 
in remodelling of the actin cytoskeleton following flg22 treatment. The timing of the 
rearrangement also implicates a mechanism in addition to Ca2+ to trigger the severing 
function of VLN2 and VLN3. The intracellular Ca2+ burst following flg22 treatment is transient 
and intracellular levels usually return to normal within 20-30 min (Ranf et al. 2011). 
Therefore an additional mechanism is needed to maintain VLN2 and VLN3 severing activity, 
and this is likely to be via phosphorylation from endosomal MPKs.  
 
The model (Figure 6.6) for the functioning of VLN2 and VLN3 in the cells response to 
bacteria assumes that VLN2 and VLN3 are more phosphorylated on some residues after 
flg22 treatment. The relevance of this actin re-orientation following flg22 is still unclear. It is 
most likely to allow the focal re-localisation of the actin cytoskeleton for polar secretion and 
the observed re-localisation of organelles following pathogen challenge. 
6.3.4 Conclusions and outlook 
The data presented here implicates VLN3 and GTP in the defence responses of A. thaliana 
against spray inoculated Pto DC3000 and that they are phosphorylated after flg22 treatment. 
That these two proteins are targets of endosomal MPKs, of course, needs to be confirmed. 
This data also supports the hypothesis that signalling during flg22 induced responses is 
transduced from endosomes, but is not conclusive.  
These data are promising but the crucial next steps for the gtpmutants are to test the 
expression levels of the transcript in these mutants. Secondly both VLN3 and GTP have 
been cloned and need to be co-localised to confirm their endosomal localisation. The next 
step is to confirm the phosphorylation status of these protiens after flg22 treatment and 
determine whether MPKs are responsible for this phosphorylation. These data combined 
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would provide strong evidence for phosphorylation of these proteins from endosome 
localised signalling components. 
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7 Discussion and Outlook 
7.1 Objectives and achievements 
The aims of this thesis were: 
5. Establish the proteomes of LE/MVBs. 
6. Determine LE/MVB proteome changes relevant to FLS2-induced signalling. 
7. Investigate endosome localised proteins involved in immune signalling. 
8. Examine the relevance of endosome-localised pools of signalling proteins to the 
overall cellular response to flg22. 
 
I have broadly achieved these aims. Whilst I have not yet obtained conclusive results 
supporting the latest aim, I have been able to develop a method for enrichment of various 
endomembrane compartments that is useful to the wider cell biology community and clarifies 
the involvement of proteins localising to endosomes in the establishment of plant immunity.  
 
The principal contributions presented in this thesis are: 
 Development of a method for endomembrane enrichment that is faster and more 
applicable to different endomembrane compartments than other published methods 
(Chapter 3). 
 Further elucidated the close interaction of RFP-RABF2b/ARA7-labelled LE/MVBs to 
the TGN compared to RABF1/ARA6-RFP-labelled LE/MVBs (Chapter 4). 
 Made a potential link between LE/MVBs and secretion of defence-related flavonols 
(Chapter 5). 
 Revealed that endosomes are locations of defence-activated signalling components 
(Chapter 5) 
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 Evidence for endosomal signalling based on roles of the MPK targets VLN3 
(cytoskeleton) and GTP (antimicrobial secretion) in anti-bacterial immunity (Chapter 
6). 
 
These data have developed our understanding of plant cells and have a variety of 
implications for disease and cell biology. 
7.2 Discussion 
7.2.1 Immuno-precipitation advances endomembrane proteomics 
Excellent developments have been made in elucidating the proteomes of endomembrane 
compartments, such as the Golgi and the vacuole, with techniques based on separation 
through differing biophysical properties, reviewed Parsons et al. (2013). We are now 
beginning to appreciate the functional differentiation between biophysically similar 
compartments such as the various populations of the TGN or LE/MVBs. Recent reviews end 
with pleas for more proteomic data to elucidate the differences in endomembrane 
compartments (Drakakaki and Dandekar 2013, Parsons et al. 2013, Bar and Avni 2014). 
Therefore, the IP technique presented in Chapters 3 and 4 is a very useful tool for the 
community. 
 
The data presented in Chapters 3 and 4 demonstrates that affinity purification can be applied 
to biophysically similar endomembrane compartments to assess their functional differences. 
The method presented requires limited prior knowledge of compartment properties and relies 
primarily on a single IP step. This can be contrasted with the similar approach of Drakakaki 
at al. (2012) where enrichment of the TGN was required before IP, making my method 
significantly faster and easier as well as more applicable to other endomembrane 
compartments. This method is not entirely unique, IP has been used to purify SNARE 
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complexes and their interactors (Fujiwara et al. 2014). However, this is the first study to 
focus on LE/MVBs and the RAB GTPases that regulate them. 
 
The principle advantages of this IP method is the ability to discriminate between 
biophysically similar populations of endomembrane compartments and the comparative ease 
and applicability of IP methods. Only suitable marker proteins, such as those used for 
microscopic analysis, are required. Furthermore IP provides an attractive complement to co-
localisation studies with CLSM, and allows inferences about activation status that is 
unattainable with microscopy alone (Section 5.2.5). IP-based techniques are not without 
limitations since definition of the purified material can only be as good as the definition of the 
marker protein, which may not be entirely straightforward. I was only able to use the markers 
as they had already been partially characterised with CLSM, Electron microscopy (EM) and 
centrifugation based proteomic studies (Ueda et al. 2004, Konopka et al. 2008, Geldner et 
al. 2009). Thus for preliminary characterisation of new systems or organelles, it is necessary 
to identify and characterize putative marker proteins before the IP-based method can be 
used.  
 
It is important to emphasise that a diversity of techniques are utilised to characterise the 
proteome of a compartment. As demonstrated, in Section 4.2.3 and a recent review 
(Parsons et al. 2013), diverse techniques provide a more thorough examination of an 
organelle than with one technique alone. However, due to the ease and applicability of 
affinity purification this is a very useful method until new techniques that can combine the 
unbiased nature of shotgun proteomics and the spatial resolution of microscopy, such as MS 
imaging (Malmstrom et al. 2009), become more widely available. 
7.2.2 Proteomic dissection is essential to understand the TGN 
The TGN is a complex organelle with very diverse functions. Our understanding of this 
organelle is primarily based on microscopy studies. As discussed in Sections 4.1.3/7.2.1 
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these techniques are limited as only a few proteins can be assessed in one experiment. To 
properly determine relative abundances of TGN proteins in each subdomain of the TGN, 
thorough quantitative proteomic analysis is needed. The high degree of overlap between the 
RFP-RABF2b/ARA7 proteome and that of the VHA-A1 proteome (Section 4.2.4) in 
combination with that of Groen et al.(2013) and Drakakaki et al.(2012), further implicate a 
VHA-A1 labelled TGN sub-population or domain in the formation of RFP-RABF2b/ARA7 
labelled LE/MVBs. As the RABF1/ARA6-RFP proteome is lacking in TGN markers, 
RABF1/ARA6-RFP labelled LE/MVBs are unlikely to form from the TGN as ARA7/RABF2b 
labelled LE/MVBs do. This accords well with observations that RABF1/ARA6-RFP is later on 
the endocytic route than RFP-RABF2b/ARA7 (Ueda et al. 2004) and that RABF1/ARA6-RFP 
labelled LE/MVBs may form directly from the PM (Ebine et al. 2011, Ebine et al. 2012). 
These data, therefore, also contribute to the growing body of evidence of mechanisms 
underpinning the functional differentiation between LE/MVBs. 
 
Further studies, utilising this IP method specifically focussing on quantifying proteins 
associating with several different TGN markers such as SYP61/VHA-
A1/SYP43/RABA1b/RABA2a/VAMP721, are necessary to better characterise the 
compartmentalisation within the TGN. These data would allow us to better understand the 
role of different domains within the TGN and test the model presented in Figure 4.10. 
7.2.3 LE/MVBs provide a vehicle through which defence compounds could be 
secreted 
The data from Section 5.2.3 demonstrates that RHM1 is involved in resistance to bacteria 
potentially through flavonol biosynthesis at LE/MVBs. This observation suggests another 
defence compound as well as other phenolics and H2O2 accumulate in LE/MVBs (Snyder et 
al. 1991, Collins et al. 2003, An et al. 2006) and the redirection of LE/MVBs to haustoria 
suggests that these compartments are the route of their secretion (Lu et al. 2012, Bozkurt et 
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al. 2014). The combination of these published examples and my data, demonstrates another 
role for LE/MVBs in pathogen defence.  
 
Furthermore, GTP may also play a role in pathogen defence by recruiting antimicrobial 
transporters to sites of pathogen detection, based on homology to mammalian proteins (Kim 
et al. 2011, Dupont and Hunter 2012, Yamamoto et al. 2012). It is tempting to speculate that 
GTP regulates recruitment of transporters to load antimicrobials into LE/MVBs or the 
extrahaustorial matrix after haustorium formation. It would be useful to determine whether 
GTP can recruit ABC transporters, such as PEN3 (Stein et al. 2006), to LE/MVBs as this is 
the next logical step to test this speculation. 
 
GTP may be guarded by an R protein to explain the stunted growth phenotype. Whilst this 
needs to be tested, Pto DC3000 may produce an effector that targets GTP to inhibit LE/MVB 
mediated resistance. Overactivation of defence has been described in knock outs of positive 
PTI regulators such as BAK1 (He et al. 2007, Kemmerling et al. 2007), BIK1 (Zhang et al. 
2010) and PMR4 (Nishimura et al. 2003). GTP could be guarded by an R gene in a similar 
manner to MPK4 (Petersen et al. 2000), and when knocked out, defence signalling is 
constitutively triggered. 
7.2.4 VLN3 could provide the mechanism by which the cytoskeleton is remodelled 
following pathogen attack 
Whilst it is well established that the cytoskeleton and endomembrane trafficking is altered 
during defence, the mechanisms by which these are implemented are unknown. Myosins, 
regulate FLS2 endosome movement and mediate pathogen resistance to fungal pathogens 
(Yang et al. 2014). Furthermore upon pathogen challenge or PAMP treatment the actin 
cytoskeleton re-models (Henty-Ridilla et al. 2013), presumably to regulate the altered 
endomembrane trafficking. Yet, the mechanism by which actin is regulated upon pathogen 
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challenge is unknown. Thus, VLN3 is likely to be the link between FLS2 signalling and 
cytoskeletal remodelling, probably through MPK phosphorylation.   
7.2.5 Endosomes function as sites of active signal transduction 
The identification of LE/MVB localised MPKs that are activated following flg22 treatment 
(Section 5.2.5/5.2.6), supports the hypothesis that LE/MVBs act as signalling platforms 
following flg22 treatment. If these MPKs were signalling then they would have to be localised 
to the cytosolic face of the LE/MVBs, unlike FLS2 which localises to the intraluminal vesicles 
(Spallek et al. 2013). The alternative explanation for this localisation of active MPKs is that 
these MPKs are endocytosed with FLS2 to be degraded. This explanation is less likely, 
however, as MKK2 and MKK5 were identified in LE/MVB IPs before elicitation and additional 
literature suggests MPKs localise to endosomes constitutively (Müller et al. 2010, Gu and 
Innes 2011). Furthermore, potential MPK targets were also identified in the combined 
LE/MVB proteome. The next step with this work is to test whether these endosome localised 
potential MPK targets are phosphorylated by MPKs. It must be confirmed whether VLN3 and 
GTP are genuine targets of endosomal MPKs. Finally the requirement of the endosome-
localised MPK pool in signalling following bacterial attack needs to be assessed.  
 
The identification of a target of flg22-induced MPKs localising to LE/MVBs is not totally 
novel. Lyst-interacting protein5 (LIP5) is targeted by MPK3 and 6 and localises to RFP-
RABF2b/ARA7 labelled LE/MVBs (Wang et al. 2014). However, this thesis provides the first 
evidence of active MPKs localising to LE/MVBs, and it is most likely that endosomal MPKs 
will phosphorylate their endosome-associated targets. All of these data together argue that 
endosomes function as sites of signal transduction during bacterial attack. As there are 
endosome localised MPKs and an protein phosphorylated by MPKs localising to LE/MVBs 
both before and after flg22 treatment, it is likely that endosomes probably function as sites of 
signal transduction during bacterial attack.  
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7.2.6 The plasma membrane is the predominant site of FLS2 signal activation 
The data presented in this thesis (Summarised in Section 7.2.4) argues that endosomes are 
important for localising signalling components in flg22 induced signalling. Certainly, 
activation of RBOHD and the triggering of the ROS burst occurs at the PM (Kadota et al. 
2014, Monaghan et al. 2014) and is exaggerated when FLS2 endocytosis is inhibited (Smith 
et al. 2014). Furthermore, recent studies have argued that endocytosis of the receptor is not 
required for the signalling of FLS2 (Smith et al. 2014) and for BES1 de-phosphorylation for 
BRI1 (Irani et al. 2012). It has also been concluded that signalling of both of these proteins 
primarily originates from the PM (Irani et al. 2012, Bar and Avni 2014, Smith et al. 2014) 
potentially conflicting with this thesis. Even data supporting endosomal signalling in plants is 
controversial and has either been contradicted (Geldner et al. 2007) or involves prolonged 
endomembrane trafficking inhibitor treatment, making it difficult to ascribe the observed 
effects to endocytosis of the receptor only (Sharfman et al. 2011).  
 
This subject is even more hotly debated in the animal field by assessing the relative 
importance of endosomal signalling in EGF perception and EGFR signalling. Numerous 
studies have demonstrated that interference with receptor endocytosis can either promote or 
reduce EGF induced MPK activation (Vieira et al. 1996, Miaczynska et al. 2004, Purvanov et 
al. 2010, Brankatschk et al. 2012, Sousa et al. 2012). Perhaps the most convincing study 
was performed by Brankatschk et al.(2012). In this study, extensive transcriptional profiling 
with a series of trafficking mutants after EGF treatment were used to demonstrate that most 
genes were regulated from the PM, and only a subset were altered only when the receptor 
was endocytosed properly (Brankatschk et al. 2012). Therefore the contribution of 
endosomal signalling to overall levels of MPK phosphorylation and gene activation appears 
to be minimal.  
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7.2.7 Endosomal contribution to signalling 
Conversely, endosomes have been shown to be signalling platforms for a variety of 
signalling cascades induced by receptor kinases including EGFR and now probably for 
FLS2. APPL is a transcription factor recruited to endosomes in the cell periphery following 
application of NGF and endocytosis of the activated receptor TrkA in human PC12 cells 
(Varsano et al. 2006). APPL1 then recruits a G-protein regulator and both are trafficked ~5 
µm to the perinuclear region of the cell to dissociate and promote TrkA signalling  (Lin et al. 
2006, Varsano et al. 2006) by nucleosome remodelling (Miaczynska et al. 2004). Similarly, 
after EGF treatment of HeLa cells, the endocytosed EGFR receptor is trafficked to the 
perinuclear region with APPL which can then alter transcription (Miaczynska et al. 2004). 
The use of endosomes to transport signalling components is also found in fungi. During 
Ustilago maydis infection of Zea mays, endosomes are used to transport Cdk1 related 
kinase (CRK1), an MPK, from the growing invasive hyphal tip to the nucleus (Bielska et al. 
2014), demonstrating that endosomes provide a platform for signal transduction. 
 
Endosome localisation is also important for some signalling proteins to reach full activation. 
The endosome localisation of the EGF-activated MEK-ERK MPKs is necessary for their full 
levels of phosphorylation (Teis et al. 2002, Nada et al. 2009). Moreover, full MPK activation 
can be delayed when endosomes are excluded from the perinuclear region of cells following 
EGF treatment (Taub et al. 2007). It is therefore clear that endosomes do have a function as 
sites of signal transduction. 
 
The two conflicting views can be reconciled by looking at the specific questions they 
address. Work by Vieira et al. (1996), Miaczynska et al. (2004), Taub et al. (2007), Purvanov 
et al. (2010), Brankatschk et al. (2012), Irani et al. (2012), Sousa et al.(2012), Smith et 
al.(2014) focuses on whether maximal responses can be activated when endocytosis of the 
receptor is inhibited. The best studies supporting endosomal signalling assesses whether 
endosome localisation of signalling components is important for the overall signal 
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transduction (Miaczynska et al. 2004, Lin et al. 2006, Varsano et al. 2006, Taub et al. 2007, 
Nada et al. 2009), therefore testing a slightly different hypothesis. It is therefore important to 
distinguish between whether the endocytosed receptor activates signalling components from 
endosomes and whether other (non-receptor) endosome localised proteins contribute to 
signalling.  
7.2.8 Outlook 
To further test the role of endosome localised MPKs it will ultimately be necessary to prevent 
MPK association with endosomes. The mechanism by which MPKs associate with 
membranes is currently unknown and so selective interference is impossible. Alternatively 
specific interference of FLS2 endocytosis is essential to determine whether endocytosed 
FLS2 can contribute to signalling. However, the published methods that alter FLS2 
endocytosis have numerous off target effects and so make conclusions based on these data 
very difficult to interpret. These two pieces of data are crucial to make general conclusions 
about endosomal signalling but they fall outside of the scope of this thesis.  
7.3 Endosomes as sites of signal transduction during bacterial 
attack 
From the data in this thesis, it cannot be concluded as to whether FLS2 is signalling directly 
from endosomes,and based on the work of Smith et al. (2014) and Spallek et al. (2013) this 
is unlikely. However, from my data we can conclude that endosomes act as sites for signal 
transduction from MPKs, but it is still unclear whether signalling proteins localised to 
endosomes provide a significant contribution to signalling. I suggest the model in Figure 7.1 
as the principal mechanisms by which endosomes could contribute to signalling.  
 
If endosomes act as signalling platforms for some MPKs following flg22 treatment the 
question arises of why. There are three reasons why signalling from the PM and endosomes 
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could provide an advantage as a route compared to a PM proteins signalling to cytosolic 
proteins alone. 
1. Endosomes can provide spatial information to a response 
2. Signal transduction through protein-protein interaction is more efficient on a 
membrane than in the cytosol 
3. Endosomes allow for the required speed of transport for necessary for the observed 
speed of signal transduction. 
These possibilities will be examined in turn. 
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Figure 7.1.Model of the relevance of signalling from endosomes.1. The FLS2 
receptor complex, localised to the PM, triggers signalling through phosphorylation of 
PM localised proteins such as BIK1 and MPKs. 2. The receptor is endocytosed 
following activation, ultimately into intraluminal vesicles. 3. MPKs localised to 
endosomes are activated through an unknown mechanism. 4. Endosome localised 
proteins such as VLN3, GTP and LIP5 are phosphorylated by endosome localised 
MPKs. 5. Endosomes provide the mechanism of transport by which endosomes are 
trafficked to the nucleus. Alternatively the MPKs may diffuse through the cytosol.  6. 
Phosphorylation of endosome localised VLN3 results in actin cytoskeleton 
remodelling. 
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7.3.1 Endosomes could provide spatial information and specificity to flg22 triggered 
signalling 
Positional information from the location of signalling proteins is likely to contribute to defence 
responses. The three candidate targets of endosomal MPK signalling following flg22 
treatment - VLN3, GTP and LIP5 (Wang et al. 2014) - require specific localisation within the 
cell to fulfil their function. To take VLN3 as an example, it needs to interact with the 
cytoskeleton to fulfil its function of regulating actin (Khurana et al. 2010, van der Honing et 
al. 2012). Therefore phosphorylation of VLN3 by MPKs localised to endosomes travelling 
along actin filaments is supported by the fact that the two components are localised together. 
It is also tempting to suggest that the direction of endosome movement provides the 
positional information required to re-orientate the actin cytoskeleton after PAMP perception. 
Endosomes travelling along the cytoskeleton would constitute an excellent vehicle to modify 
specific actin filaments and cables as only specific populations of VLN3 would be 
phosphorylated by MPKs. Furthermore, numerous other endomembrane regulators are 
phosphorylated after flg22 treatment, such as SYP121 and SYP122 (Benschop et al. 2007), 
potentially targets for other endomembrane localised signalling components. Interestingly 
SYP121 is involved in penetration resistance to Bgh (Assaad et al. 2004). This 
phosphorylation my assist PEN1 in mediating defence related secretion. Spatial localisation 
of signalling components, such as MPKs, could provide the specificity to ensure specific 
regulators are phosphorylated. 
7.3.2 Mechanistically signalling from endosomes is more efficient than signalling in 
the cytosol 
Recent reviews highlighted that signal transduction from membranes mechanistically is more 
efficient than from the cytosol (Antonny 2011, Schmick and Bastiaens 2014). When protein-
protein interactions are modelled in the cytosol and from membranes it is clear that 
interactions are favoured when both proteins localise to a membrane. Although protein 
diffusion is reduced in membranes, proteins are limited to two dimensions of movement so 
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making protein-protein interactions of proteins localised to membranes more likely (Antonny 
2011, Schmick and Bastiaens 2014). Exactly how applicable these modelling data are to 
FLS2 induced signalling from endosomes is unclear. Scaffold proteins can locally increase 
the concentrations of proteins to promote interactions and provide a benefit analogous to 
membrane localisation in terms of protein-protein interaction dynamics.  
 
Whilst the formation of protein complexes is beneficial in terms of promoting protein-protein 
interactions when all components are able to freely diffuse. It will ultimately reduce the 
motility of the complex within the cytoplasm as will now be explored. 
7.3.3 Endosomes can provide the long range transport for MPKs necessary for flg22 
induced signalling 
FLS2 signalling complexes localised only to the PM may be able to phosphorylate the same 
number of MPKs but not all MPKs are equally relevant to signalling. As was suggested in a 
recent review, a moving signalling platform on endosomes could activate defence responses 
in the cell faster than from the PM alone (Geldner and Robatzek 2008). Furthermore, as 
demonstrated in U. maydis infection of Z. mays, signalling needs to be combined with 
correct transport to elicit the appropriate response (Bielska et al. 2014). Therefore maximal 
activation of certain signalling proteins can be achieved from the PM by a receptor, but this 
does not mean that the same strength of signal is transmitted to where it is relevant.  
 
One of the principal assumptions of cellular biochemistry is that proteins freely diffuse within 
the cell. This assumption, though commonly used, rarely holds up to close scrutiny (Luby-
Phelps 2000). If this assumption is not valid, activation of a number of signalling components 
is insufficient for signalling, but correct intracellular transport is needed as well. The 
cytoplasm is a crowded environment packed with proteins, nucleic acids and membranes, as 
so artfully demonstrated in the drawings of Dr Goodsell (Goodsell 2009, Goodsell 2009, Voet 
and Voet 2009, Goodsell 2010). Estimates of the protein concentration of bacterial cytosol 
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are as much as 30% (Luby-Phelps 2000, Malmstrom et al. 2009). The rates of diffusion of 
proteins through the cytoplasm are substantially slower than through water. For example, 
GFP diffuses 10-20 times slower in the cytoplasm than in water and diffusion speed 
decreases exponentially with object size (Luby-Phelps 2000, Ellis 2001). Therefore proteins, 
such as MPKs, that signal in multi-protein complexes are likely to move very slowly, if at all 
in the cytoplasm. Movement of a large signalling complex such as a MPK-MPKK-MPKKK 
complex by 10 µm presents an almost insurmountable problem by free diffusion as the time 
required to move these distances would be in the range of 10 min (Luby-Phelps 2000, 
Bielska et al. 2014), probably even more in a plant leaf epidermal cell with the added 
complication of the large vacuole. Movement of signalling proteins from the cell periphery to 
their sites of function requires a method of driven transport to initiate the very early 
transcriptional changes in the observed time frames of <10 min of flg22 treatment (Navarro 
et al. 2004). Cytoplasmic streaming of proteins can generate movement of up to 60 μm/s in 
some plant and green algae species (Tominaga and Nakano 2012, Henn and Sadot 2014), 
5 μm a second, but this would require the protein to have some membrane or cytoskeletal 
association. Endosomes are, therefore, a likely candidate vehicle by which signals reach the 
nucleus or other organelles from the PM. These data also reinforce the hypothesis that 
localisation of signalling proteins is as important as number of signalling proteins activated.  
7.3.4 Signalling from the PM, cytosol and endosomes occurs during bacterial attack 
Clearly perception of flg22 and activation of immediate responses by FLS2 such as the ROS 
burst and MPK phosphorylation are activated from the PM and are important to determining 
signal transduction. In addition signalling proteins certainly localise to the cytosol. In order for 
signalling proteins to require the necessary distances and to efficiently transduce signals, a 
cytosolic localisation alone is unlikely. During bacterial attack, it is clear that endosomes are 
not the sole platform from which MPKs signal. They are the site for signal transduction to 
LIP5 at least and probably VLN3 and GTP. It is also likely that a mechanism of transport 
other than diffusion is required to allow MPKs to signal to the nucleus in the observed time 
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frames, endosomes may fulfil this role. For speed of movement, localisation and efficiency of 
signalling, endosomes are good candidates for signalling platforms in addition to the PM and 
cytosol. Thus endosomes probably are sites of signal transduction during bacterial attack. 
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